<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><?covid-19-tdm ?><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65774</article-id><article-id pub-id-type="doi">10.7554/eLife.65774</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-221939"><name><surname>Chen</surname><given-names>Paul Z</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5261-1610</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221940"><name><surname>Bobrovitz</surname><given-names>Niklas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7883-4484</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221941"><name><surname>Premji</surname><given-names>Zahra</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6899-0528</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76108"><name><surname>Koopmans</surname><given-names>Marion</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13699"><name><surname>Fisman</surname><given-names>David N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5009-6926</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-218726"><name><surname>Gu</surname><given-names>Frank X</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8749-9075</contrib-id><email>f.gu@utoronto.ca</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Chemical Engineering &amp; Applied Chemistry, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution>Temerty Faculty of Medicine, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff3"><label>3</label><institution>Department of Critical Care Medicine, Cumming School of Medicine, University of Calgary</institution><addr-line><named-content content-type="city">Calgary</named-content></addr-line><country>Canada</country></aff><aff id="aff4"><label>4</label><institution>O'Brien Institute of Public Health, University of Calgary</institution><addr-line><named-content content-type="city">Calgary</named-content></addr-line><country>Canada</country></aff><aff id="aff5"><label>5</label><institution>Libraries &amp; Cultural Resources, University of Calgary</institution><addr-line><named-content content-type="city">Calgary</named-content></addr-line><country>Canada</country></aff><aff id="aff6"><label>6</label><institution>Department of Viroscience, Erasmus University Medical Center</institution><addr-line><named-content content-type="city">Rotterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff7"><label>7</label><institution>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff8"><label>8</label><institution>Division of Infectious Diseases, Temerty Faculty of Medicine, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff9"><label>9</label><institution>Institute of Biomedical Engineering, University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>van der Meer</surname><given-names>Jos WM</given-names></name><role>Reviewing Editor</role><aff><institution>Radboud University Medical Centre</institution><country>Netherlands</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>van der Meer</surname><given-names>Jos WM</given-names></name><role>Senior Editor</role><aff><institution>Radboud University Medical Centre</institution><country>Netherlands</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>16</day><month>04</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65774</elocation-id><history><date date-type="received" iso-8601-date="2020-12-15"><day>15</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-04-15"><day>15</day><month>04</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Chen et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Chen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65774-v2.pdf"/><abstract><sec id="abs1"><title>Background:</title><p>Which virological factors mediate overdispersion in the transmissibility of emerging viruses remains a long-standing question in infectious disease epidemiology.</p></sec><sec id="abs2"><title>Methods:</title><p>Here, we use systematic review to develop a comprehensive dataset of respiratory viral loads (rVLs) of SARS-CoV-2, SARS-CoV-1 and influenza A(H1N1)pdm09. We then comparatively meta-analyze the data and model individual infectiousness by shedding viable virus via respiratory droplets and aerosols.</p></sec><sec id="abs3"><title>Results:</title><p>The analyses indicate heterogeneity in rVL as an intrinsic virological factor facilitating greater overdispersion for SARS-CoV-2 in the COVID-19 pandemic than A(H1N1)pdm09 in the 2009 influenza pandemic. For COVID-19, case heterogeneity remains broad throughout the infectious period, including for pediatric and asymptomatic infections. Hence, many COVID-19 cases inherently present minimal transmission risk, whereas highly infectious individuals shed tens to thousands of SARS-CoV-2 virions/min via droplets and aerosols while breathing, talking and singing. Coughing increases the contagiousness, especially in close contact, of symptomatic cases relative to asymptomatic ones. Infectiousness tends to be elevated between 1 and 5 days post-symptom onset.</p></sec><sec id="abs4"><title>Conclusions:</title><p>Intrinsic case variation in rVL facilitates overdispersion in the transmissibility of emerging respiratory viruses. Our findings present considerations for disease control in the COVID-19 pandemic as well as future outbreaks of novel viruses.</p></sec><sec id="abs5"><title>Funding:</title><p>Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant program, NSERC Senior Industrial Research Chair program and the Toronto COVID-19 Action Fund.</p></sec></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>To understand how viruses spread scientists look at two things. One is – on average – how many other people each infected person spreads the virus to. The other is how much variability there is in the number of people each person with the virus infects. Some viruses like the 2009 influenza H1N1, a new strain of influenza that caused a pandemic beginning in 2009, spread pretty uniformly, with many people with the virus infecting around two other people. Other viruses like SARS-CoV-2, the one that causes COVID-19, are more variable. About 10 to 20% of people with COVID-19 cause 80% of subsequent infections – which may lead to so-called superspreading events – while 60-75% of people with COVID-19 infect no one else.</p><p>Learning more about these differences can help public health officials create better ways to curb the spread of the virus. Chen et al. show that differences in the concentration of virus particles in the respiratory tract may help to explain why superspreaders play such a big role in transmitting SARS-CoV-2, but not the 2009 influenza H1N1 virus. Chen et al. reviewed and extracted data from studies that have collected how much virus is present in people infected with either SARS-CoV-2, a similar virus called SARS-CoV-1 that caused the SARS outbreak in 2003, or with 2009 influenza H1N1.</p><p>Chen et al. found that as the variability in the concentration of the virus in the airways increased, so did the variability in the number of people each person with the virus infects. Chen et al. further used mathematical models to estimate how many virus particles individuals with each infection would expel via droplets or aerosols, based on the differences in virus concentrations from their analyses. The models showed that most people with COVID-19 infect no one because they expel little – if any – infectious SARS-CoV-2 when they talk, breathe, sing or cough. Highly infectious individuals on the other hand have high concentrations of the virus in their airways, particularly the first few days after developing symptoms, and can expel tens to thousands of infectious virus particles per minute. By contrast, a greater proportion of people with 2009 influenza H1N1 were potentially infectious but tended to expel relatively little infectious virus when the talk, sing, breathe or cough.</p><p>These results help explain why superspreaders play such a key role in the ongoing pandemic. This information suggests that to stop this virus from spreading it is important to limit crowd sizes, shorten the duration of visits or gatherings, maintain social distancing, talk in low volumes around others, wear masks, and hold gatherings in well-ventilated settings. In addition, contact tracing can prioritize the contacts of people with high concentrations of virus in their airways.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>COVID-19</kwd><kwd>emerging pathogens</kwd><kwd>influenza</kwd><kwd>overdispersion</kwd><kwd>superspreading</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id><institution>Natural Sciences and Engineering Research Council of Canada</institution></institution-wrap></funding-source><award-id>Vanier Scholarship 608544</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Paul Z</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>Canadian COVID-19 Rapid Research Fund OV4-170360</award-id><principal-award-recipient><name><surname>Fisman</surname><given-names>David N</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id><institution>Natural Sciences and Engineering Research Council of Canada</institution></institution-wrap></funding-source><award-id>Senior Industrial Research Chair</award-id><principal-award-recipient><name><surname>Gu</surname><given-names>Frank X</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Toronto COVID-19 Action Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gu</surname><given-names>Frank X</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Broader case variation in respiratory viral load, and in shedding virus via droplets and aerosols, for SARS-CoV-2 than influenza A(H1N1)pdm09 facilitates greater transmission heterogeneity in the COVID-19 pandemic than the 2009 flu pandemic.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, causing the coronavirus disease 2019 (COVID-19) pandemic with more than 129.2 million infections and 2.8 million deaths (as of 1 April 2021) (<xref ref-type="bibr" rid="bib22">Dong et al., 2020</xref>). For respiratory virus transmission, airway epithelial cells shed virions to the extracellular fluid before atomization (from breathing, talking, singing, coughing and aerosol-generating procedures) partitions them into a polydisperse mixture of particles that are expelled to the ambient environment. Aerosols (≤100 μm) can be inhaled nasally, whereas droplets (&gt;100 μm) tend to be excluded (<xref ref-type="bibr" rid="bib95">Prather et al., 2020</xref>; <xref ref-type="bibr" rid="bib100">Roy and Milton, 2004</xref>). For direct transmission, droplets must be sprayed ballistically onto susceptible tissue (<xref ref-type="bibr" rid="bib68">Liu et al., 2017a</xref>). Hence, droplets predominantly deposit on nearby surfaces, potentiating indirect transmission. Aerosols can be further categorized based on typical travel characteristics: short-range aerosols (50–100 μm) tend to settle within 2 m; long-range ones (10–50 μm) often travel beyond 2 m based on emission force; and buoyant aerosols (≤10 μm) remain suspended and travel based on airflow profiles for minutes to many hours (<xref ref-type="bibr" rid="bib68">Liu et al., 2017a</xref>; <xref ref-type="bibr" rid="bib117">Wei and Li, 2015</xref>). Although proximity has been associated with infection risk for COVID-19 (<xref ref-type="bibr" rid="bib19">Chu et al., 2020</xref>), studies have also suggested that long-range airborne transmission occurs conditionally (<xref ref-type="bibr" rid="bib31">Hamner et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Lu et al., 2020a</xref>; <xref ref-type="bibr" rid="bib88">Park et al., 2020</xref>).</p><p>While the basic reproductive number has been estimated to be 2.0–3.6 (<xref ref-type="bibr" rid="bib35">Hao et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Li et al., 2020a</xref>), transmissibility of SARS-CoV-2 is highly overdispersed (dispersion parameter <italic>k</italic>, 0.10–0.58), with numerous instances of superspreading (<xref ref-type="bibr" rid="bib31">Hamner et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Lu et al., 2020a</xref>; <xref ref-type="bibr" rid="bib88">Park et al., 2020</xref>) and few cases (10–20%) causing many secondary infections (80%) (<xref ref-type="bibr" rid="bib7">Bi et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Endo et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Laxminarayan et al., 2020</xref>). Similarly, few cases drive the transmission of SARS-CoV-1 (<italic>k</italic>, 0.16–0.17) (<xref ref-type="bibr" rid="bib70">Lloyd-Smith et al., 2005</xref>), whereas influenza A(H1N1)pdm09 transmits more homogeneously (<italic>k</italic>, 7.4–14.4) (<xref ref-type="bibr" rid="bib9">Brugger and Althaus, 2020</xref>; <xref ref-type="bibr" rid="bib98">Roberts and Nishiura, 2011</xref>), despite both viruses spreading by contact, droplets and aerosols (<xref ref-type="bibr" rid="bib21">Cowling et al., 2013</xref>; <xref ref-type="bibr" rid="bib125">Yu et al., 2004</xref>). Although understanding the determinants of viral overdispersion is crucial towards characterizing transmissibility and developing effective strategies to limit infection (<xref ref-type="bibr" rid="bib61">Lee et al., 2020</xref>), mechanistic associations for <italic>k</italic> remain unclear. As an empirical estimate, <italic>k</italic> depends on myriad extrinsic (behavioral, environmental and invention) and host factors. Nonetheless, <italic>k</italic> remains similar across distinct outbreaks for a virus (<xref ref-type="bibr" rid="bib70">Lloyd-Smith et al., 2005</xref>), suggesting that intrinsic virological factors mediate virus overdispersion.</p><p>Here, we investigated how intrinsic case variation in respiratory viral loads (rVLs) facilitates overdispersion in SARS-CoV-2 transmissibility. By systematic review, we developed a comprehensive dataset of rVLs from cases of COVID-19, SARS and A(H1N1)pdm09. Using comparative meta-analyses, we found that heterogeneity in rVL was associated with overdispersion among these emerging infections. To assess potential sources of case heterogeneity, we analyzed SARS-CoV-2 rVLs across age and symptomatology subgroups as well as disease course. To interpret the influence of heterogeneity in rVL on individual infectiousness, we modeled likelihoods of shedding viable virus via respiratory droplets and aerosols.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Systematic review</title><p>We conducted a systematic review on virus quantitation in respiratory specimens taken during the infectious periods of SARS-CoV-2 (−3 to 10 days from symptom onset [DFSO]) (<xref ref-type="bibr" rid="bib3">Arons et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">He et al., 2020</xref>; <xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref>), SARS-CoV-1 (0–20 DFSO) (<xref ref-type="bibr" rid="bib92">Pitzer et al., 2007</xref>) and A(H1N1)pdm09 (−2 to 9 DFSO) (<xref ref-type="bibr" rid="bib44">Ip et al., 2017</xref>) (Materials and methods). The systematic search (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>, <xref ref-type="supplementary-material" rid="fig1sdata3">Figure 1—source data 3</xref>, <xref ref-type="supplementary-material" rid="fig1sdata4">Figure 1—source data 4</xref>, <xref ref-type="supplementary-material" rid="fig1sdata5">Figure 1—source data 5</xref>) identified 4274 results. After screening and full-text review, 64 studies met the inclusion criteria and contributed to the systematic dataset (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<italic>N</italic> = 9631 total specimens), which included adult (<italic>N</italic> = 5033) and pediatric (<italic>N</italic> = 1608) cases from 15 countries and specimen measurements for asymptomatic (<italic>N</italic> = 2387), presymptomatic (<italic>N</italic> = 28) and symptomatic (<italic>N</italic> = 7161) infections. According to a hybrid Joanna Briggs Institute critical appraisal checklist, risk of bias was low for most contributing studies (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Development of the systematic dataset.</title><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Search strategy used for MEDLINE.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig1-data1-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Search strategy used for EMBASE.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig1-data2-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Search strategy used for Cochrane Central.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig1-data3-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>Search strategy used for Web of Science Core Collection.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig1-data4-v2.docx"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Search strategy used for medRxiv and bioRxiv.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig1-data5-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title>Association of overdispersion with heterogeneity in rVL</title><p>We hypothesized that individual case variation in rVL facilitates the distinctions in <italic>k</italic> among COVID-19, SARS and A(H1N1)pdm09. For each study in the systematic dataset, we used specimen measurements (viral RNA concentration in a respiratory specimen) to estimate rVLs (viral RNA concentration in the respiratory tract) (Materials and methods). To investigate the relationship between <italic>k</italic> and heterogeneity in rVL, we performed a meta-regression using each contributing study (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), which showed a weak, negative association between the two variables (meta-regression slope <italic>t</italic>-test: p=0.038, Pearson’s <italic>r</italic> = −0.26).</p><p>Using contributing studies with low risk of bias, meta-regression (<xref ref-type="fig" rid="fig2">Figure 2</xref>) showed a strong, negative association between <italic>k</italic> and heterogeneity in rVL for these three viruses (meta-regression slope <italic>t</italic>-test: p&lt;0.001, Pearson’s <italic>r</italic> = −0.73). In this case, each unit increase (one log<sub>10</sub> copies/ml) in the standard deviation (SD) of rVL decreased log(<italic>k</italic>) by a factor of −1.41 (95% confidence interval [CI]: −1.78 to −1.03), suggesting that broader heterogeneity in rVL facilitates greater overdispersion in the transmissibility of SARS-CoV-2 than of A(H1N1)pmd09. To investigate mechanistic aspects of this association, we conducted a series of analyses on rVL and then modeled the influence of heterogeneity in rVL on individual infectiousness.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Association of overdispersion in SARS-CoV-2, SARS-CoV-1 and A(H1N1)pdm09 transmissibility with heterogeneity in respiratory viral load (rVL).</title><p>Meta-regression of dispersion parameter (<italic>k</italic>) with the standard deviation (SD) of rVLs from contributing studies with low risk of bias (Pearson’s <italic>r</italic> = −0.73). Pooled estimates of <italic>k</italic> were determined from the literature for each infection. Blue, red and yellow circles denote A(H1N1)pdm09 (<italic>N</italic> = 22), COVID-19 (<italic>N</italic> = 24) and SARS (<italic>N</italic> = 7) studies, respectively. Circle sizes denote weighting in the meta-regression. The p-value was obtained using the meta-regression slope <italic>t</italic>-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Meta-regression between dispersion in SARS-CoV-2, SARS-CoV-1 and A(H1N1)pdm09 transmissibility and heterogeneity in respiratory viral load (rVL).</title><p>Meta-regression of dispersion parameter (<italic>k</italic>) with the standard deviation (SD) of rVLs from all contributing studies (Pearson’s <italic>r</italic> = −0.26). Pooled estimates of <italic>k</italic> were determined from the literature. Blue, red and yellow circles denote A(H1N1)pdm09 (<italic>N</italic> = 27), COVID-19 (<italic>N</italic> = 29) and SARS (<italic>N</italic> = 8) studies, respectively. Circle sizes denote weighting in the meta-regression. The p-value was obtained using the meta-regression slope <italic>t</italic>-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Meta-analysis of respiratory viral loads (rVLs) of SARS-CoV-2, SARS-CoV-1 and influenza A(H1N1)pdm09 during the estimated infectious period.</title><p>Random-effects meta-analyses comparing the expected rVLs for COVID-19, SARS and A(H1N1)pdm09 cases during the infectious period. Quantitative specimen measurements were used to estimate rVLs, which refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), not admitted (N), community (C), adult (A), pediatric (P), symptomatic (S), presymptomatic (Ps) and asymptomatic (As). Specimen types: endotracheal aspirate (ETA), nasopharyngeal aspirate (NPA), nasopharyngeal swab (NPS), oropharyngeal swab (OPS), posterior oropharyngeal saliva (POS) and sputum (Spu). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test and the <italic>I</italic><sup>2</sup> statistic. One-sided Welch’s <italic>t</italic>-tests compared the expected SARS-CoV-2 rVL with those of SARS-CoV-1 and A(H1N1)pdm09 (non-significance, p&gt;0.05).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig2-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Meta-analysis and subgroup analyses of rVL</title><p>We first compared rVLs among the emerging infections. We performed a random-effects meta-analysis (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), which approximated the expected rVL when encountering a COVID-19, SARS or A(H1N1)pdm09 case during the infectious period. This showed that the expected rVL of SARS-CoV-2 was comparable to that of SARS-CoV-1 (one-sided Welch’s <italic>t</italic>-test: p=0.111) but lesser than that of A(H1N1)pdm09 (p=0.040).</p><p>We also performed random-effects subgroup analyses for COVID-19 (<xref ref-type="fig" rid="fig3">Figure 3</xref>), which showed that expected SARS-CoV-2 rVLs were similar between pediatric and adult cases (p=0.476) and comparable between symptomatic/presymptomatic and asymptomatic infections (p=0.090). Since these meta-analyses had significant between-study heterogeneity among the mean estimates (Cochran’s <italic>Q</italic> test: p&lt;0.001 for each meta-analysis), we conducted risk-of-bias sensitivity analyses; meta-analyses of low-risk-of-bias studies continued to show significant heterogeneity (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1</xref>–<xref ref-type="fig" rid="fig3s5">5</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Subgroup analyses of SARS-CoV-2 respiratory viral load (rVL) during the infectious period.</title><p>Random-effects meta-analyses comparing the expected rVLs of adult (≥18 years old) COVID-19 cases with pediatric (&lt;18 years old) ones (top) and symptomatic/presymptomatic infections with asymptomatic ones (bottom) during the infectious period. Quantitative rVLs refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), not admitted (N), community (C), adult (A), pediatric (P), symptomatic (S), presymptomatic (Ps) and asymptomatic (As). Specimen types: endotracheal aspirate (ETA), nasopharyngeal aspirate (NPA), nasopharyngeal swab (NPS), oropharyngeal swab (OPS), posterior oropharyngeal saliva (POS) and sputum (Spu). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test and the <italic>I</italic><sup>2</sup> statistic. One-sided Welch’s <italic>t</italic>-tests compared expected rVLs between the COVID-19 subgroups (non-significance, p&gt;0.05).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Risk-of-bias sensitivity analysis of between-study heterogeneity for SARS-CoV-2 respiratory viral load (rVL) during the estimated infectious period.</title><p>Random-effects meta-analyses, based on the risk of bias of contributing studies, of the expected rVLs of COVID-19 cases during the infectious period. Quantitative rVLs refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), not admitted (N), community (C), adult (A), pediatric (P), symptomatic (S), presymptomatic (Ps) and asymptomatic (As). Specimen types: endotracheal aspirate (ETA), nasopharyngeal aspirate (NPA), nasopharyngeal swab (NPS), oropharyngeal swab (OPS), posterior oropharyngeal saliva (POS) and sputum (Spu). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. One-sided Welch’s <italic>t</italic>-test for difference (non-significance, p&gt;0.05). Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test (non-significance, p&gt;0.05) and the <italic>I</italic><sup>2</sup> statistic (<italic>I</italic><sup>2</sup> &lt; 30% indicates low between-study heterogeneity).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Risk-of-bias sensitivity analysis of between-study heterogeneity for SARS-CoV-1 respiratory viral load (rVL) during the estimated infectious period.</title><p>Random-effects meta-analyses, based on the risk of bias of contributing studies, of the expected rVLs of SARS cases during the infectious period. Quantitative rVLs refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), adult (A) and symptomatic (S). Specimen types: nasopharyngeal aspirate (NPA) and nasopharyngeal swab (NPS). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. One-sided Welch’s <italic>t</italic>-test for difference, non-significance (p&gt;0.05). Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test (non-significance, p&gt;0.05) and the <italic>I</italic><sup>2</sup> statistic (<italic>I</italic><sup>2</sup> &lt; 30% indicates low between-study heterogeneity).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Risk-of-bias sensitivity analysis of between-study heterogeneity for A(H1N1)pdm09 respiratory viral load (rVL) during the estimated infectious period.</title><p>Random-effects meta-analyses, based on the risk of bias of contributing studies, of the expected rVLs of A(H1N1)pdm09 cases during the infectious period. Quantitative rVLs refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), not admitted (N), community (C), adult (A), pediatric (P), symptomatic (S), presymptomatic (Ps) and asymptomatic (As). Specimen types: nasopharyngeal aspirate (NPA), nasopharyngeal swab (NPS) and oropharyngeal swab (OPS). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. One-sided Welch’s <italic>t</italic>-test for difference (non-significance, p&gt;0.05). Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test (non-significance, p&gt;0.05) and the <italic>I</italic><sup>2</sup> statistic (<italic>I</italic><sup>2</sup> &lt; 30% indicates low between-study heterogeneity).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Risk-of-bias sensitivity analysis of between-study heterogeneity for SARS-CoV-2 respiratory viral load (rVL) for adult COVID-19 cases during the estimated infectious period.</title><p>Random-effects meta-analyses, based on the risk of bias of contributing studies, of the expected rVLs of adult (≥18 years old) COVID-19 cases during the infectious period. Quantitative rVLs refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), not admitted (N), community (C), adult (A), pediatric (P), symptomatic (S), presymptomatic (Ps) and asymptomatic (As). Specimen types: endotracheal aspirate (ETA), nasopharyngeal aspirate (NPA), nasopharyngeal swab (NPS), oropharyngeal swab (OPS), posterior oropharyngeal saliva (POS) and sputum (Spu). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. One-sided Welch’s <italic>t</italic>-test for difference (non-significance, p&gt;0.05). Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test (non-significance, p&gt;0.05) and the <italic>I</italic><sup>2</sup> statistic (<italic>I</italic><sup>2</sup> &lt;30% indicates low between-study heterogeneity).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Risk-of-bias sensitivity analysis of between-study heterogeneity for SARS-CoV-2 respiratory viral load (rVL) for symptomatic/presymptomatic COVID-19 cases during the estimated infectious period.</title><p>Random-effects meta-analyses, based on the risk of bias of contributing studies, of the expected rVLs of symptomatic/presymptomatic (≥18 years old) COVID-19 cases during the infectious period. Quantitative rVLs refer to virus concentrations in the respiratory tract. Case types: hospitalized (H), not admitted (N), community (C), adult (A), pediatric (P), symptomatic (S), presymptomatic (Ps) and asymptomatic (As). Specimen types: endotracheal aspirate (ETA), nasopharyngeal swab (NPS), oropharyngeal swab (OPS), posterior oropharyngeal saliva (POS) and sputum (Spu). Dashes denote case numbers that were not obtained. Box sizes denote weighting in the overall estimates. One-sided Welch’s <italic>t</italic>-test for difference (non-significance, p&gt;0.05). Between-study heterogeneity was assessed using the p-value from Cochran’s <italic>Q</italic> test (non-significance, p&gt;0.05) and the <italic>I</italic><sup>2</sup> statistic the <italic>I</italic><sup>2</sup> statistic (<italic>I</italic><sup>2</sup> &lt; 30% indicates low between-study heterogeneity).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig3-figsupp5-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Distributions of rVL</title><p>We next analyzed rVL distributions. For all three viruses, rVLs best conformed to Weibull distributions (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), and we fitted the entirety of individual sample data for each virus in the systematic dataset (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1N</xref>). While COVID-19 and SARS cases tended to shed lesser virus than those with A(H1N1)pdm09 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), broad heterogeneity in SARS-CoV-2 and SARS-CoV-1 rVLs inverted this relationship for highly infectious individuals (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A-C</xref>). At the 90th case percentile (cp) throughout the infectious period, the estimated rVL was 8.91 (95% CI: 8.83–9.00) log<sub>10</sub> copies/ml for SARS-CoV-2, whereas it was 8.62 (8.47–8.76) log<sub>10</sub> copies/ml for A(H1N1)pdm09 (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). The SD of the overall rVL distribution for SARS-CoV-2 was 2.04 log<sub>10</sub> copies/ml, while it was 1.45 log<sub>10</sub> copies/ml for A(H1N1)pdm09, showing that heterogeneity in rVL was indeed broader for SARS-CoV-2.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Heterogeneity and kinetics of SARS-CoV-2 respiratory viral load (rVL).</title><p>(<bold>A</bold>) Estimated distribution of rVL for SARS-CoV-2 (<italic>N</italic> = 3834 samples from <italic>N</italic> = 26 studies) and A(H1N1)pdm09 (<italic>N</italic> = 512 samples from <italic>N</italic> = 10 studies) throughout the infectious periods. (<bold>B, C</bold>) Estimated distribution of SARS-CoV-2 rVL for adult (<italic>N</italic> = 3575 samples from <italic>N</italic> = 20 studies) and pediatric (<italic>N</italic> = 198 samples from <italic>N</italic> = 9 studies) (<bold>B</bold>) and symptomatic/presymptomatic (<italic>N</italic> = 1574 samples from <italic>N</italic> = 22 studies) and asymptomatic (<italic>N</italic> = 2221 samples from <italic>N</italic> = 7 studies) (<bold>C</bold>) COVID-19 cases. (<bold>D</bold>) SARS-CoV-2 rVLs fitted to a mechanistic model of viral kinetics (black curve, <italic>r</italic><sup>2</sup> = 0.84 for mean estimates). Filled circles and bars depict mean estimates and 95% confidence intervals. Open circles show the entirety of individual sample data over days from symptom onset (DFSO) (left to right<italic>, N</italic> = 3, 15, 50, 63, 71, 75, 85, 93, 105, 136, 123, 128 and 115 samples from <italic>N</italic> = 21 studies). (<bold>E</bold>) Estimated distributions of SARS-CoV-2 rVL across DFSO. Weibull distributions were fitted on the entirety of individual sample data for the virus, subgroup or DFSO in the systematic dataset. Arrows denote 90th case percentiles for SARS-CoV-2 rVL distributions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Respiratory viral loads for SARS-CoV-2, SARS-CoV-1 and A(H1N1)pdm09 best conform to Weibull distributions.</title><p>(<bold>A</bold>–<bold>D</bold>) Normal (p≤0.01) (<bold>A</bold>), lognormal (p≤0.01) (<bold>B</bold>), gamma (p≤0.005) (<bold>C</bold>) and Weibull (p&gt;0.10, not significant [NS]) (<bold>D</bold>) probability plots for individual sample data of SARS-CoV-2 respiratory viral loads (rVLs) across days from symptom onset in the systematic dataset (<italic>N</italic> = 941 samples from <italic>N</italic> = 20 studies). (<bold>E</bold>–<bold>H</bold>) Normal (p&gt;0.05, NS) (<bold>E</bold>), lognormal (p≤0.01) (<bold>F</bold>), gamma (p&gt;0.05, NS) (<bold>G</bold>) and Weibull (p&gt;0.10, NS) (<bold>H</bold>) probability plots for individual sample data of SARS-CoV-1 rVLs in the systematic dataset (<italic>N</italic> = 303 samples from <italic>N</italic> = 5 studies). (<bold>I</bold>– <bold>L</bold>) Normal (p≤0.01) (<bold>I</bold>), lognormal (p≤0.01) (<bold>J</bold>), gamma (p≤0.005) (<bold>K</bold>) and Weibull (p&gt;0.10, NS) (<bold>L</bold>) probability plots for individual sample data of A(H1N1)pdm09 rVLs in the systematic dataset (<italic>N</italic> = 512 samples from <italic>N</italic> = 10 studies). These categories included rVL data from positive (above the detection limit) assay measurements. The p-values were determined using the modified Kolmogorov–Smirnov test for the goodness of fit of each distribution. When the null hypothesis is accepted (NS at p&gt;0.05), the probability density function cannot be rejected to describe the distribution of the data. Blue circles, black lines and red lines represent individual sample data, expected distributions and 95% confidence intervals, respectively. (<bold>M</bold>–<bold>O</bold>) Histograms and fitted Weibull distributions of the above data for SARS-CoV-2 (<bold>M</bold>), SARS-CoV-1 (<bold>N</bold>) and A(H1N1)pdm09 (<bold>O</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Case heterogeneity in respiratory viral loads (rVLs) across viruses, COVID-19 subgroups and disease course.</title><p>(<bold>A–C</bold>) Estimated rVLs of SARS-CoV-2 (<bold>A</bold>), SARS-CoV-1 (<bold>B</bold>) and A(H1N1)pdm09 (<bold>C</bold>) across case percentile (cp) throughout the infectious periods. (<bold>D</bold>–<bold>G</bold>) Estimated SARS-CoV-2 rVLs for adult (<bold>D</bold>), pediatric (<bold>E</bold>), symptomatic/presymptomatic (<bold>F</bold>) and asymptomatic (<bold>G</bold>) cases across cp throughout the infectious period. (<bold>H</bold>–<bold>S</bold>) Estimated SARS-CoV-2 rVLs across cp on different days from symptom onset (DFSO) during the infectious period. Earlier DFSO were excluded based on limited data. Data ranged between the 1st and 99th cps. Lines and bands represent estimates and 95% confidence intervals, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Descriptive parameters for respiratory viral loads based on individual sample data.</title><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Editable version of <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig4-figsupp3-data1-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig4-figsupp3-v2.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Model parameters describing SARS-CoV-2 kinetics during respiratory infection.</title><p><supplementary-material id="fig4s4sdata1"><label>Figure 4—figure supplement 4—source data 1.</label><caption><title>Editable version of <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-fig4-figsupp4-data1-v2.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig4-figsupp4-v2.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>Kinetics of SARS-CoV-2 and airway epithelial cells during respiratory infection.</title><p>(<bold>A, B</bold>) Estimated kinetics of uninfected (blue) and productively infected (red) airway epithelial cells (left axis) and SARS-CoV-2 (right axis) in the respiratory tract, as shown in linear (<bold>A</bold>) and logarithmic (<bold>B</bold>) scales.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig4-figsupp5-v2.tif"/></fig></fig-group><p>To assess potential sources of heterogeneity in SARS-CoV-2 rVL, we compared rVL distributions among COVID-19 subgroups. In addition to comparable mean estimates (<xref ref-type="fig" rid="fig3">Figure 3</xref>), adult, pediatric, symptomatic/presymptomatic and asymptomatic COVID-19 cases showed similar rVL distributions (<xref ref-type="fig" rid="fig4">Figure 4B, C</xref>), with SDs of 2.03, 2.06, 2.00 and 2.01 log<sub>10</sub> copies/ml, respectively. Thus, age and symptomatology minimally influenced case variation in SARS-CoV-2 rVL during the infectious period.</p></sec><sec id="s2-5"><title>SARS-CoV-2 kinetics during respiratory infection</title><p>To analyze the influences of disease course, we delineated individual SARS-CoV-2 rVLs by DFSO and fitted the mean estimates to a mechanistic model for respiratory virus kinetics (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and Materials and methods). The outputs indicated that, on average, each productively infected cell in the airway epithelium shed SARS-CoV-2 at 1.33 (95% CI: 0.74–1.93) copies/ml day<sup>−1</sup> and infected up to 9.25 susceptible cells (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>). The turnover rate for infected epithelial cells was 0.71 (0.26–1.15) days<sup>−1</sup>, while the half-life of SARS-CoV-2 RNA before clearance from the respiratory tract was 0.21 (0.11–2.75) days. By extrapolating the model to an initial rVL of 0 log<sub>10</sub> copies/ml, the estimated incubation period was 5.38 days, which agrees with epidemiological findings (<xref ref-type="bibr" rid="bib65">Li et al., 2020a</xref>). Conversely, the expected duration of shedding was 25.1 DFSO. Thus, SARS-CoV-2 rVL increased exponentially after infection, peaked around 1 DFSO along with the proportion of infected epithelial cells (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>) and then diminished exponentially.</p><p>To evaluate case heterogeneity across the infectious period, we fitted distributions for each DFSO (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), which showed that high SARS-CoV-2 rVLs also increased from the presymptomatic period, peaked at 1 DFSO and then decreased towards the end of the first week of illness. For the 90th cp at 1 DFSO, the rVL was 9.84 (95% CI: 9.17–10.56) log<sub>10</sub> copies/ml, an order of magnitude greater than the overall 90th cp estimate. High rVLs between 1 and 5 DFSO were elevated above the expected values from the overall rVL distribution (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). At −1 DFSO, the 90th cp rVL was 8.30 (6.88–10.02) log<sub>10</sub> copies/ml, while it was 7.93 (7.35–8.56) log<sub>10</sub> copies/ml at 10 DFSO. Moreover, heterogeneity in rVL remained broad across the infectious period, with SDs of 1.83–2.44 log<sub>10</sub> copies/ml between −1 to 10 DFSO (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2H-S</xref>).</p></sec><sec id="s2-6"><title>Likelihood that droplets and aerosols contain virions</title><p>Towards analyzing the influence of heterogeneity in rVL on individual infectiousness, we first modeled the likelihood of respiratory particles containing viable SARS-CoV-2. Since rVL is an intensive quantity, the volume fraction of virions is low and viral partitioning coincides with atomization, we used Poisson statistics to model likelihood profiles. To calculate an unbiased estimator of partitioning (the expected number of viable copies per particle), our method multiplied rVL estimates with particle volumes during atomization and an assumed viability proportion of 0.1% in equilibrated particles (Materials and methods).</p><p>When expelled by the mean COVID-19 case during the infectious period, respiratory particles showed low likelihoods of carrying viable SARS-CoV-2 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Aerosols (equilibrium aerodynamic diameter [<italic>d</italic><sub>a</sub>] ≤ 100 µm) were ≤3.16% (95% CI: 2.61–3.71%) likely to contain a virion. Droplets also had low likelihoods: at <italic>d</italic><sub>a</sub> = 200 µm, they were 22.3% (21.4–23.2%), 3.36% (3.03–3.69%) and 0.34% (0.29–0.39%) likely to contain one, two or three virions, respectively.</p><p>COVID-19 cases with high rVLs, however, expelled particles with considerably greater likelihoods of carrying viable copies (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D, E</xref>). For the 80th cp during the infectious period, aerosols (<italic>d</italic><sub>a</sub> ≤ 100 µm) were ≤87.9% (95% CI: 87.2–88.5%) likely to carry at least one SARS-CoV-2 virion. For the 90th cp, larger aerosols tended to contain multiple virions (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). At 1 DFSO, these estimates were greatest, and ≤98.8% (98.1–99.4%) of buoyant aerosols (<italic>d</italic><sub>a</sub> ≤ 10 µm) contained at least one viable copy of SARS-CoV-2 for the 98th cp. When expelled by high cps, droplets (<italic>d</italic><sub>a</sub> &gt; 100 µm) tended to contain tens to thousands of SARS-CoV-2 virions (<xref ref-type="fig" rid="fig5">Figure 5B,</xref> <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Heterogeneity in shedding SARS-CoV-2 via droplets and aerosols.</title><p>(<bold>A, B</bold>) Estimated likelihood of respiratory particles containing viable SARS-CoV-2 when expelled by the mean (top) or 98th case percentile (cp) (bottom) COVID-19 cases at −1 (<bold>A</bold>) or 1 (<bold>B</bold>) days from symptom onset (DFSO). For higher number of virions, some likelihood curves were omitted to aid visualization. When the likelihood for zero virions approaches 0%, particles are expected to contain at least one viable copy. (<bold>C</bold>–<bold>F</bold>) Rate that the mean and 98th cp COVID-19 cases at 1 DFSO shed viable SARS-CoV-2 by talking, singing, breathing or coughing over particle size. (<bold>G</bold>) Relative contributions of droplets and aerosols to shedding virions for each respiratory activity (left). Relative contribution of buoyant, long-range and short-range aerosols to shedding virions via aerosols for each respiratory activity (right). (<bold>H</bold>) Case heterogeneity in the total shedding rate (over all particle sizes) of virions via singing across the infectious period. Earlier presymptomatic days were excluded based on limited data. Data range between the 1st and 99th cps. Lines and bands represent estimates and 95% confidence intervals, respectively, for estimated likelihoods or Poisson means.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Likelihood of respiratory particles containing SARS-CoV-2 or A(H1N1)pdm09.</title><p>(<bold>A–E</bold>) Estimated likelihood that droplets and aerosols contain viable SARS-CoV-2 when expelled by the 25th case percentile (cp) (<bold>A</bold>), mean (<bold>B</bold>), 65th cp (<bold>C</bold>), 80th cp (<bold>D</bold>) or 90th cp (<bold>E</bold>) for COVID-19 cases during the infectious period. (<bold>F–J</bold>) Estimated likelihood that droplets and aerosols contain viable A(H1N1)pdm09 when expelled by the 25th cp (<bold>F</bold>), mean (<bold>G</bold>), 65th cp (<bold>H</bold>), 80th cp (<bold>I</bold>) or 90th cp (<bold>J</bold>) for A(H1N1)pmd09 cases during the infectious period. For higher number of virions, some likelihood curves were omitted to aid visualization. Equilibrium particle diameters were taken to be 0.3 times the hydrated diameter during atomization. When the likelihood for zero virions approaches 0%, particles are expected to contain at least one viable copy. Lines and bands represent estimates and 95% confidence intervals, respectively, for estimated likelihoods.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Rate profiles for particle expelled by respiratory activities.</title><p>(<bold>A–D</bold>) Rate profiles of particles expelled while talking (<bold>A</bold>), singing (<bold>B</bold>), breathing (<bold>C</bold>) and coughing (<bold>D</bold>). (<bold>E</bold>) Comparison of the rate profiles of aerosol emission from singing and different amplitudes of talking. The rate profiles were calculated from the normalized concentrations in <xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref> (<bold>A, B, D and E</bold>) and <xref ref-type="bibr" rid="bib82">Morawska et al., 2009</xref> (<bold>C</bold>) or collected from Asadi et al. (2019) (<bold>E</bold>). Equilibrium particle diameters were taken to be 0.3 times the hydrated diameter during atomization. Breathing was taken to expel negligible quantities of larger particles based on the bronchiolar fluid film burst mechanism.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Heterogeneity in shedding SAR-CoV-2 via talking, breathing and coughing.</title><p>(<bold>A–C</bold>) Case heterogeneity in the total SARS-CoV-2 shedding rate (over all particle sizes) by talking at a moderate amplitude (<bold>A</bold>), breathing (<bold>B</bold>) or coughing (<bold>C</bold>) for COVID-19 cases across the infectious period. Earlier presymptomatic days were excluded based on low specimen numbers. Data represent estimated rates for viable virus and range between the 1st and 99thcase percentiles. Lines and bands represent estimates and 95% confidence intervals, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig5-figsupp3-v2.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>Heterogeneity in infectiousness for COVID-19 and A(H1N1)pmd09 cases during the infectious period.</title><p>(<bold>A, B</bold>) Estimated time for a A(H1N1)pdm09 case to expel one virion via only aerosols (<bold>A</bold>) or either droplets or aerosols (<bold>B</bold>) by talking, singing, breathing or coughing. (<bold>C, D</bold>) Estimated time for a COVID-19 case to expel one SARS-CoV-2 virion via only aerosols (<bold>C</bold>) or either droplets or aerosols (<bold>D</bold>) by talking, singing, breathing or coughing. Data represent estimated times to expel viable virus and range between the 1st and 99th case percentiles (cps). Vertical arrows depict the cp expected to shed one virion in 24 hr (talking, singing or breathing) or 100 coughs. Lines and bands represent estimates and 95% confidence intervals, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig5-figsupp4-v2.tif"/></fig><fig id="fig5s5" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 5.</label><caption><title>Heterogeneity in shedding A(H1N1)pdm09 via droplets and aerosols.</title><p>(<bold>A–D</bold>) Case heterogeneity in the total A(H1N1)pdm09 shedding rates while talking (<bold>A</bold>), singing (<bold>B</bold>), breathing (<bold>C</bold>) and coughing (<bold>D</bold>) during the infectious period. Data represent estimated rates for viable virus and range between the 1st and 99thcase percentiles. Lines and bands represent estimates and 95% confidence intervals, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65774-fig5-figsupp5-v2.tif"/></fig></fig-group></sec><sec id="s2-7"><title>Shedding SARS-CoV-2 via respiratory droplets and aerosols</title><p>Using the partitioning estimates in conjunction with published profiles of the particles expelled by respiratory activities (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), we next modeled the rates at which talking, singing, breathing and coughing shed viable SARS-CoV-2 across <italic>d</italic><sub>a</sub> (<xref ref-type="fig" rid="fig5">Figure 5C-F</xref>). Singing shed virions more rapidly than talking based on the increased emission of aerosols. Voice amplitude, however, had a significant effect on aerosol production, and talking loudly emitted aerosols at similar rates to singing (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2E</xref>). Based on the generation of larger aerosols and droplets, talking and singing shed virions significantly more rapidly than breathing (<xref ref-type="fig" rid="fig5">Figure 5C-E</xref>). Each cough shed similar quantities of virions as in a minute of talking (<xref ref-type="fig" rid="fig5">Figure 5C, F</xref>).</p><p>Each of these respiratory activities expelled aerosols at greater rates than droplets, but particle size correlated with the likelihood of containing virions according to our model. Talking, singing and coughing expelled virions at comparable proportions via droplets (55.6–59.4%) and aerosols (40.6–44.4%), whereas breathing did so predominantly within aerosols (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Moreover, short-range aerosols mediated most of the virions (79.2–81.9%) shed via aerosols while talking normally and coughing. In comparison, while singing, or talking loudly, buoyant (14.5%) and long-range (17.5%) aerosols carried a larger proportion of the virions shed via aerosols (<xref ref-type="fig" rid="fig5">Figure 5G</xref>).</p></sec><sec id="s2-8"><title>Influence of heterogeneity in rVL on individual infectiousness</title><p>To interpret how heterogeneity in rVL influences individual infectiousness, we modeled total SARS-CoV-2 shedding rates (over all particle sizes) for each respiratory activity (<xref ref-type="fig" rid="fig5">Figure 5H,</xref> <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Between the 1st and the 99th cps, the estimates for a respiratory activity spanned ≥8.48 orders of magnitude on each DFSO; cumulatively from −1 to 10 DFSO, they spanned 11.0 orders of magnitude. Hence, many COVID-19 cases inherently presented minimal transmission risk, whereas highly infectious individuals shed considerable quantities of SARS-CoV-2. For the 98th cp at 1 DFSO, singing expelled 313 (95% CI: 37.5–3158) virions/min to the ambient environment, talking emitted 293 (35.1–2664) virions/min, breathing exhaled 1.54 (0.18–15.5) virions/min and coughing discharged 249 (29.8–25111) virions/cough; these estimates were approximately two orders of magnitude greater than those for the 85th cp. For the 98th cp at −1 DFSO, singing shed 14.5 (0.15–4515) virions/min and breathing exhaled 7.13 × 10<sup>−2</sup> (7.20 × 10<sup>−4</sup>–220.2) virions/min. The estimates at 9–10 DFSO were similar to these presymptomatic ones (<xref ref-type="fig" rid="fig5">Figure 5H,</xref> <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B</xref>). As indicated by comparable mean rVLs (<xref ref-type="fig" rid="fig3">Figure 3</xref>) and heterogeneities in rVL (<xref ref-type="fig" rid="fig4">Figure 4B, C</xref>), adult, pediatric, symptomatic/presymptomatic and asymptomatic COVID-19 subgroups presented similar distributions for shedding virions through these activities.</p><p>We also compared the influence of case variation on individual infectiousness between A(H1N1)pdm09 and COVID-19. Aerosol spread accounted for approximately half of A(H1N1)pdm09 transmission events (<xref ref-type="bibr" rid="bib21">Cowling et al., 2013</xref>), and the 50% human infectious dose for aerosolized influenza A virus is approximately 1–3 virions in the absence of neutralizing antibodies (<xref ref-type="bibr" rid="bib27">Fabian et al., 2008</xref>). Based on the model, 62.9% of A(H1N1)pdm09 cases were infectious (shed ≥1 virion) via aerosols within 24 hr of talking loudly or singing (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A</xref>), and the estimate was 58.6% within 24 hr of talking normally and 22.3% within 24 hr of breathing. In comparison, 48.0% of COVID-19 cases shed ≥1 virion via aerosols in 24 hr of talking loudly or singing (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4C</xref>). Notably, only 61.4% of COVID-19 cases shed ≥1 virion via either droplets or aerosols in 24 hr of talking loudly or singing (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4D</xref>). While the human infectious dose of SARS-CoV-2 by any exposure route remains unelucidated, it must be at least one viable copy. Thus, at least 38.6% of COVID-19 cases were expected to present negligible risk to spread SARS-CoV-2 through either droplets or aerosols in 24 hr. The proportion of potentially infectious cases further decreased as the threshold increased: 55.8, 42.5 and 25.0% of COVID-19 cases were expected to shed ≥2, ≥10 and ≥100 virions, respectively, in 24 hr of talking loudly or singing during the infectious period.</p><p>While these analyses indicated that a greater proportion of A(H1N1)pdm09 cases were inherently infectious, 18.8% of COVID-19 cases shed virions more rapidly than those infected with A(H1N1)pdm09 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). At the 98th cp for A(H1N1)pdm09, singing expelled 4.38 (2.85–6.78) virions/min and breathing exhaled 2.15 × 10<sup>−2</sup> (1.40 × 10<sup>−2</sup>–30.34×10<sup>−2</sup>) virions/min. Highly infectious COVID-19 cases expelled virions at rates that were up to 1–2 orders of magnitude greater than their A(H1N1)pdm09 counterparts (<xref ref-type="fig" rid="fig5">Figure 5H,</xref> <xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>This study provided systematic analyses of several factors characterizing SARS-CoV-2 transmissibility. First, our results indicate that broader heterogeneity in rVL facilitates greater overdispersion for SARS-CoV-2 than A(H1N1)pdm09. They suggest that many COVID-19 cases infect no one (<xref ref-type="bibr" rid="bib7">Bi et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Endo et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Laxminarayan et al., 2020</xref>) because they inherently present minimal transmission risk via respiratory droplets or aerosols, although behavioral and environmental factors may further influence risk. Meanwhile, highly infectious cases can shed tens to thousands of SARS-CoV-2 virions/min, especially between 1 and 5 DFSO, potentiating superspreading events. The model estimates, when corrected to copies rather than virions, align with recent clinical findings for exhalation rates of SARS-CoV-2 (<xref ref-type="bibr" rid="bib77">Ma et al., 2020</xref>). In comparison, a greater proportion of A(H1N1)pdm09 cases are infectious but shed virions at low rates, which concurs with more uniform transmission and few superspreading events observed during the 2009 H1N1 pandemic (<xref ref-type="bibr" rid="bib9">Brugger and Althaus, 2020</xref>; <xref ref-type="bibr" rid="bib98">Roberts and Nishiura, 2011</xref>). Moreover, our analyses suggest that heterogeneity in rVL may be generally associated with overdispersion for viral respiratory infections. In this case, rVL distribution can serve as an early correlate for transmission patterns, including superspreading, during outbreaks of novel respiratory viruses. When considered jointly with contact-tracing studies, this provides epidemiological triangulation on <italic>k</italic>: heterogeneity in rVL indirectly estimates <italic>k</italic> via an association, whereas contact tracing empirically characterizes transmission chains to estimate <italic>k</italic> but is limited by incomplete or incorrect recall of contact events by cases. When transmission is highly overdispersed, targeted interventions may disproportionately mitigate infection (<xref ref-type="bibr" rid="bib61">Lee et al., 2020</xref>), with models showing that focused control efforts on the most infectious cases outperform random control policies (<xref ref-type="bibr" rid="bib70">Lloyd-Smith et al., 2005</xref>).</p><p>Second, we analyzed SARS-CoV-2 kinetics during respiratory infection. While heterogeneity remains broad throughout the infectious period, rVL tends to peak at 1 DFSO and be elevated for 1–5 DFSO, coinciding with the period of highest attack rates observed among close contacts (<xref ref-type="bibr" rid="bib16">Cheng et al., 2020</xref>). These results indicate that transmission risk tends to be greatest near, and soon after, illness rather than in the presymptomatic period, which concurs with large tracing studies (6.4–12.6% of secondary infections from presymptomatic transmission) (<xref ref-type="bibr" rid="bib23">Du et al., 2020</xref>; <xref ref-type="bibr" rid="bib116">Wei et al., 2020</xref>) rather than early temporal models (~44%) (<xref ref-type="bibr" rid="bib36">He et al., 2020</xref>). Furthermore, our kinetic analysis suggests that, on average, SARS-CoV-2 reaches diagnostic concentrations 1.54–3.17 days after respiratory infection (−3.84 to −2.21 DFSO), assuming assay detection limits of 1–3 log<sub>10</sub> copies/ml, respectively, for nasopharyngeal swabs immersed in 1 ml of transport media.</p><p>Third, we assessed the relative infectiousness of COVID-19 subgroups. As a common symptom of COVID-19 (<xref ref-type="bibr" rid="bib30">Guan et al., 2020</xref>), coughing sheds considerable numbers of virions via droplets and short-range aerosols. Thus, symptomatic infections tend to be more contagious than asymptomatic ones, providing one reason as to why asymptomatic cases transmit SARS-CoV-2 at lower relative rates (<xref ref-type="bibr" rid="bib66">Li et al., 2020b</xref>), especially in close contact (<xref ref-type="bibr" rid="bib76">Luo et al., 2020</xref>), despite similar rVLs and increased contact patterns. Accordingly, children (48–54% of symptomatic cases present with cough) (<xref ref-type="bibr" rid="bib74">Lu et al., 2020b</xref>; <xref ref-type="bibr" rid="bib106">Team and CDC COVID-19 Response Team, 2020</xref>) may be less contagious than adults (68–80%) (<xref ref-type="bibr" rid="bib30">Guan et al., 2020</xref>; <xref ref-type="bibr" rid="bib106">Team and CDC COVID-19 Response Team, 2020</xref>) based on tendencies of symptomatology rather than rVL. Conversely, coughing sheds few virions via smaller aerosols. While singing and talking loudly, highly infectious cases can shed tens to hundreds of SARS-CoV-2 virions/min via long-range and buoyant aerosols.</p><p>Our study has limitations. The systematic search found a limited number of studies reporting quantitative specimen measurements from the presymptomatic period, meaning that these estimates may be sensitive to sampling bias. Although additional studies have reported semiquantitative metrics (cycle thresholds), these data were excluded because they cannot be compared on an absolute scale due to batch effects (<xref ref-type="bibr" rid="bib34">Han et al., 2021</xref>), limiting use in compound analyses. In addition, our models considered virion partitioning during atomization to be a Poisson process, which stochastically associates partitioning with particle volume. Partitioning mechanisms associated with surface area, perhaps such as film bursting (<xref ref-type="bibr" rid="bib8">Bird et al., 2010</xref>; <xref ref-type="bibr" rid="bib49">Johnson and Morawska, 2009</xref>), may enrich the quantities of virions in smaller aerosols, based on their surface area-to-volume ratio. As severe COVID-19 is associated with high, persistent SARS-CoV-2 shedding in the lower respiratory tract (<xref ref-type="bibr" rid="bib13">Chen et al., 2021</xref>) and small particles are typically generated there (<xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>), severe cases may also expel higher quantities of virions via smaller aerosols.</p><p>Furthermore, this study considered population-level estimates of the infectious periods, viability proportions and profiles for respiratory particles, which omit individual or environmental variation. Studies differ in their measurements of the emission rates and size distributions of the particles expelled during respiratory activities (<xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>; <xref ref-type="bibr" rid="bib101">Schijven et al., 2020</xref>). Their characterization methods may prompt these differences, or they may be due to individual variation, including from distinctions in respiratory capacity, especially for young children, and phonetic tendencies (<xref ref-type="bibr" rid="bib4">Asadi et al., 2020</xref>). Some patients shed SARS-CoV-2 with diminishing viability soon after symptom onset (<xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref>), whereas others produce replication-competent virus for weeks (<xref ref-type="bibr" rid="bib111">van Kampen et al., 2021</xref>). The proportion of viable SARS-CoV-2 in respiratory particles, and how case characteristics or environmental factors influence it, remains under investigation (<xref ref-type="bibr" rid="bib29">Fears et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Lednicky et al., 2020</xref>; <xref ref-type="bibr" rid="bib83">Morris et al., 2020</xref>). Cumulatively, these sources of variation may influence the shedding model estimates, further increasing heterogeneity in individual infectiousness.</p><p>Taken together, our findings provide a potential path forward for disease control. While talking, singing and coughing, our models indicate that SARS-CoV-2 is shed via droplets (55.6–59.4% of shed virions), short-range aerosols (30.1–34.9%), long-range aerosols (7.7–8.3%) and buoyant aerosols (0.01–6.5%). Transmission, however, requires exposure. For direct transmission, droplets tend to be sprayed ballistically onto susceptible tissue. Aerosols can be inhaled, may penetrate more deeply into the lungs and more easily facilitate superspreading events. However, with short durations of stay in well-ventilated areas, the exposure risk for both droplets and aerosols remains correlated with proximity to infectious cases (<xref ref-type="bibr" rid="bib68">Liu et al., 2017a</xref>; <xref ref-type="bibr" rid="bib95">Prather et al., 2020</xref>). Strategies to abate infection should limit crowd numbers and duration of stay while reinforcing distancing, low-voice amplitudes and widespread mask usage; well-ventilated settings can be recognized as lower-risk venues. Coughing can shed considerable quantities of virions, while rVL tends to peak at 1 DFSO and can be high throughout the infectious period. Thus, immediate, sustained self-isolation upon illness is crucial to curb transmission from symptomatic cases. Collectively, our analyses highlight the role of cases with high rVLs in propelling the COVID-19 pandemic. While diagnosing COVID-19, qRT-PCR can also triage contact tracing, prioritizing these patients: for nasopharyngeal swabs immersed in 1 ml of transport media, ≥7.14 (95% CI: 7.07–7.22) log<sub>10</sub> copies/ml corresponds to the top 20% of COVID-19 cases for variants before August 2020. Doing so may identify asymptomatic and presymptomatic infections more efficiently, a key step towards mitigation and elimination as the pandemic continues.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Search strategy, selection criteria and data collection</title><p>We undertook a systematic review and prospectively submitted the protocol for registration on PROSPERO (registration number, CRD42020204637). Other than the title of this study, we have followed PRISMA reporting guidelines (<xref ref-type="bibr" rid="bib80">Moher et al., 2009</xref>). The systematic review was conducted according to Cochrane methods guidance (<xref ref-type="bibr" rid="bib37">Higgins et al., 2019</xref>).</p><p>The search included papers that (i) reported positive, quantitative measurements (copies/ml or an equivalent metric) of SARS-CoV-2, SARS-CoV-1 or A(H1N1)pdm09 in human respiratory specimens (endotracheal aspirate [ETA], nasopharyngeal aspirate [NPA], nasopharyngeal swab [NPS], oropharyngeal swab [OPS], posterior oropharyngeal saliva [POS] and sputum [Spu]) from COVID-19, SARS or A(H1N1)pdm09 cases; (ii) reported data that could be extracted from the estimated infectious periods of SARS-CoV-2 (defined as −3 to +10 DFSO for symptomatic cases and 0 to +10 days from the day of laboratory diagnosis for asymptomatic cases), SARS-CoV-1 (defined as 0 to +20 DFSO or the equivalent asymptomatic period) or A(H1N1)pdm09 (defined as −2 to +9 DFSO for symptomatic cases and 0 days to +9 days from the day of laboratory diagnosis for asymptomatic cases); and (iii) reported data for two or more cases with laboratory-confirmed COVID-19, SARS or A(H1N1)pdm09 based on World Health Organization (WHO) case definitions. Quantitative specimen measurements were considered after RNA extraction for diagnostic sequences of SARS-CoV-2 (<italic>Ofr1b</italic>, <italic>N</italic>, <italic>RdRp</italic> and <italic>E</italic> genes), SARS-CoV-1 (<italic>Ofr1b</italic>, <italic>N</italic> and <italic>RdRp</italic> genes) and A(H1N1)pdm09 (<italic>HA</italic> and <italic>M</italic> genes).</p><p>Studies were excluded, in the following order, if they (i) studied an ineligible disease; (ii) had an ineligible study design, including those that were reviews of evidence (e.g., scoping, systematic or narrative), did not include primary clinical human data, reported data for less than two cases due to an increased risk of selection bias, were incomplete (e.g., ongoing clinical trials), did not report an RNA extraction step before measurement or were studies of environmental samples; (iii) reported an ineligible metric for specimen concentration (e.g., qualitative RT-PCR or cycle threshold [Ct] values without calibration included in the study); (iv) reported quantitative measurements from an ineligible specimen type (e.g., blood specimens, pooled specimens or self-collected POS or Spu patient specimens in the absence of a healthcare professional); (v) reported an ineligible sampling period (consisted entirely of data that could not be extracted from within the infectious period); or (vi) were duplicates of an included study (e.g., preprinted version of a published paper or duplicates not identified by Covidence). We included data from control groups receiving standard of care in interventional studies but excluded data from the intervention group. Patients in the intervention group are, by definition, systematically different from general case populations because they receive therapies not being widely used for treatment, which may influence virus concentrations. Interventional studies examining the comparative effectiveness of two or more treatments were excluded for the same reason. Studies exclusively reporting semiquantitative measurements (e.g., Ct values) of specimen concentration were excluded as these measurements are sensitive to batch and instrument variation and, without proper calibration, cannot be compared on an absolute scale across studies (<xref ref-type="bibr" rid="bib34">Han et al., 2021</xref>).</p><p>We searched, without the use of filters or language restrictions, the following sources: MEDLINE (via Ovid, 1946 to 7 August 2020), EMBASE (via Ovid, 1974 to 7 August 2020), Cochrane Central Register of Controlled Trials (via Ovid, 1991 to 7 August 2020), Web of Science Core Collection (including Science Citation Index Expanded, 1900 to 7 August 2020; Social Sciences Citation Index, 1900 to 7 August 2020; Arts &amp; Humanities Citation Index, 1975 to 7 August 2020; Conference Proceedings Citation Index – Science, 1990 to 7 August 2020; Conference Proceedings Citation Index – Social Sciences &amp; Humanities, 1990 to 7 August 2020; and Emerging Sources Citation Index, 2015 to 7 August 2020), as well as medRxiv and bioRxiv (both searched through Google Scholar via the Publish or Perish program, to 7 August 2020). We also gathered studies by searching through the reference lists of review articles identified by the database search, by searching through the reference lists of included articles, through expert recommendation (by Eric J. Topol and Akiko Iwasaki on Twitter) and by hand-searching through journals (<italic>Nature</italic>, <italic>Nat. Med.</italic>, <italic>Science</italic>, <italic>NEJM</italic>, <italic>Lancet</italic>, <italic>Lancet Infect. Dis.</italic>, <italic>JAMA</italic>, <italic>JAMA Intern. Med.</italic> and <italic>BMJ</italic>). A comprehensive search was developed by a librarian, which included subject headings and keywords. The search strategy had three main concepts (disease, specimen type and outcome), and each concept was combined using the appropriate Boolean operators. The search was tested against a sample set of known articles that were pre-identified. The line-by-line search strategies for all databases are included in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>, <xref ref-type="supplementary-material" rid="fig1sdata3">Figure 1—source data 3</xref>, <xref ref-type="supplementary-material" rid="fig1sdata4">Figure 1—source data 4</xref>, <xref ref-type="supplementary-material" rid="fig1sdata5">Figure 1—source data 5</xref>. The search results were exported from each database and uploaded to the Covidence online system for deduplication and screening.</p><p>Two authors independently screened titles and abstracts, reviewed full texts, collected data and assessed risk of bias via Covidence and a hybrid critical appraisal checklist based on the Joanna Briggs Institute (JBI) tools for case series, analytical cross-sectional studies and prevalence studies (<xref ref-type="bibr" rid="bib81">Moola et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Munn et al., 2019</xref>; <xref ref-type="bibr" rid="bib84">Munn et al., 2015</xref>). To evaluate the sample size in a study, we used the following calculation:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>n</mml:mi><mml:mrow><mml:mo>∗</mml:mo></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>z</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi>σ</mml:mi></mml:mrow><mml:msup><mml:mi>d</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf1"><mml:msup><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> is the sample size threshold, <inline-formula><mml:math id="inf2"><mml:mi>z</mml:mi></mml:math></inline-formula> is the z-score for the level of confidence (95%), <inline-formula><mml:math id="inf3"><mml:mi>σ</mml:mi></mml:math></inline-formula> is the standard deviation (assumed to be 3 log<sub>10</sub> copies/ml, one quarter of the full range of rVLs) and <inline-formula><mml:math id="inf4"><mml:mi>d</mml:mi></mml:math></inline-formula> is the marginal error (assumed to be 1 log<sub>10</sub> copies/ml, based on the minimum detection limit for qRT-PCR across studies) (<xref ref-type="bibr" rid="bib50">Johnston et al., 2019</xref>). The hybrid JBI critical appraisal checklist is shown in the Appendix. Studies were considered to have low risk of bias if they met the majority of the items, indicating that the estimates were likely to be correct for the target population. Inconsistencies were resolved by discussion and consensus.</p><p>The search found 29 studies for COVID-19 (<xref ref-type="bibr" rid="bib2">Argyropoulos et al., 2020</xref>; <xref ref-type="bibr" rid="bib6">Baggio et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Fajnzylber et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Han et al., 2020a</xref>; <xref ref-type="bibr" rid="bib33">Han et al., 2020b</xref>; <xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref>; <xref ref-type="bibr" rid="bib41">Hurst et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Iwasaki et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Kawasuji et al., 2020</xref>; <xref ref-type="bibr" rid="bib53">L'Huillier et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Lavezzo et al., 2020</xref>; <xref ref-type="bibr" rid="bib62">Lennon et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Lucas et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Mitjà et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Pan et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Peng et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Perera et al., 2020</xref>; <xref ref-type="bibr" rid="bib102">Shi et al., 2020</xref>; <xref ref-type="bibr" rid="bib103">Shrestha et al., 2020</xref>; <xref ref-type="bibr" rid="bib110">To et al., 2020</xref>; <xref ref-type="bibr" rid="bib111">van Kampen et al., 2021</xref>; <xref ref-type="bibr" rid="bib112">Vetter et al., 2020</xref>; <xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref>; <xref ref-type="bibr" rid="bib120">Wyllie et al., 2020</xref>; <xref ref-type="bibr" rid="bib121">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="bib124">Yonker et al., 2020</xref>; <xref ref-type="bibr" rid="bib126">Zhang et al., 2020a</xref>; <xref ref-type="bibr" rid="bib128">Zheng et al., 2020</xref>; <xref ref-type="bibr" rid="bib129">Zou et al., 2020</xref>), 8 studies for SARS (<xref ref-type="bibr" rid="bib11">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="bib14">Cheng et al., 2004</xref>; <xref ref-type="bibr" rid="bib18">Chu et al., 2005</xref>; <xref ref-type="bibr" rid="bib17">Chu et al., 2004</xref>; <xref ref-type="bibr" rid="bib38">Hung et al., 2004</xref>; <xref ref-type="bibr" rid="bib89">Peiris et al., 2003</xref>; <xref ref-type="bibr" rid="bib94">Poon et al., 2004</xref>; <xref ref-type="bibr" rid="bib93">Poon et al., 2003</xref>) and 27 studies for A(H1N1)pdm09 (<xref ref-type="bibr" rid="bib10">Chan et al., 2011</xref>; <xref ref-type="bibr" rid="bib15">Cheng et al., 2010</xref>; <xref ref-type="bibr" rid="bib20">Cowling et al., 2010</xref>; <xref ref-type="bibr" rid="bib24">Duchamp et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Esposito et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Hung et al., 2010</xref>; <xref ref-type="bibr" rid="bib43">Ip et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Ito et al., 2012</xref>; <xref ref-type="bibr" rid="bib52">Killingley et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Launes et al., 2012</xref>; <xref ref-type="bibr" rid="bib59">Lee et al., 2011a</xref>; <xref ref-type="bibr" rid="bib60">Lee et al., 2011b</xref>; <xref ref-type="bibr" rid="bib63">Li et al., 2010a</xref>; <xref ref-type="bibr" rid="bib64">Li et al., 2010b</xref>; <xref ref-type="bibr" rid="bib71">Loeb et al., 2012</xref>; <xref ref-type="bibr" rid="bib72">Lu et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Meschi et al., 2011</xref>; <xref ref-type="bibr" rid="bib86">Ngaosuwankul et al., 2010</xref>; <xref ref-type="bibr" rid="bib96">Rath et al., 2012</xref>; <xref ref-type="bibr" rid="bib99">Rodrigues Guimarães Alves et al., 2020</xref>; <xref ref-type="bibr" rid="bib104">Suess et al., 2010</xref>; <xref ref-type="bibr" rid="bib107">Thai et al., 2014</xref>; <xref ref-type="bibr" rid="bib108">To et al., 2010a</xref>; <xref ref-type="bibr" rid="bib109">To et al., 2010b</xref>; <xref ref-type="bibr" rid="bib115">Watanabe et al., 2011</xref>; <xref ref-type="bibr" rid="bib119">Wu et al., 2012</xref>; <xref ref-type="bibr" rid="bib123">Yang et al., 2011</xref>), and data were collected from each study. For preprinted studies that were published as journal articles before the revised submission of this manuscript, we included the citation for the journal article. Descriptive statistics on quantitative specimen measurements were collected from confirmed cases directly if reported numerically or using WebPlotDigitizer 4.3 (<ext-link ext-link-type="uri" xlink:href="https://apps.automeris.io/wpd/">https://apps.automeris.io/wpd/</ext-link>) if reported graphically. Individual specimen measurements were collected directly if reported numerically or, when the data were clearly represented, using the tool if reported graphically. We also collected the relevant numbers of cases, types of cases, reported treatments, volumes of transport media, numbers of specimens and DFSO (for symptomatic cases) or day relative to initial laboratory diagnosis (for asymptomatic cases) on which each specimen was taken. Hospitalized cases were defined as those being tested in a hospital setting and then admitted. Non-admitted cases were defined as those being tested in a hospital setting but not admitted. Community cases were defined as those being tested in a community setting. Symptomatic, presymptomatic and asymptomatic infections were defined as in the study. Based on rare description in contributing studies, paucisymptomatic infections, when described, were included with symptomatic ones. Pediatric cases were defined as those below 18 years of age or as defined in the study. Adult cases were defined as those 18 years of age or higher or as defined in the study.</p></sec><sec id="s4-2"><title>Calculation of rVLs from specimen measurements</title><p>In this study, viral concentrations in respiratory specimens were denoted as specimen measurements, whereas viral concentrations in the respiratory tract were denoted as rVLs. To determine rVLs, each collected quantitative specimen measurement was converted to rVL based on the dilution factor. For example, measurements from swabbed specimens (NPS and OPS) typically report the RNA concentration in viral transport media. Based on the expected uptake volume for swabs (0.128 ± 0.031 ml, mean ± SD) (<xref ref-type="bibr" rid="bib114">Warnke et al., 2014</xref>) or reported collection volume for expulsed fluid in the study (e.g., 0.5–1 ml) along with the reported volume of transport media in the study (e.g., 1 ml), we calculated the dilution factor for each respiratory specimen to estimate the rVL. If the diluent volume was not reported, then the dilution factor was calculated assuming a volume of 1 ml (NPS and OPS), 2 ml (POS and ETA) or 3 ml (NPA) of transport media (<xref ref-type="bibr" rid="bib56">Lavezzo et al., 2020</xref>; <xref ref-type="bibr" rid="bib94">Poon et al., 2004</xref>; <xref ref-type="bibr" rid="bib110">To et al., 2020</xref>). Unless dilution was reported for Spu specimens, we used the specimen measurement as the rVL (<xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref>). The non-reporting of diluent volume was noted as an element increasing risk of bias in the hybrid JBI critical appraisal checklist. Specimen measurements (based on instrumentation, calibration, procedures and reagents) are not standardized and, as DFSO is typically based on patient recall, there is also inherent uncertainty in these values. While the above procedures (including only quantitative measurements after extraction as an inclusion criterion, considering assay detection limits and correcting for specimen dilution) have considered many of these factors, non-standardization remains an inherent limitation in the variability of specimen measurements.</p></sec><sec id="s4-3"><title>Meta-regression of <italic>k</italic> and heterogeneity in rVL</title><p>To assess the relationship between <italic>k</italic> and heterogeneity in rVL, we performed a univariate meta-regression (<inline-formula><mml:math id="inf5"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:mrow><mml:mo>=</mml:mo><mml:mi>a</mml:mi></mml:math></inline-formula>*<inline-formula><mml:math id="inf6"><mml:mi>S</mml:mi><mml:mi>D</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi></mml:math></inline-formula>, where <inline-formula><mml:math id="inf7"><mml:mi>a</mml:mi></mml:math></inline-formula> is the slope for association and <inline-formula><mml:math id="inf8"><mml:mi>b</mml:mi></mml:math></inline-formula> is the intercept) between pooled estimates of <italic>k</italic> (based on studies describing community transmission) for COVID-19 (<italic>k</italic> = 0.409) (<xref ref-type="bibr" rid="bib1">Adam et al., 2020</xref>; <xref ref-type="bibr" rid="bib105">Tariq et al., 2020</xref>; <xref ref-type="bibr" rid="bib127">Zhang et al., 2020b</xref>; <xref ref-type="bibr" rid="bib57">Laxminarayan et al., 2020</xref>; <xref ref-type="bibr" rid="bib7">Bi et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Endo et al., 2020</xref>; <xref ref-type="bibr" rid="bib97">Riou and Althaus, 2020</xref>), SARS (<italic>k</italic> = 0.165) (<xref ref-type="bibr" rid="bib70">Lloyd-Smith et al., 2005</xref>) and A(H1N1)pdm09 (<italic>k</italic> = 8.155) (<xref ref-type="bibr" rid="bib9">Brugger and Althaus, 2020</xref>; <xref ref-type="bibr" rid="bib98">Roberts and Nishiura, 2011</xref>) and the SD of the rVLs in contributing studies. Since SD was the metric, we used a fixed-effects model. For weighting in the meta-regression, we used the proportion of rVL samples from each study relative to the entire systematic dataset (<inline-formula><mml:math id="inf9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">o</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>). All calculations were performed in units of log<sub>10</sub> copies/ml. As the meta-regression used pooled estimates of <italic>k</italic> for each infection, it assumed that there was no correlated bias to <italic>k</italic> across contributing studies. The limit of detection for qRT-PCR instruments used in the included studies did not significantly affect the analysis of heterogeneity in rVL as these limits tended to be below the values found for specimens with low virus concentrations. The meta-regression was conducted using all contributing studies and showed a weak association. Meta-regression was also conducted using studies that had low risk of bias according to the hybrid JBI critical appraisal checklist and showed a strong association. The p-value for association was obtained using the meta-regression slope <italic>t</italic>-test for <inline-formula><mml:math id="inf10"><mml:mi>a</mml:mi></mml:math></inline-formula>, the effect estimate. While there is intrinsic measurement error in virus quantitation, based on the systematic review protocol and study design (as described above), this error should similarly increase heterogeneity in rVL for each virus, and the difference in heterogeneity in rVL between viruses should arise from the viruses.</p></sec><sec id="s4-4"><title>Meta-analysis of rVLs</title><p>Based on the search design and composition of contributing studies, the meta-analysis overall estimates were the expected SARS-CoV-2, SARS-CoV-1 and A(H1N1)pdm09 rVL when encountering a COVID-19, SARS or A(H1N1)pdm09 case, respectively, during their infectious period. Pooled estimates and 95% CIs for the expected rVL of each virus across their infectious period were calculated using a random-effects meta-analysis (DerSimonian and Laird method). For studies reporting summary statistics in medians and interquartile or total ranges, we derived estimates of the mean and variance and calculated the 95% CIs (<xref ref-type="bibr" rid="bib113">Wan et al., 2014</xref>). All calculations were performed in units of log<sub>10</sub> copies/ml. Between-study heterogeneity in meta-analysis was assessed using Cochran’s <italic>Q</italic> test and the <italic>I</italic><sup>2</sup> and τ<sup>2</sup> statistics. If significant between-study heterogeneity in meta-analysis was encountered, sensitivity analysis based on the risk of bias of contributing studies was performed. The meta-analyses were conducted using STATA 14.2 (StataCorp LLC, College Station, TX, USA).</p></sec><sec id="s4-5"><title>Age and symptomatology subgroup analyses of SARS-CoV-2 rVLs</title><p>The overall estimate for each subgroup was the expected rVL when encountering a case of that subgroup during the infectious period. Studies reporting data exclusively from a subgroup of interest were directly included in the analysis after rVL estimations. For studies in which data for these subgroups constituted only part of its dataset, rVLs from the subgroup were extracted to calculate the mean, variance and 95% CIs. Random-effects meta-analysis was performed as described above. For meta-analyses of pediatric and asymptomatic COVID-19 cases, contributing studies had low risk of bias, and no risk-of-bias sensitivity analyses were performed for these subgroups.</p></sec><sec id="s4-6"><title>Distributions of rVL</title><p>We pooled the entirety of individual sample data in the systematic dataset by disease, COVID-19 subgroups and DFSO. For analyses of SARS-CoV-2 dynamics across disease course, we included estimated rVLs from negative qRT-PCR measurements of respiratory specimens for cases that had previously been quantitatively confirmed to have COVID-19. These rVLs were estimated based on the reported assay detection limit in the respective study. Probability plots and modified Kolmogorov–Smirnov tests used the Blom scoring method and were used to determine the suitability of normal, lognormal, gamma and Weibull distributions to describe the distribution of rVLs for SARS-CoV-2, SARS-CoV-1 and A(H1N1)pdm09. For each virus, the data best conformed to Weibull distributions, which is described by the probability density function<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>υ</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mi>α</mml:mi><mml:mi>β</mml:mi></mml:mfrac><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mi>υ</mml:mi><mml:mi>β</mml:mi></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>α</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>υ</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>α</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf11"><mml:mi>α</mml:mi></mml:math></inline-formula> is the shape factor, <inline-formula><mml:math id="inf12"><mml:mi>β</mml:mi></mml:math></inline-formula> is the scale factor and <inline-formula><mml:math id="inf13"><mml:mi>υ</mml:mi></mml:math></inline-formula> is rVL (<inline-formula><mml:math id="inf14"><mml:mi>υ</mml:mi><mml:mo>≥</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula> log<sub>10</sub> copies/ml). Weibull distributions were fitted on the entirety of collected individual sample data for the respective category. Since individual specimen measurements could not be collected from all studies, there was a small bias on the mean estimate for each fitted distribution. Thus, for the curves shown in <xref ref-type="fig" rid="fig4">Figure 4B, C</xref>, the mean of the Weibull distributions summarized in <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref> was adjusted to be the subgroup meta-analysis estimate for correction; the SD and distribution around that mean remained consistent.</p><p>For each Weibull distribution, the value of the rVL at the <inline-formula><mml:math id="inf15"><mml:mi>x</mml:mi></mml:math></inline-formula> th percentile was determined using the quantile function,<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>υ</mml:mi><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:msup><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mi>ln</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>x</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi>α</mml:mi></mml:mrow></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>For cp curves, we used <xref ref-type="disp-formula" rid="equ3">Equation (3)</xref> to determine rVLs from the 1st cp to the 99th cp (step size, 1%). Curve fitting to <xref ref-type="disp-formula" rid="equ2">Equation (2)</xref> and calculation of <xref ref-type="disp-formula" rid="equ3">Equation (3)</xref> and its 95% CI was performed using the Distribution Fitter application in Matlab R2019b (MathWorks, Inc, Natick, MA, USA).</p></sec><sec id="s4-7"><title>Viral kinetics</title><p>To model SARS-CoV-2 kinetics during respiratory infection, we used a mechanistic epithelial cell-limited model for the respiratory tract (<xref ref-type="bibr" rid="bib5">Baccam et al., 2006</xref>), based on the system of differential equations:<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>V</mml:mi></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:mi>δ</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mi>I</mml:mi><mml:mo>−</mml:mo><mml:mi>c</mml:mi><mml:mi>V</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf16"><mml:mi>T</mml:mi></mml:math></inline-formula> is the number of uninfected target cells, <inline-formula><mml:math id="inf17"><mml:mi>I</mml:mi></mml:math></inline-formula> is the number of productively infected cells, <inline-formula><mml:math id="inf18"><mml:mi>V</mml:mi></mml:math></inline-formula> is the rVL, <inline-formula><mml:math id="inf19"><mml:mi>β</mml:mi></mml:math></inline-formula> is the infection rate constant, <inline-formula><mml:math id="inf20"><mml:mi>p</mml:mi></mml:math></inline-formula> is the rate at which airway epithelial cells shed virus to the extracellular fluid, <inline-formula><mml:math id="inf21"><mml:mi>c</mml:mi></mml:math></inline-formula> is the clearance rate of virus and <inline-formula><mml:math id="inf22"><mml:mi>δ</mml:mi></mml:math></inline-formula> is the clearance rate of productively infected cells. Using these parameters, the viral half-life in the respiratory tract (<inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>) and the half-life of productively infected cells (<inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mi>δ</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>) could be estimated. Moreover, the cellular basic reproductive number (the expected number of secondary infected cells from a single productively infected cell placed in a population of susceptible cells) was calculated by<disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:mi mathvariant="normal">c</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mi>β</mml:mi><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>δ</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>For initial parameterization, <xref ref-type="disp-formula" rid="equ4 equ5 equ6">Equations (4)–(6)</xref> were simplified according to a quasi-steady state approximation (<xref ref-type="bibr" rid="bib42">Ikeda et al., 2016</xref>) to<disp-formula id="equ8"><label>(8)</label><mml:math id="m8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:mi>T</mml:mi><mml:mi>V</mml:mi></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ9"><label>(9)</label><mml:math id="m9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>r</mml:mi><mml:mi>T</mml:mi><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:mi>δ</mml:mi><mml:mi>V</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf25"><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mi>p</mml:mi><mml:mi>β</mml:mi><mml:mo>/</mml:mo><mml:mi>c</mml:mi></mml:math></inline-formula>, for a form with greater numerical stability. The system of differential equations was fitted on the mean estimates of SARS-CoV-2 rVL between -2 and 10 DFSO using the entirety of individual sample data in units of copies/ml. Numerical analysis was implemented using the Fit ODE app in OriginPro 2019b (OriginLab Corporation, Northampton, MA, USA) via the Runge–Kutta method and initial parameters <inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> of 4 copies/ml, 0 cells and 5 × 10<sup>7</sup> cells, respectively, for the range –5 to 10 DFSO. The analysis was first performed with <xref ref-type="disp-formula" rid="equ8 equ9">Equations (8) and (9)</xref>. These output parameters were then used to initialize final analysis using <xref ref-type="disp-formula" rid="equ4 equ5 equ6">Equations (4)–(6)</xref>, where the estimates for <inline-formula><mml:math id="inf29"><mml:mi>β</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf30"><mml:mi>δ</mml:mi></mml:math></inline-formula> were input as fixed and variable parameters, respectively. The fitted line and its coefficient of determination (<italic>r</italic><sup>2</sup>) were presented. The estimated half-life of SARS-CoV-2 RNA has a skewed 95% CI (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>). As <inline-formula><mml:math id="inf31"><mml:mi>c</mml:mi></mml:math></inline-formula> is in the denominator of the equation for half-life (<inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mo>/</mml:mo><mml:mi>c</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>), <inline-formula><mml:math id="inf33"><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is sensitive to <italic>c</italic> below 1, which is the case for its lower 95% CI (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4</xref>) and the source of the skew.</p><p>To estimate the average incubation period, we extrapolated the kinetic model to 0 log<sub>10</sub> copies/ml pre-symptom onset. To estimate the average duration of shedding, we extrapolated the model to 0 log<sub>10</sub> copies/ml post-symptom onset. Unlike in experimental studies, this estimate for duration of shedding was not defined by assay detection limits. To estimate the average DFSO on which SARS-CoV-2 concentration reached diagnostic levels, we extrapolated the model pre-symptom onset to the equivalent of 1 and 3 log<sub>10</sub> copies/ml (chosen as example assay detection limits) in specimen concentration for NPSs immersed in 1 ml of transport media, as described by the dilution factor estimation above. The average time from respiratory infection to reach diagnostic levels was then calculated by subtracting these values from the estimated average incubation period. The extrapolated time for SARS-CoV-2 to reach diagnostic concentrations in the respiratory tract should be validated in tracing studies, in which contacts are prospectively subjected to daily sampling.</p></sec><sec id="s4-8"><title>Likelihood of respiratory particles containing virions</title><p>To calculate an unbiased estimator for viral partitioning (the expected number of viable copies in an expelled particle at a given size), we multiplied rVLs with the volume equation for spherical particles during atomization and the estimated viability proportion, according to the following equation:<disp-formula id="equ10"><label>(10)</label><mml:math id="m10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>λ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>π</mml:mi><mml:mi>ρ</mml:mi><mml:msub><mml:mi>v</mml:mi><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mi>γ</mml:mi><mml:mi>υ</mml:mi></mml:mrow><mml:mn>6</mml:mn></mml:mfrac><mml:msup><mml:mi>d</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf34"><mml:mi>λ</mml:mi></mml:math></inline-formula> is the expectation value, <inline-formula><mml:math id="inf35"><mml:mi>ρ</mml:mi></mml:math></inline-formula> is the material density of the respiratory particle (997 kg/m<sup>3</sup>), <inline-formula><mml:math id="inf36"><mml:msub><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the volumetric conversion factor (1 ml/g), <inline-formula><mml:math id="inf37"><mml:mi>γ</mml:mi></mml:math></inline-formula> is the viability proportion, <inline-formula><mml:math id="inf38"><mml:mi>υ</mml:mi></mml:math></inline-formula> is the rVL and <inline-formula><mml:math id="inf39"><mml:mi>d</mml:mi></mml:math></inline-formula> is the hydrated diameter of the particle during atomization.</p><p>The model assumed <inline-formula><mml:math id="inf40"><mml:mi>γ</mml:mi></mml:math></inline-formula> was 0.1% as a population-level estimate. For influenza, approximately 0.1% of copies in particles expelled from the respiratory tract represent viable virus (<xref ref-type="bibr" rid="bib122">Yan et al., 2018</xref>), which is equivalent to one viable copy in 3 log<sub>10</sub> copies/ml for rVL or, after dilution in transport media, roughly one in 4 log<sub>10</sub> copies/ml for specimen concentration. Respiratory specimens taken from influenza cases show positive cultures for specimen concentrations down to 4 log<sub>10</sub> copies/ml (<xref ref-type="bibr" rid="bib54">Lau et al., 2010</xref>). Likewise, for COVID-19 cases, recent reports also show culture-positive respiratory specimens with SARS-CoV-2 concentrations down to 4 log<sub>10</sub> copies/ml (<xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref>), including from pediatric (<xref ref-type="bibr" rid="bib53">L'Huillier et al., 2020</xref>) and asymptomatic (<xref ref-type="bibr" rid="bib3">Arons et al., 2020</xref>) cases. Moreover, replication-competent SARS-CoV-2 has been found in respiratory specimens taken throughout the respiratory tract (mouth, nasopharynx, oropharynx and lower respiratory tract) (<xref ref-type="bibr" rid="bib47">Jeong et al., 2020</xref>; <xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref>). Taken together, these considerations suggested that the assumption for viability proportion (0.1%) was suitable to model the likelihood of respiratory particles containing viable SARS-CoV-2. In accordance with the discussion above, the model did not differentiate this population-level viability estimate based on age, symptomatology or sites of atomization. Based on the relative relationship between the residence time of expelled particles before assessment (~5 s) (<xref ref-type="bibr" rid="bib122">Yan et al., 2018</xref>), we took the viability proportion to be for equilibrated particles.</p><p>Likelihood profiles were determined using Poisson statistics, as described by the probability mass function<disp-formula id="equ11"><label>(11)</label><mml:math id="m11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>P</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>X</mml:mi><mml:mo>=</mml:mo><mml:mi>k</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>λ</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msup><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>λ</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf41"><mml:mi>k</mml:mi></mml:math></inline-formula> is the number of virions partitioned within the particle. For <inline-formula><mml:math id="inf42"><mml:mi>λ</mml:mi></mml:math></inline-formula>, 95% CIs were determined using the variance of its rVL estimate. To determine 95% CIs for likelihood profiles from the probability mass function, we used the delta method, which specifies<disp-formula id="equ12"><label>(12)</label><mml:math id="m12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>V</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>g</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="bold-italic">θ</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>≈</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mover><mml:mi>g</mml:mi><mml:mrow><mml:mo>˙</mml:mo></mml:mrow></mml:mover><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="bold-italic">θ</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>′</mml:mo></mml:msup><mml:mi>D</mml:mi><mml:mover><mml:mi>g</mml:mi><mml:mrow><mml:mo>˙</mml:mo></mml:mrow></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="bold-italic">θ</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf43"><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi mathvariant="bold">D</mml:mi></mml:math></inline-formula> is the covariance matrix of <inline-formula><mml:math id="inf44"><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:math></inline-formula> and <inline-formula><mml:math id="inf45"><mml:mover accent="true"><mml:mrow><mml:mi>g</mml:mi></mml:mrow><mml:mo>˙</mml:mo></mml:mover><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the gradient of <inline-formula><mml:math id="inf46"><mml:mi>g</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="bold-italic">θ</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula>. For the univariate Poisson distribution, <inline-formula><mml:math id="inf47"><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mi mathvariant="bold">D</mml:mi><mml:mo>=</mml:mo><mml:mi>λ</mml:mi></mml:math></inline-formula> and<disp-formula id="equ13"><label>(13)</label><mml:math id="m13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mover><mml:mi>g</mml:mi><mml:mrow><mml:mo>˙</mml:mo></mml:mrow></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mi>θ</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mi>λ</mml:mi><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>λ</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>!</mml:mo></mml:mrow></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>−</mml:mo><mml:mi>λ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p></sec><sec id="s4-9"><title>Rate profiles of particles expelled by respiratory activities</title><p>Distributions from the literature were used to determine the rate profiles of particles expelled during respiratory activities. For breathing, talking and coughing, we used data from <xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>. For singing, we used data from <xref ref-type="bibr" rid="bib82">Morawska et al., 2009</xref> for smaller aerosols (<italic>d</italic><sub>a</sub> &lt; 20 μm) and used the profiles from talking for larger aerosols and droplets based on the oral cavity mechanism from <xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>. Rate profiles (particles/min or particles/cough) were calculated based on the corrected normalized concentration (d<italic>C</italic><sub>n</sub>/dlog<italic>D</italic><sub>p</sub>, in units of particles/cm<sup>3</sup>) at each discrete particle size, normalization (32 size channels per decade) for the aerodynamic particle sizer used, unit conversion (cm<sup>3</sup> to l) and the sample flow rate (1 l/min). For coughing, the calculation assumed that participants coughed 10 times in the 30-s sampling interval. To determine the corrected normalized concentrations for breathing, we used a particle dilution factor of 4 and evaporation factor of 0.5, consistent with the other respiratory activities in <xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>. Breathing was taken to expel negligible quantities of larger respiratory particles based on the bronchiolar fluid film burst mechanism (<xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>). To account for intermittent breathing while talking and singing, the rate profiles for these activities included the contribution of aerosols expelled by breathing. We compared these rate profiles with those collected from talking loudly and talking quietly from <xref ref-type="bibr" rid="bib4">Asadi et al., 2020</xref>. In our models, we took the diameter of dehydrated respiratory particles to be 0.3 times the initial size when atomized in the respiratory tract (<xref ref-type="bibr" rid="bib48">Johnson et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Lieber et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Liu et al., 2017b</xref>). Equilibrium aerodynamic diameter was calculated by <inline-formula><mml:math id="inf48"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>ρ</mml:mi><mml:mo>/</mml:mo><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn><mml:mi/></mml:mrow></mml:msup></mml:math></inline-formula>, where <inline-formula><mml:math id="inf49"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the dehydrated diameter, <inline-formula><mml:math id="inf50"><mml:mi>ρ</mml:mi></mml:math></inline-formula> is the material density of the respiratory particle and <inline-formula><mml:math id="inf51"><mml:msub><mml:mrow><mml:mi>ρ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is the reference material density (1 g/cm<sup>3</sup>). Curves based on discrete particle measurements were connected using the nonparametric Akima spline function.</p></sec><sec id="s4-10"><title>Shedding virions via respiratory droplets and aerosols</title><p>To model the respiratory shedding rate across particle size, rVL estimates and the hydrated diameters of particles expelled by a respiratory activity were input into <xref ref-type="disp-formula" rid="equ10">Equation (10)</xref>, and the output was then multiplied by the rate profile of the activity (talking, singing, breathing or coughing). To assess the relative contribution of aerosols and droplets to mediating respiratory viral shedding for a given respiratory activity, we calculated the proportion of the cumulative hydrated volumetric rate contributed by buoyant aerosols (<italic>d</italic><sub>a</sub> ≤ 10 μm), long-range aerosols (10 μm &lt; <italic>d</italic><sub>a</sub> ≤ 50 μm), short-range aerosols (50 μm &lt; <italic>d</italic><sub>a</sub> ≤ 100 μm) and droplets (<italic>d</italic><sub>a</sub> &gt; 10 μm) for that respiratory activity. Since the Poisson mean was proportional to cumulative volumetric rate, this estimate of the relative contribution of aerosols and droplets to respiratory viral shedding was consistent among viruses and cps in the model.</p><p>To determine the total respiratory shedding rate for a given respiratory activity across cp, we determined the cumulative hydrated volumetric rate (by summing the hydrated volumetric rates across particle sizes for that respiratory activity) of particle atomization and input it into <xref ref-type="disp-formula" rid="equ10">Equation (10)</xref>. Using rVLs and their variances as determined by the Weibull quantile functions, we then calculated the Poisson means and their 95% CIs at the different cps.</p><p>To assess the influence of heterogeneity in rVL on individual infectiousness, we first considered transmission of A(H1N1)pdm09 via aerosols (<xref ref-type="bibr" rid="bib21">Cowling et al., 2013</xref>). The 50% human infectious dose (HID<sub>50</sub>) of aerosolized A(H1N1)pdm09 was taken to be 1–3 virions (<xref ref-type="bibr" rid="bib27">Fabian et al., 2008</xref>). To determine the expected time required for a A(H1N1)pdm09 case to shed one virion via aerosols, we took the reciprocal of the Poisson means and their 95% CIs at the different cps of the estimated shedding rates. The expected time required for a COVID-19 case to shed one virion via aerosols or one virion via droplets or aerosols was determined in a same manner.</p></sec><sec id="s4-11"><title>Data availability</title><p>The systematic dataset and model outputs from this study were uploaded to Zenodo (<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4658971">https://zenodo.org/record/4658971</ext-link>). The code generated during this study is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/paulzchen/sars2-heterogeneity">https://github.com/paulzchen/sars2-heterogeneity</ext-link>; <xref ref-type="bibr" rid="bib12">Chen, 2020</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:57b14db983deae91178faf5c83f85a6cedee91d4;origin=https://github.com/paulzchen/sars2-heterogeneity;visit=swh:1:snp:597ec3dc5321e259f925aec344c21e3e112ba518;anchor=swh:1:rev:06649ccfb6e92918b439332314ebf330abfa3d16">swh:1:rev:06649ccfb6e92918b439332314ebf330abfa3d16</ext-link>). The systematic review protocol was prospectively registered on PROSPERO (registration number, CRD42020204637).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank T Alba (Toronto) for discussion on statistical methods. We thank J Jimenez (Colorado) for discussion on the characteristics of aerosols and droplets. We thank E Lavezzo and A Chrisanti (Padova) and A Wyllie, A Ko and N Grubaugh (Yale) for responses to data inquiries. PZC was supported by the NSERC Vanier Scholarship (608544). DNF was supported by the Canadian Institutes of Health Research (Canadian COVID-19 Rapid Research Fund, OV4-170360). FXG was supported by the NSERC Senior Industrial Research Chair program, NSERC Discovery Grant program and the Toronto COVID-19 Action Fund.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Supervision, Funding acquisition, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-65774-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The systematic dataset and model outputs from this study are uploaded to Zenodo (<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4658971">https://zenodo.org/record/4658971</ext-link>). The code generated during this study is available at GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/paulzchen/sars2-heterogeneity">https://github.com/paulzchen/sars2-heterogeneity</ext-link>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:06649ccfb6e92918b439332314ebf330abfa3d16">https://archive.softwareheritage.org/swh:1:rev:06649ccfb6e92918b439332314ebf330abfa3d16</ext-link>). The systematic review protocol was prospectively registered on PROSPERO (registration number, CRD42020204637).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>PZ</given-names></name><name><surname>Bobrovitz</surname><given-names>N</given-names></name><name><surname>Premji</surname><given-names>Z</given-names></name><name><surname>Koopmans</surname><given-names>M</given-names></name><name><surname>Fisman</surname><given-names>DN</given-names></name><name><surname>Gu</surname><given-names>FX</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols</data-title><source>Zenodo</source><pub-id assigning-authority="Zenodo" pub-id-type="doi">10.5281/zenodo/4658971</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname> <given-names>DC</given-names></name><name><surname>Wu</surname> <given-names>P</given-names></name><name><surname>Wong</surname> <given-names>JY</given-names></name><name><surname>Lau</surname> <given-names>EHY</given-names></name><name><surname>Tsang</surname> <given-names>TK</given-names></name><name><surname>Cauchemez</surname> <given-names>S</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong</article-title><source>Nature Medicine</source><volume>26</volume><fpage>1714</fpage><lpage>1719</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-1092-0</pub-id><pub-id pub-id-type="pmid">32943787</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argyropoulos</surname> <given-names>KV</given-names></name><name><surname>Serrano</surname> <given-names>A</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Black</surname> <given-names>M</given-names></name><name><surname>Feng</surname> <given-names>X</given-names></name><name><surname>Shen</surname> <given-names>G</given-names></name><name><surname>Call</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>MJ</given-names></name><name><surname>Lytle</surname> <given-names>A</given-names></name><name><surname>Belovarac</surname> <given-names>B</given-names></name><name><surname>Vougiouklakis</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>LH</given-names></name><name><surname>Moran</surname> <given-names>U</given-names></name><name><surname>Heguy</surname> <given-names>A</given-names></name><name><surname>Troxel</surname> <given-names>A</given-names></name><name><surname>Snuderl</surname> <given-names>M</given-names></name><name><surname>Osman</surname> <given-names>I</given-names></name><name><surname>Cotzia</surname> <given-names>P</given-names></name><name><surname>Jour</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Patients with outcome and symptoms</article-title><source>The American Journal of Pathology</source><volume>190</volume><fpage>1881</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2020.07.001</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arons</surname> <given-names>MM</given-names></name><name><surname>Hatfield</surname> <given-names>KM</given-names></name><name><surname>Reddy</surname> <given-names>SC</given-names></name><name><surname>Kimball</surname> <given-names>A</given-names></name><name><surname>James</surname> <given-names>A</given-names></name><name><surname>Jacobs</surname> <given-names>JR</given-names></name><name><surname>Taylor</surname> <given-names>J</given-names></name><name><surname>Spicer</surname> <given-names>K</given-names></name><name><surname>Bardossy</surname> <given-names>AC</given-names></name><name><surname>Oakley</surname> <given-names>LP</given-names></name><name><surname>Tanwar</surname> <given-names>S</given-names></name><name><surname>Dyal</surname> <given-names>JW</given-names></name><name><surname>Harney</surname> <given-names>J</given-names></name><name><surname>Chisty</surname> <given-names>Z</given-names></name><name><surname>Bell</surname> <given-names>JM</given-names></name><name><surname>Methner</surname> <given-names>M</given-names></name><name><surname>Paul</surname> <given-names>P</given-names></name><name><surname>Carlson</surname> <given-names>CM</given-names></name><name><surname>McLaughlin</surname> <given-names>HP</given-names></name><name><surname>Thornburg</surname> <given-names>N</given-names></name><name><surname>Tong</surname> <given-names>S</given-names></name><name><surname>Tamin</surname> <given-names>A</given-names></name><name><surname>Tao</surname> <given-names>Y</given-names></name><name><surname>Uehara</surname> <given-names>A</given-names></name><name><surname>Harcourt</surname> <given-names>J</given-names></name><name><surname>Clark</surname> <given-names>S</given-names></name><name><surname>Brostrom-Smith</surname> <given-names>C</given-names></name><name><surname>Page</surname> <given-names>LC</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Lewis</surname> <given-names>J</given-names></name><name><surname>Montgomery</surname> <given-names>P</given-names></name><name><surname>Stone</surname> <given-names>ND</given-names></name><name><surname>Clark</surname> <given-names>TA</given-names></name><name><surname>Honein</surname> <given-names>MA</given-names></name><name><surname>Duchin</surname> <given-names>JS</given-names></name><name><surname>Jernigan</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>2081</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2008457</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadi</surname> <given-names>S</given-names></name><name><surname>Wexler</surname> <given-names>AS</given-names></name><name><surname>Cappa</surname> <given-names>CD</given-names></name><name><surname>Barreda</surname> <given-names>S</given-names></name><name><surname>Bouvier</surname> <given-names>NM</given-names></name><name><surname>Ristenpart</surname> <given-names>WD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Effect of voicing and articulation manner on aerosol particle emission during human speech</article-title><source>PLOS ONE</source><volume>15</volume><elocation-id>e0227699</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0227699</pub-id><pub-id pub-id-type="pmid">31986165</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baccam</surname> <given-names>P</given-names></name><name><surname>Beauchemin</surname> <given-names>C</given-names></name><name><surname>Macken</surname> <given-names>CA</given-names></name><name><surname>Hayden</surname> <given-names>FG</given-names></name><name><surname>Perelson</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Kinetics of influenza A virus infection in humans</article-title><source>Journal of Virology</source><volume>80</volume><fpage>7590</fpage><lpage>7599</lpage><pub-id pub-id-type="doi">10.1128/JVI.01623-05</pub-id><pub-id pub-id-type="pmid">16840338</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggio</surname> <given-names>S</given-names></name><name><surname>L'Huillier</surname> <given-names>AG</given-names></name><name><surname>Yerly</surname> <given-names>S</given-names></name><name><surname>Bellon</surname> <given-names>M</given-names></name><name><surname>Wagner</surname> <given-names>N</given-names></name><name><surname>Rohr</surname> <given-names>M</given-names></name><name><surname>Huttner</surname> <given-names>A</given-names></name><name><surname>Blanchard-Rohner</surname> <given-names>G</given-names></name><name><surname>Loevy</surname> <given-names>N</given-names></name><name><surname>Kaiser</surname> <given-names>L</given-names></name><name><surname>Jacquerioz</surname> <given-names>F</given-names></name><name><surname>Eckerle</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19</article-title><source>Clinical Infectious Diseases</source><volume>6</volume><elocation-id>ciaa1157</elocation-id><pub-id pub-id-type="doi">10.1093/cid/ciaa1157</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname> <given-names>Q</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Mei</surname> <given-names>S</given-names></name><name><surname>Ye</surname> <given-names>C</given-names></name><name><surname>Zou</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>L</given-names></name><name><surname>Truelove</surname> <given-names>SA</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>Gao</surname> <given-names>W</given-names></name><name><surname>Cheng</surname> <given-names>C</given-names></name><name><surname>Tang</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>T</given-names></name><name><surname>Lessler</surname> <given-names>J</given-names></name><name><surname>Feng</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study</article-title><source>The Lancet Infectious Diseases</source><volume>20</volume><fpage>911</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30287-5</pub-id><pub-id pub-id-type="pmid">32353347</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname> <given-names>JC</given-names></name><name><surname>de Ruiter</surname> <given-names>R</given-names></name><name><surname>Courbin</surname> <given-names>L</given-names></name><name><surname>Stone</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Daughter bubble cascades produced by folding of ruptured thin films</article-title><source>Nature</source><volume>465</volume><fpage>759</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1038/nature09069</pub-id><pub-id pub-id-type="pmid">20535206</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugger</surname> <given-names>J</given-names></name><name><surname>Althaus</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transmission of and susceptibility to seasonal influenza in Switzerland from 2003 to 2015</article-title><source>Epidemics</source><volume>30</volume><elocation-id>100373</elocation-id><pub-id pub-id-type="doi">10.1016/j.epidem.2019.100373</pub-id><pub-id pub-id-type="pmid">31635972</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>PK</given-names></name><name><surname>Lee</surname> <given-names>N</given-names></name><name><surname>Joynt</surname> <given-names>GM</given-names></name><name><surname>Choi</surname> <given-names>KW</given-names></name><name><surname>Cheung</surname> <given-names>JL</given-names></name><name><surname>Yeung</surname> <given-names>AC</given-names></name><name><surname>Lam</surname> <given-names>P</given-names></name><name><surname>Wong</surname> <given-names>R</given-names></name><name><surname>Leung</surname> <given-names>BW</given-names></name><name><surname>So</surname> <given-names>HY</given-names></name><name><surname>Lam</surname> <given-names>WY</given-names></name><name><surname>Hui</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus</article-title><source>Journal of Clinical Virology</source><volume>50</volume><fpage>320</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2011.01.013</pub-id><pub-id pub-id-type="pmid">21330192</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>WJ</given-names></name><name><surname>Yang</surname> <given-names>JY</given-names></name><name><surname>Lin</surname> <given-names>JH</given-names></name><name><surname>Fann</surname> <given-names>CS</given-names></name><name><surname>Osyetrov</surname> <given-names>V</given-names></name><name><surname>King</surname> <given-names>CC</given-names></name><name><surname>Chen</surname> <given-names>YM</given-names></name><name><surname>Chang</surname> <given-names>HL</given-names></name><name><surname>Kuo</surname> <given-names>HW</given-names></name><name><surname>Liao</surname> <given-names>F</given-names></name><name><surname>Ho</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms</article-title><source>Clinical Infectious Diseases</source><volume>42</volume><fpage>1561</fpage><lpage>1569</lpage><pub-id pub-id-type="doi">10.1086/503843</pub-id><pub-id pub-id-type="pmid">16652313</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>PZ</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>sars2-heterogeneity</data-title><source>GitHub</source><version designator="06649cc">06649cc</version><ext-link ext-link-type="uri" xlink:href="https://github.com/paulzchen/sars2-heterogeneity">https://github.com/paulzchen/sars2-heterogeneity</ext-link></element-citation></ref><ref id="bib13"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>PZ</given-names></name><name><surname>Bobrovitz</surname> <given-names>N</given-names></name><name><surname>Premji</surname> <given-names>Z</given-names></name><name><surname>Koopmans</surname> <given-names>M</given-names></name><name><surname>Fisman</surname> <given-names>DN</given-names></name><name><surname>Gu</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2021.02.17.21251926</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>VC</given-names></name><name><surname>Hung</surname> <given-names>IF</given-names></name><name><surname>Tang</surname> <given-names>BS</given-names></name><name><surname>Chu</surname> <given-names>CM</given-names></name><name><surname>Wong</surname> <given-names>MM</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Wu</surname> <given-names>AK</given-names></name><name><surname>Tse</surname> <given-names>DM</given-names></name><name><surname>Chan</surname> <given-names>KS</given-names></name><name><surname>Zheng</surname> <given-names>BJ</given-names></name><name><surname>Peiris</surname> <given-names>JS</given-names></name><name><surname>Sung</surname> <given-names>JJ</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome</article-title><source>Clinical Infectious Diseases</source><volume>38</volume><fpage>467</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1086/382681</pub-id><pub-id pub-id-type="pmid">14765337</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>PK</given-names></name><name><surname>Wong</surname> <given-names>KK</given-names></name><name><surname>Mak</surname> <given-names>GC</given-names></name><name><surname>Wong</surname> <given-names>AH</given-names></name><name><surname>Ng</surname> <given-names>AY</given-names></name><name><surname>Chow</surname> <given-names>SY</given-names></name><name><surname>Lam</surname> <given-names>RK</given-names></name><name><surname>Lau</surname> <given-names>CS</given-names></name><name><surname>Ng</surname> <given-names>KC</given-names></name><name><surname>Lim</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load</article-title><source>Journal of Clinical Virology</source><volume>47</volume><fpage>182</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2009.11.022</pub-id><pub-id pub-id-type="pmid">20022296</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>HY</given-names></name><name><surname>Jian</surname> <given-names>SW</given-names></name><name><surname>Liu</surname> <given-names>DP</given-names></name><name><surname>Ng</surname> <given-names>TC</given-names></name><name><surname>Huang</surname> <given-names>WT</given-names></name><name><surname>Lin</surname> <given-names>HH</given-names></name><collab>Taiwan COVID-19 Outbreak Investigation Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset</article-title><source>JAMA Internal Medicine</source><volume>180</volume><fpage>1156</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2020.2020</pub-id><pub-id pub-id-type="pmid">32356867</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>CM</given-names></name><name><surname>Cheng</surname> <given-names>VC</given-names></name><name><surname>Hung</surname> <given-names>IF</given-names></name><name><surname>Wong</surname> <given-names>MM</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Chan</surname> <given-names>KS</given-names></name><name><surname>Kao</surname> <given-names>RY</given-names></name><name><surname>Poon</surname> <given-names>LL</given-names></name><name><surname>Wong</surname> <given-names>CL</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Peiris</surname> <given-names>JS</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name><collab>HKU/UCH SARS Study Group</collab></person-group><year iso-8601-date="2004">2004</year><article-title>Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings</article-title><source>Thorax</source><volume>59</volume><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1136/thorax.2003.012658</pub-id><pub-id pub-id-type="pmid">14985565</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>CM</given-names></name><name><surname>Cheng</surname> <given-names>VC</given-names></name><name><surname>Hung</surname> <given-names>IF</given-names></name><name><surname>Chan</surname> <given-names>KS</given-names></name><name><surname>Tang</surname> <given-names>BS</given-names></name><name><surname>Tsang</surname> <given-names>TH</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Viral load distribution in SARS outbreak</article-title><source>Emerging Infectious Diseases</source><volume>11</volume><fpage>1882</fpage><lpage>1886</lpage><pub-id pub-id-type="doi">10.3201/eid1112.040949</pub-id><pub-id pub-id-type="pmid">16485474</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>DK</given-names></name><name><surname>Akl</surname> <given-names>EA</given-names></name><name><surname>Duda</surname> <given-names>S</given-names></name><name><surname>Solo</surname> <given-names>K</given-names></name><name><surname>Yaacoub</surname> <given-names>S</given-names></name><name><surname>Schünemann</surname> <given-names>HJ</given-names></name><name><surname>Chu</surname> <given-names>DK</given-names></name><name><surname>Akl</surname> <given-names>EA</given-names></name><name><surname>El-harakeh</surname> <given-names>A</given-names></name><name><surname>Bognanni</surname> <given-names>A</given-names></name><name><surname>Lotfi</surname> <given-names>T</given-names></name><name><surname>Loeb</surname> <given-names>M</given-names></name><name><surname>Hajizadeh</surname> <given-names>A</given-names></name><name><surname>Bak</surname> <given-names>A</given-names></name><name><surname>Izcovich</surname> <given-names>A</given-names></name><name><surname>Cuello-Garcia</surname> <given-names>CA</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Harris</surname> <given-names>DJ</given-names></name><name><surname>Borowiack</surname> <given-names>E</given-names></name><name><surname>Chamseddine</surname> <given-names>F</given-names></name><name><surname>Schünemann</surname> <given-names>F</given-names></name><name><surname>Morgano</surname> <given-names>GP</given-names></name><name><surname>Muti Schünemann</surname> <given-names>GEU</given-names></name><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Neumann</surname> <given-names>I</given-names></name><name><surname>Chan</surname> <given-names>J</given-names></name><name><surname>Khabsa</surname> <given-names>J</given-names></name><name><surname>Hneiny</surname> <given-names>L</given-names></name><name><surname>Harrison</surname> <given-names>L</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Rizk</surname> <given-names>N</given-names></name><name><surname>Giorgi Rossi</surname> <given-names>P</given-names></name><name><surname>AbiHanna</surname> <given-names>P</given-names></name><name><surname>El-khoury</surname> <given-names>R</given-names></name><name><surname>Stalteri</surname> <given-names>R</given-names></name><name><surname>Baldeh</surname> <given-names>T</given-names></name><name><surname>Piggott</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Saad</surname> <given-names>Z</given-names></name><name><surname>Khamis</surname> <given-names>A</given-names></name><name><surname>Reinap</surname> <given-names>M</given-names></name><name><surname>Duda</surname> <given-names>S</given-names></name><name><surname>Solo</surname> <given-names>K</given-names></name><name><surname>Yaacoub</surname> <given-names>S</given-names></name><name><surname>Schünemann</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis</article-title><source>The Lancet</source><volume>395</volume><fpage>1973</fpage><lpage>1987</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31142-9</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Fang</surname> <given-names>VJ</given-names></name><name><surname>Lau</surname> <given-names>LLH</given-names></name><name><surname>So</surname> <given-names>HC</given-names></name><name><surname>Fung</surname> <given-names>ROP</given-names></name><name><surname>Ma</surname> <given-names>ESK</given-names></name><name><surname>Kwong</surname> <given-names>ASK</given-names></name><name><surname>Chan</surname> <given-names>C-W</given-names></name><name><surname>Tsui</surname> <given-names>WWS</given-names></name><name><surname>Ngai</surname> <given-names>H-Y</given-names></name><name><surname>Chu</surname> <given-names>DWS</given-names></name><name><surname>Lee</surname> <given-names>PWY</given-names></name><name><surname>Chiu</surname> <given-names>M-C</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Peiris</surname> <given-names>JSM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Comparative epidemiology of pandemic and seasonal influenza A in households</article-title><source>New England Journal of Medicine</source><volume>362</volume><fpage>2175</fpage><lpage>2184</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0911530</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Ip</surname> <given-names>DKM</given-names></name><name><surname>Fang</surname> <given-names>VJ</given-names></name><name><surname>Suntarattiwong</surname> <given-names>P</given-names></name><name><surname>Olsen</surname> <given-names>SJ</given-names></name><name><surname>Levy</surname> <given-names>J</given-names></name><name><surname>Uyeki</surname> <given-names>TM</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Malik Peiris</surname> <given-names>JS</given-names></name><name><surname>Chotpitayasunondh</surname> <given-names>T</given-names></name><name><surname>Nishiura</surname> <given-names>H</given-names></name><name><surname>Mark Simmerman</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Aerosol transmission is an important mode of influenza A virus spread</article-title><source>Nature Communications</source><volume>4</volume><elocation-id>1935</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms2922</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>E</given-names></name><name><surname>Du</surname> <given-names>H</given-names></name><name><surname>Gardner</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title><source>The Lancet Infectious Diseases</source><volume>20</volume><fpage>533</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30120-1</pub-id><pub-id pub-id-type="pmid">32087114</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>Z</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Meyers</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Serial interval of COVID-19 among publicly reported confirmed cases</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>1341</fpage><lpage>1343</lpage><pub-id pub-id-type="doi">10.3201/eid2606.200357</pub-id><pub-id pub-id-type="pmid">32191173</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duchamp</surname> <given-names>MB</given-names></name><name><surname>Casalegno</surname> <given-names>JS</given-names></name><name><surname>Gillet</surname> <given-names>Y</given-names></name><name><surname>Frobert</surname> <given-names>E</given-names></name><name><surname>Bernard</surname> <given-names>E</given-names></name><name><surname>Escuret</surname> <given-names>V</given-names></name><name><surname>Billaud</surname> <given-names>G</given-names></name><name><surname>Valette</surname> <given-names>M</given-names></name><name><surname>Javouhey</surname> <given-names>E</given-names></name><name><surname>Lina</surname> <given-names>B</given-names></name><name><surname>Floret</surname> <given-names>D</given-names></name><name><surname>Morfin</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Pandemic A(H1N1)2009 influenza virus detection by real time RT-PCR: is viral quantification useful?</article-title><source>Clinical Microbiology and Infection</source><volume>16</volume><fpage>317</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03169.x</pub-id><pub-id pub-id-type="pmid">20121827</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname> <given-names>A</given-names></name><name><surname>Abbott</surname> <given-names>S</given-names></name><name><surname>Kucharski</surname> <given-names>AJ</given-names></name><name><surname>Funk</surname> <given-names>S</given-names></name><collab>Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China</article-title><source>Wellcome Open Research</source><volume>5</volume><elocation-id>67</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15842.3</pub-id><pub-id pub-id-type="pmid">32685698</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname> <given-names>S</given-names></name><name><surname>Daleno</surname> <given-names>C</given-names></name><name><surname>Baldanti</surname> <given-names>F</given-names></name><name><surname>Scala</surname> <given-names>A</given-names></name><name><surname>Campanini</surname> <given-names>G</given-names></name><name><surname>Taroni</surname> <given-names>F</given-names></name><name><surname>Fossali</surname> <given-names>E</given-names></name><name><surname>Pelucchi</surname> <given-names>C</given-names></name><name><surname>Principi</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus</article-title><source>Virology Journal</source><volume>8</volume><elocation-id>349</elocation-id><pub-id pub-id-type="doi">10.1186/1743-422X-8-349</pub-id><pub-id pub-id-type="pmid">21752272</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabian</surname> <given-names>P</given-names></name><name><surname>McDevitt</surname> <given-names>JJ</given-names></name><name><surname>DeHaan</surname> <given-names>WH</given-names></name><name><surname>Fung</surname> <given-names>ROP</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Milton</surname> <given-names>DK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Influenza virus in human exhaled breath: an observational study</article-title><source>PLOS ONE</source><volume>3</volume><elocation-id>e2691</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0002691</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajnzylber</surname> <given-names>J</given-names></name><name><surname>Regan</surname> <given-names>J</given-names></name><name><surname>Coxen</surname> <given-names>K</given-names></name><name><surname>Corry</surname> <given-names>H</given-names></name><name><surname>Wong</surname> <given-names>C</given-names></name><name><surname>Rosenthal</surname> <given-names>A</given-names></name><name><surname>Worrall</surname> <given-names>D</given-names></name><name><surname>Giguel</surname> <given-names>F</given-names></name><name><surname>Piechocka-Trocha</surname> <given-names>A</given-names></name><name><surname>Atyeo</surname> <given-names>C</given-names></name><name><surname>Fischinger</surname> <given-names>S</given-names></name><name><surname>Chan</surname> <given-names>A</given-names></name><name><surname>Flaherty</surname> <given-names>KT</given-names></name><name><surname>Hall</surname> <given-names>K</given-names></name><name><surname>Dougan</surname> <given-names>M</given-names></name><name><surname>Ryan</surname> <given-names>ET</given-names></name><name><surname>Gillespie</surname> <given-names>E</given-names></name><name><surname>Chishti</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Jilg</surname> <given-names>N</given-names></name><name><surname>Hanidziar</surname> <given-names>D</given-names></name><name><surname>Baron</surname> <given-names>RM</given-names></name><name><surname>Baden</surname> <given-names>L</given-names></name><name><surname>Tsibris</surname> <given-names>AM</given-names></name><name><surname>Armstrong</surname> <given-names>KA</given-names></name><name><surname>Kuritzkes</surname> <given-names>DR</given-names></name><name><surname>Alter</surname> <given-names>G</given-names></name><name><surname>Walker</surname> <given-names>BD</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>JZ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 viral load is associated with increased disease severity and mortality</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5493</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19057-5</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Fears</surname> <given-names>AC</given-names></name><name><surname>Klimstra</surname> <given-names>WB</given-names></name><name><surname>Duprex</surname> <given-names>P</given-names></name><name><surname>Hartman</surname> <given-names>A</given-names></name><name><surname>Weaver</surname> <given-names>SC</given-names></name><name><surname>Plante</surname> <given-names>KC</given-names></name><name><surname>Roy</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.04.13.20063784</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname> <given-names>WJ</given-names></name><name><surname>Ni</surname> <given-names>ZY</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Liang</surname> <given-names>WH</given-names></name><name><surname>Ou</surname> <given-names>CQ</given-names></name><name><surname>He</surname> <given-names>JX</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Shan</surname> <given-names>H</given-names></name><name><surname>Lei</surname> <given-names>CL</given-names></name><name><surname>Hui</surname> <given-names>DSC</given-names></name><name><surname>Du</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>LJ</given-names></name><name><surname>Zeng</surname> <given-names>G</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name><name><surname>Chen</surname> <given-names>RC</given-names></name><name><surname>Tang</surname> <given-names>CL</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>PY</given-names></name><name><surname>Xiang</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>SY</given-names></name><name><surname>Wang</surname> <given-names>JL</given-names></name><name><surname>Liang</surname> <given-names>ZJ</given-names></name><name><surname>Peng</surname> <given-names>YX</given-names></name><name><surname>Wei</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Hu</surname> <given-names>YH</given-names></name><name><surname>Peng</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>JM</given-names></name><name><surname>Liu</surname> <given-names>JY</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>G</given-names></name><name><surname>Zheng</surname> <given-names>ZJ</given-names></name><name><surname>Qiu</surname> <given-names>SQ</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Ye</surname> <given-names>CJ</given-names></name><name><surname>Zhu</surname> <given-names>SY</given-names></name><name><surname>Zhong</surname> <given-names>NS</given-names></name><collab>China Medical Treatment Expert Group for Covid-19</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>1708</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id><pub-id pub-id-type="pmid">32109013</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamner</surname> <given-names>L</given-names></name><name><surname>Dubbel</surname> <given-names>P</given-names></name><name><surname>Capron</surname> <given-names>I</given-names></name><name><surname>Ross</surname> <given-names>A</given-names></name><name><surname>Jordan</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Lynn</surname> <given-names>J</given-names></name><name><surname>Ball</surname> <given-names>A</given-names></name><name><surname>Narwal</surname> <given-names>S</given-names></name><name><surname>Russell</surname> <given-names>S</given-names></name><name><surname>Patrick</surname> <given-names>D</given-names></name><name><surname>Leibrand</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit county, Washington, march 2020</article-title><source>MMWR. Morbidity and Mortality Weekly Report</source><volume>69</volume><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6919e6</pub-id><pub-id pub-id-type="pmid">32407303</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>MS</given-names></name><name><surname>Seong</surname> <given-names>MW</given-names></name><name><surname>Heo</surname> <given-names>EY</given-names></name><name><surname>Park</surname> <given-names>JH</given-names></name><name><surname>Kim</surname> <given-names>N</given-names></name><name><surname>Shin</surname> <given-names>S</given-names></name><name><surname>Cho</surname> <given-names>SI</given-names></name><name><surname>Park</surname> <given-names>SS</given-names></name><name><surname>Choi</surname> <given-names>EH</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Sequential analysis of viral load in a neonate and her mother infected with severe acute respiratory syndrome coronavirus 2</article-title><source>Clinical Infectious Diseases</source><volume>71</volume><fpage>2236</fpage><lpage>2239</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa447</pub-id><pub-id pub-id-type="pmid">32297925</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>MS</given-names></name><name><surname>Seong</surname> <given-names>MW</given-names></name><name><surname>Kim</surname> <given-names>N</given-names></name><name><surname>Shin</surname> <given-names>S</given-names></name><name><surname>Cho</surname> <given-names>SI</given-names></name><name><surname>Park</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>TS</given-names></name><name><surname>Park</surname> <given-names>SS</given-names></name><name><surname>Choi</surname> <given-names>EH</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul, South Korea</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>2497</fpage><lpage>2499</lpage><pub-id pub-id-type="doi">10.3201/eid2610.202449</pub-id><pub-id pub-id-type="pmid">32497001</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>MS</given-names></name><name><surname>Byun</surname> <given-names>JH</given-names></name><name><surname>Cho</surname> <given-names>Y</given-names></name><name><surname>Rim</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>RT-PCR for SARS-CoV-2: quantitative versus qualitative</article-title><source>The Lancet Infectious Diseases</source><volume>21</volume><elocation-id>165</elocation-id><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30424-2</pub-id><pub-id pub-id-type="pmid">32445709</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>X</given-names></name><name><surname>Cheng</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Wu</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reconstruction of the full transmission dynamics of COVID-19 in Wuhan</article-title><source>Nature</source><volume>584</volume><fpage>420</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2554-8</pub-id><pub-id pub-id-type="pmid">32674112</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>X</given-names></name><name><surname>Lau</surname> <given-names>EHY</given-names></name><name><surname>Wu</surname> <given-names>P</given-names></name><name><surname>Deng</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>X</given-names></name><name><surname>Lau</surname> <given-names>YC</given-names></name><name><surname>Wong</surname> <given-names>JY</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Tan</surname> <given-names>X</given-names></name><name><surname>Mo</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Liao</surname> <given-names>B</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Hu</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Zhong</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title><source>Nature Medicine</source><volume>26</volume><fpage>672</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0869-5</pub-id><pub-id pub-id-type="pmid">32296168</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Higgins</surname> <given-names>JPT</given-names></name><name><surname>Thomas</surname> <given-names>J</given-names></name><name><surname>Chandler</surname> <given-names>J</given-names></name><name><surname>Cumpston</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Page</surname> <given-names>MJ</given-names></name><name><surname>Welch</surname> <given-names>VA</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>Cochrane Handbook for Systematic Reviews of Interventions, Cochrane Book Series</source><edition>2nd ed</edition><publisher-loc>Chichester, UK</publisher-loc><publisher-name>John Wiley &amp; Sons</publisher-name></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname> <given-names>IFN</given-names></name><name><surname>Cheng</surname> <given-names>VCC</given-names></name><name><surname>Wu</surname> <given-names>AKL</given-names></name><name><surname>Tang</surname> <given-names>BSF</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Chu</surname> <given-names>CM</given-names></name><name><surname>Wong</surname> <given-names>MML</given-names></name><name><surname>Hui</surname> <given-names>WT</given-names></name><name><surname>Poon</surname> <given-names>LLM</given-names></name><name><surname>Tse</surname> <given-names>DMW</given-names></name><name><surname>Chan</surname> <given-names>KS</given-names></name><name><surname>Woo</surname> <given-names>PCY</given-names></name><name><surname>Lau</surname> <given-names>SKP</given-names></name><name><surname>Peiris</surname> <given-names>JSM</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Viral loads in clinical specimens and SARS manifestations</article-title><source>Emerging Infectious Diseases</source><volume>10</volume><fpage>1550</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.3201/eid1009.040058</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname> <given-names>IF</given-names></name><name><surname>To</surname> <given-names>KK</given-names></name><name><surname>Lee</surname> <given-names>CK</given-names></name><name><surname>Lin</surname> <given-names>CK</given-names></name><name><surname>Chan</surname> <given-names>JF</given-names></name><name><surname>Tse</surname> <given-names>H</given-names></name><name><surname>Cheng</surname> <given-names>VC</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Ho</surname> <given-names>PL</given-names></name><name><surname>Tse</surname> <given-names>CW</given-names></name><name><surname>Ng</surname> <given-names>TK</given-names></name><name><surname>Que</surname> <given-names>TL</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009</article-title><source>Clinical Infectious Diseases</source><volume>51</volume><fpage>274</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1086/653940</pub-id><pub-id pub-id-type="pmid">20575664</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname> <given-names>IF-N</given-names></name><name><surname>Lung</surname> <given-names>K-C</given-names></name><name><surname>Tso</surname> <given-names>EY-K</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Chung</surname> <given-names>TW-H</given-names></name><name><surname>Chu</surname> <given-names>M-Y</given-names></name><name><surname>Ng</surname> <given-names>Y-Y</given-names></name><name><surname>Lo</surname> <given-names>J</given-names></name><name><surname>Chan</surname> <given-names>J</given-names></name><name><surname>Tam</surname> <given-names>AR</given-names></name><name><surname>Shum</surname> <given-names>H-P</given-names></name><name><surname>Chan</surname> <given-names>V</given-names></name><name><surname>Wu</surname> <given-names>AK-L</given-names></name><name><surname>Sin</surname> <given-names>K-M</given-names></name><name><surname>Leung</surname> <given-names>W-S</given-names></name><name><surname>Law</surname> <given-names>W-L</given-names></name><name><surname>Lung</surname> <given-names>DC</given-names></name><name><surname>Sin</surname> <given-names>S</given-names></name><name><surname>Yeung</surname> <given-names>P</given-names></name><name><surname>Yip</surname> <given-names>CC-Y</given-names></name><name><surname>Zhang</surname> <given-names>RR</given-names></name><name><surname>Fung</surname> <given-names>AY-F</given-names></name><name><surname>Yan</surname> <given-names>EY-W</given-names></name><name><surname>Leung</surname> <given-names>K-H</given-names></name><name><surname>Ip</surname> <given-names>JD</given-names></name><name><surname>Chu</surname> <given-names>AW-H</given-names></name><name><surname>Chan</surname> <given-names>W-M</given-names></name><name><surname>Ng</surname> <given-names>AC-K</given-names></name><name><surname>Lee</surname> <given-names>R</given-names></name><name><surname>Fung</surname> <given-names>K</given-names></name><name><surname>Yeung</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>T-C</given-names></name><name><surname>Chan</surname> <given-names>JW-M</given-names></name><name><surname>Yan</surname> <given-names>W-W</given-names></name><name><surname>Chan</surname> <given-names>W-M</given-names></name><name><surname>Chan</surname> <given-names>JF-W</given-names></name><name><surname>Lie</surname> <given-names>AK-W</given-names></name><name><surname>Tsang</surname> <given-names>OT-Y</given-names></name><name><surname>Cheng</surname> <given-names>VC-C</given-names></name><name><surname>Que</surname> <given-names>T-L</given-names></name><name><surname>Lau</surname> <given-names>C-S</given-names></name><name><surname>Chan</surname> <given-names>K-H</given-names></name><name><surname>To</surname> <given-names>KK-W</given-names></name><name><surname>Yuen</surname> <given-names>K-Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial</article-title><source>The Lancet</source><volume>395</volume><fpage>1695</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31042-4</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Hurst</surname> <given-names>JH</given-names></name><name><surname>Heston</surname> <given-names>SM</given-names></name><name><surname>Chambers</surname> <given-names>HN</given-names></name><name><surname>Cunningham</surname> <given-names>HM</given-names></name><name><surname>Price</surname> <given-names>MJ</given-names></name><name><surname>Suarez</surname> <given-names>L</given-names></name><name><surname>Kelly</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 infections among children in the biospecimens from respiratory virus-exposed kids (BRAVE kids) study</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.08.18.20166835</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname> <given-names>H</given-names></name><name><surname>Nakaoka</surname> <given-names>S</given-names></name><name><surname>de Boer</surname> <given-names>RJ</given-names></name><name><surname>Morita</surname> <given-names>S</given-names></name><name><surname>Misawa</surname> <given-names>N</given-names></name><name><surname>Koyanagi</surname> <given-names>Y</given-names></name><name><surname>Aihara</surname> <given-names>K</given-names></name><name><surname>Sato</surname> <given-names>K</given-names></name><name><surname>Iwami</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Quantifying the effect of vpu on the promotion of HIV-1 replication in the humanized mouse model</article-title><source>Retrovirology</source><volume>13</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1186/s12977-016-0252-2</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname> <given-names>DKM</given-names></name><name><surname>Lau</surname> <given-names>LLH</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Fang</surname> <given-names>VJ</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Peiris</surname> <given-names>MJS</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections</article-title><source>Clinical Infectious Diseases</source><volume>62</volume><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1093/cid/civ909</pub-id><pub-id pub-id-type="pmid">26518469</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname> <given-names>DK</given-names></name><name><surname>Lau</surname> <given-names>LL</given-names></name><name><surname>Leung</surname> <given-names>NH</given-names></name><name><surname>Fang</surname> <given-names>VJ</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Chu</surname> <given-names>DK</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Peiris</surname> <given-names>JS</given-names></name><name><surname>Uyeki</surname> <given-names>TM</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Viral shedding and transmission potential of asymptomatic and paucisymptomatic influenza virus infections in the community</article-title><source>Clinical Infectious Diseases</source><volume>64</volume><fpage>736</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw841</pub-id><pub-id pub-id-type="pmid">28011603</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>M</given-names></name><name><surname>Nukuzuma</surname> <given-names>S</given-names></name><name><surname>Sugie</surname> <given-names>M</given-names></name><name><surname>Yoshioka</surname> <given-names>M</given-names></name><name><surname>Kon-no</surname> <given-names>M</given-names></name><name><surname>Yasutake</surname> <given-names>H</given-names></name><name><surname>Umegaki</surname> <given-names>Y</given-names></name><name><surname>Ishikawa</surname> <given-names>Y</given-names></name><name><surname>Yano</surname> <given-names>T</given-names></name><name><surname>Ihara</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Detection of pandemic influenza A (H1N1) 2009 virus RNA by real-time reverse transcription polymerase chain reaction</article-title><source>Pediatrics International</source><volume>54</volume><fpage>959</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1111/j.1442-200X.2012.03720.x</pub-id><pub-id pub-id-type="pmid">22924941</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname> <given-names>S</given-names></name><name><surname>Fujisawa</surname> <given-names>S</given-names></name><name><surname>Nakakubo</surname> <given-names>S</given-names></name><name><surname>Kamada</surname> <given-names>K</given-names></name><name><surname>Yamashita</surname> <given-names>Y</given-names></name><name><surname>Fukumoto</surname> <given-names>T</given-names></name><name><surname>Sato</surname> <given-names>K</given-names></name><name><surname>Oguri</surname> <given-names>S</given-names></name><name><surname>Taki</surname> <given-names>K</given-names></name><name><surname>Senjo</surname> <given-names>H</given-names></name><name><surname>Sugita</surname> <given-names>J</given-names></name><name><surname>Hayasaka</surname> <given-names>K</given-names></name><name><surname>Konno</surname> <given-names>S</given-names></name><name><surname>Nishida</surname> <given-names>M</given-names></name><name><surname>Teshima</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva</article-title><source>Journal of Infection</source><volume>81</volume><fpage>e145</fpage><lpage>e147</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.071</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname> <given-names>HW</given-names></name><name><surname>Kim</surname> <given-names>SM</given-names></name><name><surname>Kim</surname> <given-names>HS</given-names></name><name><surname>Kim</surname> <given-names>YI</given-names></name><name><surname>Kim</surname> <given-names>JH</given-names></name><name><surname>Cho</surname> <given-names>JY</given-names></name><name><surname>Kim</surname> <given-names>SH</given-names></name><name><surname>Kang</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>SG</given-names></name><name><surname>Park</surname> <given-names>SJ</given-names></name><name><surname>Kim</surname> <given-names>EH</given-names></name><name><surname>Choi</surname> <given-names>YK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Viable SARS-CoV-2 in various specimens from COVID-19 patients</article-title><source>Clinical Microbiology and Infection</source><volume>26</volume><fpage>1520</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2020.07.020</pub-id><pub-id pub-id-type="pmid">32711057</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>GR</given-names></name><name><surname>Morawska</surname> <given-names>L</given-names></name><name><surname>Ristovski</surname> <given-names>ZD</given-names></name><name><surname>Hargreaves</surname> <given-names>M</given-names></name><name><surname>Mengersen</surname> <given-names>K</given-names></name><name><surname>Chao</surname> <given-names>CYH</given-names></name><name><surname>Wan</surname> <given-names>MP</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Xie</surname> <given-names>X</given-names></name><name><surname>Katoshevski</surname> <given-names>D</given-names></name><name><surname>Corbett</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Modality of human expired aerosol size distributions</article-title><source>Journal of Aerosol Science</source><volume>42</volume><fpage>839</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1016/j.jaerosci.2011.07.009</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>GR</given-names></name><name><surname>Morawska</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The mechanism of breath aerosol formation</article-title><source>Journal of Aerosol Medicine and Pulmonary Drug Delivery</source><volume>22</volume><fpage>229</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1089/jamp.2008.0720</pub-id><pub-id pub-id-type="pmid">19415984</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname> <given-names>KM</given-names></name><name><surname>Lakzadeh</surname> <given-names>P</given-names></name><name><surname>Donato</surname> <given-names>BMK</given-names></name><name><surname>Szabo</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Methods of sample size calculation in descriptive retrospective burden of illness studies</article-title><source>BMC Medical Research Methodology</source><volume>19</volume><elocation-id>9</elocation-id><pub-id pub-id-type="doi">10.1186/s12874-018-0657-9</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Kawasuji</surname> <given-names>H</given-names></name><name><surname>Takegoshi</surname> <given-names>Y</given-names></name><name><surname>Kaneda</surname> <given-names>M</given-names></name><name><surname>Ueno</surname> <given-names>A</given-names></name><name><surname>Miyajima</surname> <given-names>Y</given-names></name><name><surname>Kawago</surname> <given-names>K</given-names></name><name><surname>Yamamoto</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Viral load dynamics in transmissible symptomatic patients with COVID-19</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.02.20120014</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Killingley</surname> <given-names>B</given-names></name><name><surname>Greatorex</surname> <given-names>J</given-names></name><name><surname>Cauchemez</surname> <given-names>S</given-names></name><name><surname>Enstone</surname> <given-names>JE</given-names></name><name><surname>Curran</surname> <given-names>M</given-names></name><name><surname>Read</surname> <given-names>RC</given-names></name><name><surname>Lim</surname> <given-names>WS</given-names></name><name><surname>Hayward</surname> <given-names>A</given-names></name><name><surname>Nicholson</surname> <given-names>KG</given-names></name><name><surname>Nguyen-Van-Tam</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings</article-title><source>Health Technology Assessment</source><volume>14</volume><fpage>237</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.3310/hta14460-04</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L'Huillier</surname> <given-names>AG</given-names></name><name><surname>Torriani</surname> <given-names>G</given-names></name><name><surname>Pigny</surname> <given-names>F</given-names></name><name><surname>Kaiser</surname> <given-names>L</given-names></name><name><surname>Eckerle</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Culture-Competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>2494</fpage><lpage>2497</lpage><pub-id pub-id-type="doi">10.3201/eid2610.202403</pub-id><pub-id pub-id-type="pmid">32603290</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>LLH</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Fang</surname> <given-names>VJ</given-names></name><name><surname>Chan</surname> <given-names>K</given-names></name><name><surname>Lau</surname> <given-names>EHY</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name><name><surname>Cheng</surname> <given-names>CKY</given-names></name><name><surname>Houck</surname> <given-names>PM</given-names></name><name><surname>Uyeki</surname> <given-names>TM</given-names></name><name><surname>Peiris</surname> <given-names>JSM</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Viral shedding and clinical illness in naturally acquired influenza virus infections</article-title><source>The Journal of Infectious Diseases</source><volume>201</volume><fpage>1509</fpage><lpage>1516</lpage><pub-id pub-id-type="doi">10.1086/652241</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Launes</surname> <given-names>C</given-names></name><name><surname>Garcia-Garcia</surname> <given-names>JJ</given-names></name><name><surname>Jordan</surname> <given-names>I</given-names></name><name><surname>Selva</surname> <given-names>L</given-names></name><name><surname>Rello</surname> <given-names>J</given-names></name><name><surname>Muñoz-Almagro</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Viral load at diagnosis and influenza A H1N1 (2009) disease severity in children</article-title><source>Influenza and Other Respiratory Viruses</source><volume>6</volume><fpage>e89</fpage><lpage>e92</lpage><pub-id pub-id-type="doi">10.1111/j.1750-2659.2012.00383.x</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavezzo</surname> <given-names>E</given-names></name><name><surname>Franchin</surname> <given-names>E</given-names></name><name><surname>Ciavarella</surname> <given-names>C</given-names></name><name><surname>Cuomo-Dannenburg</surname> <given-names>G</given-names></name><name><surname>Barzon</surname> <given-names>L</given-names></name><name><surname>Del Vecchio</surname> <given-names>C</given-names></name><name><surname>Rossi</surname> <given-names>L</given-names></name><name><surname>Manganelli</surname> <given-names>R</given-names></name><name><surname>Loregian</surname> <given-names>A</given-names></name><name><surname>Navarin</surname> <given-names>N</given-names></name><name><surname>Abate</surname> <given-names>D</given-names></name><name><surname>Sciro</surname> <given-names>M</given-names></name><name><surname>Merigliano</surname> <given-names>S</given-names></name><name><surname>De Canale</surname> <given-names>E</given-names></name><name><surname>Vanuzzo</surname> <given-names>MC</given-names></name><name><surname>Besutti</surname> <given-names>V</given-names></name><name><surname>Saluzzo</surname> <given-names>F</given-names></name><name><surname>Onelia</surname> <given-names>F</given-names></name><name><surname>Pacenti</surname> <given-names>M</given-names></name><name><surname>Parisi</surname> <given-names>SG</given-names></name><name><surname>Carretta</surname> <given-names>G</given-names></name><name><surname>Donato</surname> <given-names>D</given-names></name><name><surname>Flor</surname> <given-names>L</given-names></name><name><surname>Cocchio</surname> <given-names>S</given-names></name><name><surname>Masi</surname> <given-names>G</given-names></name><name><surname>Sperduti</surname> <given-names>A</given-names></name><name><surname>Cattarino</surname> <given-names>L</given-names></name><name><surname>Salvador</surname> <given-names>R</given-names></name><name><surname>Nicoletti</surname> <given-names>M</given-names></name><name><surname>Caldart</surname> <given-names>F</given-names></name><name><surname>Castelli</surname> <given-names>G</given-names></name><name><surname>Nieddu</surname> <given-names>E</given-names></name><name><surname>Labella</surname> <given-names>B</given-names></name><name><surname>Fava</surname> <given-names>L</given-names></name><name><surname>Drigo</surname> <given-names>M</given-names></name><name><surname>Gaythorpe</surname> <given-names>KAM</given-names></name><name><surname>Brazzale</surname> <given-names>AR</given-names></name><name><surname>Toppo</surname> <given-names>S</given-names></name><name><surname>Trevisan</surname> <given-names>M</given-names></name><name><surname>Baldo</surname> <given-names>V</given-names></name><name><surname>Donnelly</surname> <given-names>CA</given-names></name><name><surname>Ferguson</surname> <given-names>NM</given-names></name><name><surname>Dorigatti</surname> <given-names>I</given-names></name><name><surname>Crisanti</surname> <given-names>A</given-names></name><collab>Imperial College COVID-19 Response Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Suppression of a SARS-CoV-2 outbreak in the italian municipality of vo'</article-title><source>Nature</source><volume>584</volume><fpage>425</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2488-1</pub-id><pub-id pub-id-type="pmid">32604404</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laxminarayan</surname> <given-names>R</given-names></name><name><surname>Wahl</surname> <given-names>B</given-names></name><name><surname>Dudala</surname> <given-names>SR</given-names></name><name><surname>Gopal</surname> <given-names>K</given-names></name><name><surname>Mohan B</surname> <given-names>C</given-names></name><name><surname>Neelima</surname> <given-names>S</given-names></name><name><surname>Jawahar Reddy</surname> <given-names>KS</given-names></name><name><surname>Radhakrishnan</surname> <given-names>J</given-names></name><name><surname>Lewnard</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epidemiology and transmission dynamics of COVID-19 in two indian states</article-title><source>Science</source><volume>370</volume><fpage>691</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1126/science.abd7672</pub-id><pub-id pub-id-type="pmid">33154136</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lednicky</surname> <given-names>JA</given-names></name><name><surname>Lauzardo</surname> <given-names>M</given-names></name><name><surname>Fan</surname> <given-names>ZH</given-names></name><name><surname>Jutla</surname> <given-names>A</given-names></name><name><surname>Tilly</surname> <given-names>TB</given-names></name><name><surname>Gangwar</surname> <given-names>M</given-names></name><name><surname>Usmani</surname> <given-names>M</given-names></name><name><surname>Shankar</surname> <given-names>SN</given-names></name><name><surname>Mohamed</surname> <given-names>K</given-names></name><name><surname>Eiguren-Fernandez</surname> <given-names>A</given-names></name><name><surname>Stephenson</surname> <given-names>CJ</given-names></name><name><surname>Alam</surname> <given-names>MM</given-names></name><name><surname>Elbadry</surname> <given-names>MA</given-names></name><name><surname>Loeb</surname> <given-names>JC</given-names></name><name><surname>Subramaniam</surname> <given-names>K</given-names></name><name><surname>Waltzek</surname> <given-names>TB</given-names></name><name><surname>Cherabuddi</surname> <given-names>K</given-names></name><name><surname>Morris</surname> <given-names>JG</given-names></name><name><surname>Wu</surname> <given-names>CY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients</article-title><source>International Journal of Infectious Diseases</source><volume>100</volume><fpage>476</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2020.09.025</pub-id><pub-id pub-id-type="pmid">32949774</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>CK</given-names></name><name><surname>Lee</surname> <given-names>HK</given-names></name><name><surname>Loh</surname> <given-names>TP</given-names></name><name><surname>Lai</surname> <given-names>FY</given-names></name><name><surname>Tambyah</surname> <given-names>PA</given-names></name><name><surname>Chiu</surname> <given-names>L</given-names></name><name><surname>Koay</surname> <given-names>ES</given-names></name><name><surname>Tang</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>Comparison of pandemic (H1N1) 2009 and seasonal influenza viral loads, Singapore</article-title><source>Emerging Infectious Diseases</source><volume>17</volume><fpage>287</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.3201/eid1702.100282</pub-id><pub-id pub-id-type="pmid">21291608</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>N</given-names></name><name><surname>Chan</surname> <given-names>PK</given-names></name><name><surname>Wong</surname> <given-names>CK</given-names></name><name><surname>Wong</surname> <given-names>KT</given-names></name><name><surname>Choi</surname> <given-names>KW</given-names></name><name><surname>Joynt</surname> <given-names>GM</given-names></name><name><surname>Lam</surname> <given-names>P</given-names></name><name><surname>Chan</surname> <given-names>MC</given-names></name><name><surname>Wong</surname> <given-names>BC</given-names></name><name><surname>Lui</surname> <given-names>GC</given-names></name><name><surname>Sin</surname> <given-names>WW</given-names></name><name><surname>Wong</surname> <given-names>RY</given-names></name><name><surname>Lam</surname> <given-names>WY</given-names></name><name><surname>Yeung</surname> <given-names>AC</given-names></name><name><surname>Leung</surname> <given-names>TF</given-names></name><name><surname>So</surname> <given-names>HY</given-names></name><name><surname>Yu</surname> <given-names>AW</given-names></name><name><surname>Sung</surname> <given-names>JJ</given-names></name><name><surname>Hui</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia</article-title><source>Antiviral Therapy</source><volume>16</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.3851/IMP1722</pub-id><pub-id pub-id-type="pmid">21447873</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>EC</given-names></name><name><surname>Wada</surname> <given-names>NI</given-names></name><name><surname>Grabowski</surname> <given-names>MK</given-names></name><name><surname>Gurley</surname> <given-names>ES</given-names></name><name><surname>Lessler</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The engines of SARS-CoV-2 spread</article-title><source>Science</source><volume>370</volume><fpage>406</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1126/science.abd8755</pub-id><pub-id pub-id-type="pmid">33093098</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Lennon</surname> <given-names>NJ</given-names></name><name><surname>Bhattacharyya</surname> <given-names>RP</given-names></name><name><surname>Mina</surname> <given-names>MJ</given-names></name><name><surname>Rehm</surname> <given-names>HL</given-names></name><name><surname>Hung</surname> <given-names>DT</given-names></name><name><surname>Smole</surname> <given-names>S</given-names></name><name><surname>Gabriel</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Omparison of viral levels in individuals with or without symptoms at time of COVID-19 testing among 32,480 residents and staff of nursing homes and assisted living facilities in Massachusetts</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.07.20.20157792</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>CC</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Eng</surname> <given-names>HL</given-names></name><name><surname>You</surname> <given-names>HL</given-names></name><name><surname>Chang</surname> <given-names>LS</given-names></name><name><surname>Tang</surname> <given-names>KS</given-names></name><name><surname>Lin</surname> <given-names>YJ</given-names></name><name><surname>Kuo</surname> <given-names>HC</given-names></name><name><surname>Lee</surname> <given-names>IK</given-names></name><name><surname>Liu</surname> <given-names>JW</given-names></name><name><surname>Huang</surname> <given-names>EY</given-names></name><name><surname>Yang</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children</article-title><source>Emerging Infectious Diseases</source><volume>16</volume><fpage>1265</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.3201/eid1608.091918</pub-id><pub-id pub-id-type="pmid">20678321</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>IW</given-names></name><name><surname>Hung</surname> <given-names>IF</given-names></name><name><surname>To</surname> <given-names>KK</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Wong</surname> <given-names>SS</given-names></name><name><surname>Chan</surname> <given-names>JF</given-names></name><name><surname>Cheng</surname> <given-names>VC</given-names></name><name><surname>Tsang</surname> <given-names>OT</given-names></name><name><surname>Lai</surname> <given-names>ST</given-names></name><name><surname>Lau</surname> <given-names>YL</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment</article-title><source>Chest</source><volume>137</volume><fpage>759</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1378/chest.09-3072</pub-id><pub-id pub-id-type="pmid">20061398</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Guan</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Tong</surname> <given-names>Y</given-names></name><name><surname>Ren</surname> <given-names>R</given-names></name><name><surname>Leung</surname> <given-names>KSM</given-names></name><name><surname>Lau</surname> <given-names>EHY</given-names></name><name><surname>Wong</surname> <given-names>JY</given-names></name><name><surname>Xing</surname> <given-names>X</given-names></name><name><surname>Xiang</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Tu</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Jin</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Zhou</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Shao</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Tao</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Deng</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Shi</surname> <given-names>G</given-names></name><name><surname>Lam</surname> <given-names>TTY</given-names></name><name><surname>Wu</surname> <given-names>JT</given-names></name><name><surname>Gao</surname> <given-names>GF</given-names></name><name><surname>Cowling</surname> <given-names>BJ</given-names></name><name><surname>Yang</surname> <given-names>B</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Feng</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Early transmission dynamics in Wuhan, China, of novel Coronavirus-Infected pneumonia</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>1199</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id><pub-id pub-id-type="pmid">31995857</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>R</given-names></name><name><surname>Pei</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>B</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>T</given-names></name><name><surname>Yang</surname> <given-names>W</given-names></name><name><surname>Shaman</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)</article-title><source>Science</source><volume>368</volume><fpage>489</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1126/science.abb3221</pub-id><pub-id pub-id-type="pmid">32179701</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieber</surname> <given-names>C</given-names></name><name><surname>Melekidis</surname> <given-names>S</given-names></name><name><surname>Koch</surname> <given-names>R</given-names></name><name><surname>Bauer</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Insights into the evaporation characteristics of saliva droplets and aerosols: levitation experiments and numerical modeling</article-title><source>Journal of Aerosol Science</source><volume>154</volume><elocation-id>105760</elocation-id><pub-id pub-id-type="doi">10.1016/j.jaerosci.2021.105760</pub-id><pub-id pub-id-type="pmid">33518792</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Nielsen</surname> <given-names>PV</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Jensen</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Short-range airborne transmission of expiratory droplets between two people</article-title><source>Indoor Air</source><volume>27</volume><fpage>452</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1111/ina.12314</pub-id><pub-id pub-id-type="pmid">27287598</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Ooi</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Evaporation and dispersion of respiratory droplets from coughing</article-title><source>Indoor Air</source><volume>27</volume><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1111/ina.12297</pub-id><pub-id pub-id-type="pmid">26945674</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Smith</surname> <given-names>JO</given-names></name><name><surname>Schreiber</surname> <given-names>SJ</given-names></name><name><surname>Kopp</surname> <given-names>PE</given-names></name><name><surname>Getz</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Superspreading and the effect of individual variation on disease emergence</article-title><source>Nature</source><volume>438</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nature04153</pub-id><pub-id pub-id-type="pmid">16292310</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeb</surname> <given-names>M</given-names></name><name><surname>Singh</surname> <given-names>PK</given-names></name><name><surname>Fox</surname> <given-names>J</given-names></name><name><surname>Russell</surname> <given-names>ML</given-names></name><name><surname>Pabbaraju</surname> <given-names>K</given-names></name><name><surname>Zarra</surname> <given-names>D</given-names></name><name><surname>Wong</surname> <given-names>S</given-names></name><name><surname>Neupane</surname> <given-names>B</given-names></name><name><surname>Singh</surname> <given-names>P</given-names></name><name><surname>Webby</surname> <given-names>R</given-names></name><name><surname>Fonseca</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Longitudinal study of influenza molecular viral shedding in hutterite communities</article-title><source>Journal of Infectious Diseases</source><volume>206</volume><fpage>1078</fpage><lpage>1084</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis450</pub-id><pub-id pub-id-type="pmid">22837493</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>PX</given-names></name><name><surname>Deng</surname> <given-names>YY</given-names></name><name><surname>Yang</surname> <given-names>GL</given-names></name><name><surname>Liu</surname> <given-names>WL</given-names></name><name><surname>Liu</surname> <given-names>YX</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>YX</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Relationship between respiratory viral load and lung lesion severity: a study in 24 cases of pandemic H1N1 2009 influenza A pneumonia</article-title><source>Journal of Thoracic Disease</source><volume>4</volume><fpage>377</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.3978/j.issn.2072-1439.2012.08.02</pub-id><pub-id pub-id-type="pmid">22934140</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Gu</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>C</given-names></name><name><surname>Su</surname> <given-names>W</given-names></name><name><surname>Lai</surname> <given-names>Z</given-names></name><name><surname>Zhou</surname> <given-names>D</given-names></name><name><surname>Yu</surname> <given-names>C</given-names></name><name><surname>Xu</surname> <given-names>B</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>COVID-19 outbreak associated with air conditioning in restaurant, Guangzhou, China, 2020</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>1628</fpage><lpage>1631</lpage><pub-id pub-id-type="doi">10.3201/eid2607.200764</pub-id><pub-id pub-id-type="pmid">32240078</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Du</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>YY</given-names></name><name><surname>Qu</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Bao</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Shao</surname> <given-names>J</given-names></name><name><surname>Peng</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Xiang</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Silva</surname> <given-names>RM</given-names></name><name><surname>Pinkerton</surname> <given-names>KE</given-names></name><name><surname>Shen</surname> <given-names>K</given-names></name><name><surname>Xiao</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Wong</surname> <given-names>GWK</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>SARS-CoV-2 infection in children</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>1663</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2005073</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname> <given-names>C</given-names></name><name><surname>Wong</surname> <given-names>P</given-names></name><name><surname>Klein</surname> <given-names>J</given-names></name><name><surname>Castro</surname> <given-names>TBR</given-names></name><name><surname>Silva</surname> <given-names>J</given-names></name><name><surname>Sundaram</surname> <given-names>M</given-names></name><name><surname>Ellingson</surname> <given-names>MK</given-names></name><name><surname>Mao</surname> <given-names>T</given-names></name><name><surname>Oh</surname> <given-names>JE</given-names></name><name><surname>Israelow</surname> <given-names>B</given-names></name><name><surname>Takahashi</surname> <given-names>T</given-names></name><name><surname>Tokuyama</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>P</given-names></name><name><surname>Venkataraman</surname> <given-names>A</given-names></name><name><surname>Park</surname> <given-names>A</given-names></name><name><surname>Mohanty</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Wyllie</surname> <given-names>AL</given-names></name><name><surname>Vogels</surname> <given-names>CBF</given-names></name><name><surname>Earnest</surname> <given-names>R</given-names></name><name><surname>Lapidus</surname> <given-names>S</given-names></name><name><surname>Ott</surname> <given-names>IM</given-names></name><name><surname>Moore</surname> <given-names>AJ</given-names></name><name><surname>Muenker</surname> <given-names>MC</given-names></name><name><surname>Fournier</surname> <given-names>JB</given-names></name><name><surname>Campbell</surname> <given-names>M</given-names></name><name><surname>Odio</surname> <given-names>CD</given-names></name><name><surname>Casanovas-Massana</surname> <given-names>A</given-names></name><name><surname>Herbst</surname> <given-names>R</given-names></name><name><surname>Shaw</surname> <given-names>AC</given-names></name><name><surname>Medzhitov</surname> <given-names>R</given-names></name><name><surname>Schulz</surname> <given-names>WL</given-names></name><name><surname>Grubaugh</surname> <given-names>ND</given-names></name><name><surname>Dela Cruz</surname> <given-names>C</given-names></name><name><surname>Farhadian</surname> <given-names>S</given-names></name><name><surname>Ko</surname> <given-names>AI</given-names></name><name><surname>Omer</surname> <given-names>SB</given-names></name><name><surname>Iwasaki</surname> <given-names>A</given-names></name><collab>Yale IMPACT Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Longitudinal analyses reveal immunological misfiring in severe COVID-19</article-title><source>Nature</source><volume>584</volume><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2588-y</pub-id><pub-id pub-id-type="pmid">32717743</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Liao</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Jing</surname> <given-names>Q</given-names></name><name><surname>Zheng</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Yang</surname> <given-names>S</given-names></name><name><surname>Bi</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>W</given-names></name><name><surname>Zhu</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name><name><surname>Chen</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Cheng</surname> <given-names>X</given-names></name><name><surname>Cai</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>P</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Han</surname> <given-names>Z</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Mao</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China : a prospective cohort study</article-title><source>Annals of Internal Medicine</source><volume>173</volume><fpage>879</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.7326/M20-2671</pub-id><pub-id pub-id-type="pmid">32790510</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Qi</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Yao</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour</article-title><source>Clinical Infectious Diseases</source><volume>28</volume><elocation-id>ciaa1283</elocation-id><pub-id pub-id-type="doi">10.1093/cid/ciaa1283</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meschi</surname> <given-names>S</given-names></name><name><surname>Selleri</surname> <given-names>M</given-names></name><name><surname>Lalle</surname> <given-names>E</given-names></name><name><surname>Bordi</surname> <given-names>L</given-names></name><name><surname>Valli</surname> <given-names>MB</given-names></name><name><surname>Ferraro</surname> <given-names>F</given-names></name><name><surname>Ippolito</surname> <given-names>G</given-names></name><name><surname>Petrosillo</surname> <given-names>N</given-names></name><name><surname>Lauria</surname> <given-names>FN</given-names></name><name><surname>Capobianchi</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Duration of viral shedding in hospitalized patients infected with pandemic H1N1</article-title><source>BMC Infectious Diseases</source><volume>11</volume><elocation-id>140</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-11-140</pub-id><pub-id pub-id-type="pmid">21605362</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitjà</surname> <given-names>O</given-names></name><name><surname>Corbacho-Monné</surname> <given-names>M</given-names></name><name><surname>Ubals</surname> <given-names>M</given-names></name><name><surname>Tebe</surname> <given-names>C</given-names></name><name><surname>Peñafiel</surname> <given-names>J</given-names></name><name><surname>Tobias</surname> <given-names>A</given-names></name><name><surname>Ballana</surname> <given-names>E</given-names></name><name><surname>Alemany</surname> <given-names>A</given-names></name><name><surname>Riera-Martí</surname> <given-names>N</given-names></name><name><surname>Pérez</surname> <given-names>CA</given-names></name><name><surname>Suñer</surname> <given-names>C</given-names></name><name><surname>Laporte</surname> <given-names>P</given-names></name><name><surname>Admella</surname> <given-names>P</given-names></name><name><surname>Mitjà</surname> <given-names>J</given-names></name><name><surname>Clua</surname> <given-names>M</given-names></name><name><surname>Bertran</surname> <given-names>L</given-names></name><name><surname>Sarquella</surname> <given-names>M</given-names></name><name><surname>Gavilán</surname> <given-names>S</given-names></name><name><surname>Ara</surname> <given-names>J</given-names></name><name><surname>Argimon</surname> <given-names>JM</given-names></name><name><surname>Casabona</surname> <given-names>J</given-names></name><name><surname>Cuatrecasas</surname> <given-names>G</given-names></name><name><surname>Cañadas</surname> <given-names>P</given-names></name><name><surname>Elizalde-Torrent</surname> <given-names>A</given-names></name><name><surname>Fabregat</surname> <given-names>R</given-names></name><name><surname>Farré</surname> <given-names>M</given-names></name><name><surname>Forcada</surname> <given-names>A</given-names></name><name><surname>Flores-Mateo</surname> <given-names>G</given-names></name><name><surname>Muntada</surname> <given-names>E</given-names></name><name><surname>Nadal</surname> <given-names>N</given-names></name><name><surname>Narejos</surname> <given-names>S</given-names></name><name><surname>Gil-Ortega</surname> <given-names>AN</given-names></name><name><surname>Prat</surname> <given-names>N</given-names></name><name><surname>Puig</surname> <given-names>J</given-names></name><name><surname>Quiñones</surname> <given-names>C</given-names></name><name><surname>Reyes-Ureña</surname> <given-names>J</given-names></name><name><surname>Ramírez-Viaplana</surname> <given-names>F</given-names></name><name><surname>Ruiz</surname> <given-names>L</given-names></name><name><surname>Riveira-Muñoz</surname> <given-names>E</given-names></name><name><surname>Sierra</surname> <given-names>A</given-names></name><name><surname>Velasco</surname> <given-names>C</given-names></name><name><surname>Vivanco-Hidalgo</surname> <given-names>RM</given-names></name><name><surname>Sentís</surname> <given-names>A</given-names></name><name><surname>G-Beiras</surname> <given-names>C</given-names></name><name><surname>Clotet</surname> <given-names>B</given-names></name><name><surname>Vall-Mayans</surname> <given-names>M</given-names></name><collab>BCN PEP-CoV-2 RESEARCH GROUP</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial</article-title><source>Clinical Infectious Diseases</source><volume>16</volume><elocation-id>ciaa1009</elocation-id><pub-id pub-id-type="doi">10.1093/cid/ciaa1009</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname> <given-names>D</given-names></name><name><surname>Liberati</surname> <given-names>A</given-names></name><name><surname>Tetzlaff</surname> <given-names>J</given-names></name><name><surname>Altman</surname> <given-names>DG</given-names></name><collab>PRISMA Group</collab></person-group><year iso-8601-date="2009">2009</year><article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title><source>PLOS Medicine</source><volume>6</volume><elocation-id>e1000097</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Moola</surname> <given-names>S</given-names></name><name><surname>Munn</surname> <given-names>Z</given-names></name><name><surname>Tufanaru</surname> <given-names>C</given-names></name><name><surname>Aromataris</surname> <given-names>E</given-names></name><name><surname>Sears</surname> <given-names>K</given-names></name><name><surname>Sfetcu</surname> <given-names>R</given-names></name><name><surname>Mu</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>Chapter 7: systematic reviews of etiology and risk</chapter-title><person-group person-group-type="editor"><name><surname>Aromataris</surname> <given-names>E</given-names></name><name><surname>Munn</surname> <given-names>Z</given-names></name></person-group><source>Joanna Briggs Institute Reviewer's Manual. the Joanna Briggs Institute</source><publisher-name>The Joanna Briggs Institute</publisher-name><fpage>5</fpage><lpage>19</lpage></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morawska</surname> <given-names>L</given-names></name><name><surname>Johnson</surname> <given-names>GR</given-names></name><name><surname>Ristovski</surname> <given-names>ZD</given-names></name><name><surname>Hargreaves</surname> <given-names>M</given-names></name><name><surname>Mengersen</surname> <given-names>K</given-names></name><name><surname>Corbett</surname> <given-names>S</given-names></name><name><surname>Chao</surname> <given-names>CYH</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Katoshevski</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities</article-title><source>Journal of Aerosol Science</source><volume>40</volume><fpage>256</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.jaerosci.2008.11.002</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>DH</given-names></name><name><surname>Yinda</surname> <given-names>KC</given-names></name><name><surname>Gamble</surname> <given-names>A</given-names></name><name><surname>Rossine</surname> <given-names>FW</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name><name><surname>Bushmaker</surname> <given-names>T</given-names></name><name><surname>Lloyd-Smith</surname> <given-names>JO</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.10.16.341883</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munn</surname> <given-names>Z</given-names></name><name><surname>Moola</surname> <given-names>S</given-names></name><name><surname>Lisy</surname> <given-names>K</given-names></name><name><surname>Riitano</surname> <given-names>D</given-names></name><name><surname>Tufanaru</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data</article-title><source>International Journal of Evidence-Based Healthcare</source><volume>13</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1097/XEB.0000000000000054</pub-id><pub-id pub-id-type="pmid">26317388</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munn</surname> <given-names>Z</given-names></name><name><surname>Barker</surname> <given-names>TH</given-names></name><name><surname>Moola</surname> <given-names>S</given-names></name><name><surname>Tufanaru</surname> <given-names>C</given-names></name><name><surname>Stern</surname> <given-names>C</given-names></name><name><surname>McArthur</surname> <given-names>A</given-names></name><name><surname>Aromataris</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Methodological quality of case series studies: an introduction to the JBI critical appraisal tool</article-title><source>JBI Database of Systematic Reviews and Implementation Reports</source><volume>23</volume><elocation-id>e00099</elocation-id><pub-id pub-id-type="doi">10.11124/JBISRIR-D-19-00099</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngaosuwankul</surname> <given-names>N</given-names></name><name><surname>Noisumdaeng</surname> <given-names>P</given-names></name><name><surname>Komolsiri</surname> <given-names>P</given-names></name><name><surname>Pooruk</surname> <given-names>P</given-names></name><name><surname>Chokephaibulkit</surname> <given-names>K</given-names></name><name><surname>Chotpitayasunondh</surname> <given-names>T</given-names></name><name><surname>Sangsajja</surname> <given-names>C</given-names></name><name><surname>Chuchottaworn</surname> <given-names>C</given-names></name><name><surname>Farrar</surname> <given-names>J</given-names></name><name><surname>Puthavathana</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses</article-title><source>Virology Journal</source><volume>7</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.1186/1743-422X-7-75</pub-id><pub-id pub-id-type="pmid">20403211</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Yang</surname> <given-names>P</given-names></name><name><surname>Poon</surname> <given-names>LLM</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Viral load of SARS-CoV-2 in clinical samples</article-title><source>The Lancet Infectious Diseases</source><volume>20</volume><fpage>411</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30113-4</pub-id><pub-id pub-id-type="pmid">32105638</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>SY</given-names></name><name><surname>Kim</surname> <given-names>YM</given-names></name><name><surname>Yi</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Na</surname> <given-names>BJ</given-names></name><name><surname>Kim</surname> <given-names>CB</given-names></name><name><surname>Kim</surname> <given-names>JI</given-names></name><name><surname>Kim</surname> <given-names>HS</given-names></name><name><surname>Kim</surname> <given-names>YB</given-names></name><name><surname>Park</surname> <given-names>Y</given-names></name><name><surname>Huh</surname> <given-names>IS</given-names></name><name><surname>Kim</surname> <given-names>HK</given-names></name><name><surname>Yoon</surname> <given-names>HJ</given-names></name><name><surname>Jang</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>K</given-names></name><name><surname>Chang</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>I</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Gwack</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>SS</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Kweon</surname> <given-names>S</given-names></name><name><surname>Choe</surname> <given-names>YJ</given-names></name><name><surname>Park</surname> <given-names>O</given-names></name><name><surname>Park</surname> <given-names>YJ</given-names></name><name><surname>Jeong</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus disease outbreak in call center, South Korea</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>1666</fpage><lpage>1670</lpage><pub-id pub-id-type="doi">10.3201/eid2608.201274</pub-id><pub-id pub-id-type="pmid">32324530</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname> <given-names>JSM</given-names></name><name><surname>Chu</surname> <given-names>CM</given-names></name><name><surname>Cheng</surname> <given-names>VCC</given-names></name><name><surname>Chan</surname> <given-names>KS</given-names></name><name><surname>Hung</surname> <given-names>IFN</given-names></name><name><surname>Poon</surname> <given-names>LLM</given-names></name><name><surname>Law</surname> <given-names>KI</given-names></name><name><surname>Tang</surname> <given-names>BSF</given-names></name><name><surname>Hon</surname> <given-names>TYW</given-names></name><name><surname>Chan</surname> <given-names>CS</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Ng</surname> <given-names>JSC</given-names></name><name><surname>Zheng</surname> <given-names>BJ</given-names></name><name><surname>Ng</surname> <given-names>WL</given-names></name><name><surname>Lai</surname> <given-names>RWM</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study</article-title><source>The Lancet</source><volume>361</volume><fpage>1767</fpage><lpage>1772</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)13412-5</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>W</given-names></name><name><surname>Luo</surname> <given-names>Q</given-names></name><name><surname>Chen</surname> <given-names>D</given-names></name><name><surname>Lei</surname> <given-names>Z</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Deng</surname> <given-names>K</given-names></name><name><surname>Lin</surname> <given-names>B</given-names></name><name><surname>Gao</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens</article-title><source>Journal of Medical Virology</source><volume>92</volume><fpage>1676</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1002/jmv.25936</pub-id><pub-id pub-id-type="pmid">32330305</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname> <given-names>R</given-names></name><name><surname>Tso</surname> <given-names>E</given-names></name><name><surname>Tsang</surname> <given-names>OTY</given-names></name><name><surname>Tsang</surname> <given-names>DNC</given-names></name><name><surname>Fung</surname> <given-names>K</given-names></name><name><surname>Leung</surname> <given-names>YWY</given-names></name><name><surname>Chin</surname> <given-names>AWH</given-names></name><name><surname>Chu</surname> <given-names>DKW</given-names></name><name><surname>Cheng</surname> <given-names>SMS</given-names></name><name><surname>Poon</surname> <given-names>LLM</given-names></name><name><surname>Chuang</surname> <given-names>VWM</given-names></name><name><surname>Peiris</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild coronavirus disease</article-title><source>Emerging Infectious Diseases</source><volume>26</volume><fpage>2701</fpage><lpage>2704</lpage><pub-id pub-id-type="doi">10.3201/eid2611.203219</pub-id><pub-id pub-id-type="pmid">32749957</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitzer</surname> <given-names>VE</given-names></name><name><surname>Leung</surname> <given-names>GM</given-names></name><name><surname>Lipsitch</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China</article-title><source>American Journal of Epidemiology</source><volume>166</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1093/aje/kwm082</pub-id><pub-id pub-id-type="pmid">17493952</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname> <given-names>LL</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Wong</surname> <given-names>OK</given-names></name><name><surname>Yam</surname> <given-names>WC</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Lo</surname> <given-names>YM</given-names></name><name><surname>Peiris</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Early diagnosis of SARS coronavirus infection by real time RT-PCR</article-title><source>Journal of Clinical Virology</source><volume>28</volume><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2003.08.004</pub-id><pub-id pub-id-type="pmid">14522060</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname> <given-names>LL</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Wong</surname> <given-names>OK</given-names></name><name><surname>Cheung</surname> <given-names>TK</given-names></name><name><surname>Ng</surname> <given-names>I</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name><name><surname>Seto</surname> <given-names>WH</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name><name><surname>Guan</surname> <given-names>Y</given-names></name><name><surname>Peiris</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays</article-title><source>Clinical Chemistry</source><volume>50</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2003.023663</pub-id><pub-id pub-id-type="pmid">14709637</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prather</surname> <given-names>KA</given-names></name><name><surname>Marr</surname> <given-names>LC</given-names></name><name><surname>Schooley</surname> <given-names>RT</given-names></name><name><surname>McDiarmid</surname> <given-names>MA</given-names></name><name><surname>Wilson</surname> <given-names>ME</given-names></name><name><surname>Milton</surname> <given-names>DK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Airborne transmission of SARS-CoV-2</article-title><source>Science</source><volume>370</volume><fpage>303</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1126/science.abf0521</pub-id><pub-id pub-id-type="pmid">33020250</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rath</surname> <given-names>B</given-names></name><name><surname>von Kleist</surname> <given-names>M</given-names></name><name><surname>Tief</surname> <given-names>F</given-names></name><name><surname>Karsch</surname> <given-names>K</given-names></name><name><surname>Tuerk</surname> <given-names>E</given-names></name><name><surname>Muehlhans</surname> <given-names>S</given-names></name><name><surname>Louis</surname> <given-names>F</given-names></name><name><surname>Skopnik</surname> <given-names>H</given-names></name><name><surname>Schweiger</surname> <given-names>B</given-names></name><name><surname>Duwe</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with influenza A(H1N1) 2009 and influenza B viruses</article-title><source>Pediatric Infectious Disease Journal</source><volume>31</volume><fpage>899</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e31825c7304</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riou</surname> <given-names>J</given-names></name><name><surname>Althaus</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pattern of early human-to-human transmission of wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020</article-title><source>Eurosurveillance</source><volume>25</volume><elocation-id>2000058</elocation-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2020.25.4.2000058</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>MG</given-names></name><name><surname>Nishiura</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Early estimation of the reproduction number in the presence of imported cases: pandemic influenza H1N1-2009 in New Zealand</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e17835</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017835</pub-id><pub-id pub-id-type="pmid">21637342</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues Guimarães Alves</surname> <given-names>V</given-names></name><name><surname>Perosa</surname> <given-names>AH</given-names></name><name><surname>de Souza Luna</surname> <given-names>LK</given-names></name><name><surname>Cruz</surname> <given-names>JS</given-names></name><name><surname>Conte</surname> <given-names>DD</given-names></name><name><surname>Bellei</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Influenza A(H1N1)pdm09 infection and viral load analysis in patients with different clinical presentations</article-title><source>Memórias Do Instituto Oswaldo Cruz</source><volume>115</volume><elocation-id>e200009</elocation-id><pub-id pub-id-type="doi">10.1590/0074-02760200009</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname> <given-names>CJ</given-names></name><name><surname>Milton</surname> <given-names>DK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Airborne transmission of communicable infection — The Elusive Pathway</article-title><source>New England Journal of Medicine</source><volume>350</volume><fpage>1710</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.1056/NEJMp048051</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Schijven</surname> <given-names>J</given-names></name><name><surname>Vermeulen</surname> <given-names>LC</given-names></name><name><surname>Swart</surname> <given-names>A</given-names></name><name><surname>Meijer</surname> <given-names>A</given-names></name><name><surname>Duizer</surname> <given-names>E</given-names></name><name><surname>de Roda Husman</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Exposure assessment for airborne transmission of SARS-CoV-2 via breathing, speaking, coughing and sneezing</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.07.02.20144832</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>F</given-names></name><name><surname>Wu</surname> <given-names>T</given-names></name><name><surname>Zhu</surname> <given-names>X</given-names></name><name><surname>Ge</surname> <given-names>Y</given-names></name><name><surname>Zeng</surname> <given-names>X</given-names></name><name><surname>Chi</surname> <given-names>Y</given-names></name><name><surname>Du</surname> <given-names>X</given-names></name><name><surname>Zhu</surname> <given-names>L</given-names></name><name><surname>Zhu</surname> <given-names>F</given-names></name><name><surname>Zhu</surname> <given-names>B</given-names></name><name><surname>Cui</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Association of viral load with serum biomakers among COVID-19 cases</article-title><source>Virology</source><volume>546</volume><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2020.04.011</pub-id><pub-id pub-id-type="pmid">32452410</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname> <given-names>NK</given-names></name><name><surname>Marco Canosa</surname> <given-names>F</given-names></name><name><surname>Nowacki</surname> <given-names>AS</given-names></name><name><surname>Procop</surname> <given-names>GW</given-names></name><name><surname>Vogel</surname> <given-names>S</given-names></name><name><surname>Fraser</surname> <given-names>TG</given-names></name><name><surname>Erzurum</surname> <given-names>SC</given-names></name><name><surname>Terpeluk</surname> <given-names>P</given-names></name><name><surname>Gordon</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distribution of Transmission Potential During Nonsevere COVID-19 Illness</article-title><source>Clinical Infectious Diseases</source><volume>71</volume><fpage>2927</fpage><lpage>2932</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa886</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suess</surname> <given-names>T</given-names></name><name><surname>Buchholz</surname> <given-names>U</given-names></name><name><surname>Dupke</surname> <given-names>S</given-names></name><name><surname>Grunow</surname> <given-names>R</given-names></name><name><surname>an der Heiden</surname> <given-names>M</given-names></name><name><surname>Heider</surname> <given-names>A</given-names></name><name><surname>Biere</surname> <given-names>B</given-names></name><name><surname>Schweiger</surname> <given-names>B</given-names></name><name><surname>Haas</surname> <given-names>W</given-names></name><name><surname>Krause</surname> <given-names>G</given-names></name><collab>Robert Koch Institute Shedding Investigation Group</collab></person-group><year iso-8601-date="2010">2010</year><article-title>Shedding and transmission of novel influenza virus A/H1N1 infection in households--Germany, 2009</article-title><source>American Journal of Epidemiology</source><volume>171</volume><fpage>1157</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1093/aje/kwq071</pub-id><pub-id pub-id-type="pmid">20439308</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tariq</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Roosa</surname> <given-names>K</given-names></name><name><surname>Blumberg</surname> <given-names>S</given-names></name><name><surname>Yan</surname> <given-names>P</given-names></name><name><surname>Ma</surname> <given-names>S</given-names></name><name><surname>Chowell</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020</article-title><source>BMC Medicine</source><volume>18</volume><elocation-id>166</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-020-01615-9</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Team</surname> <given-names>CC-R</given-names></name><collab>CDC COVID-19 Response Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Coronavirus disease 2019 in children - United states, February 12-April 2, 2020</article-title><source>MMWR. Morbidity and Mortality Weekly Report</source><volume>69</volume><fpage>422</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6914e4</pub-id><pub-id pub-id-type="pmid">32271728</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thai</surname> <given-names>PQ</given-names></name><name><surname>Mai</surname> <given-names>LQ</given-names></name><name><surname>Welkers</surname> <given-names>MRA</given-names></name><name><surname>Hang</surname> <given-names>NLK</given-names></name><name><surname>Thanh</surname> <given-names>LT</given-names></name><name><surname>Dung</surname> <given-names>VTV</given-names></name><name><surname>Yen</surname> <given-names>NTT</given-names></name><name><surname>Duong</surname> <given-names>TN</given-names></name><name><surname>Hoa</surname> <given-names>LNM</given-names></name><name><surname>Thoang</surname> <given-names>DD</given-names></name><name><surname>Trang</surname> <given-names>HTH</given-names></name><name><surname>de Jong</surname> <given-names>MD</given-names></name><name><surname>Wertheim</surname> <given-names>H</given-names></name><name><surname>Hien</surname> <given-names>NT</given-names></name><name><surname>Horby</surname> <given-names>P</given-names></name><name><surname>Fox</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort</article-title><source>Journal of Infection</source><volume>68</volume><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2014.01.008</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname> <given-names>KK</given-names></name><name><surname>Chan</surname> <given-names>K-H</given-names></name><name><surname>Li</surname> <given-names>IWS</given-names></name><name><surname>Tsang</surname> <given-names>T-Y</given-names></name><name><surname>Tse</surname> <given-names>H</given-names></name><name><surname>Chan</surname> <given-names>JFW</given-names></name><name><surname>Hung</surname> <given-names>IFN</given-names></name><name><surname>Lai</surname> <given-names>S-T</given-names></name><name><surname>Leung</surname> <given-names>C-W</given-names></name><name><surname>Kwan</surname> <given-names>Y-W</given-names></name><name><surname>Lau</surname> <given-names>Y-L</given-names></name><name><surname>Ng</surname> <given-names>T-K</given-names></name><name><surname>Cheng</surname> <given-names>VCC</given-names></name><name><surname>Peiris</surname> <given-names>JSM</given-names></name><name><surname>Yuen</surname> <given-names>K-Y</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Viral load in patients infected with pandemic H1N1 2009 influenza A virus</article-title><source>Journal of Medical Virology</source><volume>82</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/jmv.21664</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname> <given-names>KK</given-names></name><name><surname>Hung</surname> <given-names>IF</given-names></name><name><surname>Li</surname> <given-names>IW</given-names></name><name><surname>Lee</surname> <given-names>KL</given-names></name><name><surname>Koo</surname> <given-names>CK</given-names></name><name><surname>Yan</surname> <given-names>WW</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Ho</surname> <given-names>KY</given-names></name><name><surname>Chu</surname> <given-names>KH</given-names></name><name><surname>Watt</surname> <given-names>CL</given-names></name><name><surname>Luk</surname> <given-names>WK</given-names></name><name><surname>Lai</surname> <given-names>KY</given-names></name><name><surname>Chow</surname> <given-names>FL</given-names></name><name><surname>Mok</surname> <given-names>T</given-names></name><name><surname>Buckley</surname> <given-names>T</given-names></name><name><surname>Chan</surname> <given-names>JF</given-names></name><name><surname>Wong</surname> <given-names>SS</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Lau</surname> <given-names>CC</given-names></name><name><surname>Tse</surname> <given-names>H</given-names></name><name><surname>Cheng</surname> <given-names>VC</given-names></name><name><surname>Chan</surname> <given-names>KH</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection</article-title><source>Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America</source><volume>50</volume><fpage>850</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1086/650581</pub-id><pub-id pub-id-type="pmid">20136415</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname> <given-names>KK</given-names></name><name><surname>Tsang</surname> <given-names>OT-Y</given-names></name><name><surname>Leung</surname> <given-names>W-S</given-names></name><name><surname>Tam</surname> <given-names>AR</given-names></name><name><surname>Wu</surname> <given-names>T-C</given-names></name><name><surname>Lung</surname> <given-names>DC</given-names></name><name><surname>Yip</surname> <given-names>CC-Y</given-names></name><name><surname>Cai</surname> <given-names>J-P</given-names></name><name><surname>Chan</surname> <given-names>JM-C</given-names></name><name><surname>Chik</surname> <given-names>TS-H</given-names></name><name><surname>Lau</surname> <given-names>DP-L</given-names></name><name><surname>Choi</surname> <given-names>CY-C</given-names></name><name><surname>Chen</surname> <given-names>L-L</given-names></name><name><surname>Chan</surname> <given-names>W-M</given-names></name><name><surname>Chan</surname> <given-names>K-H</given-names></name><name><surname>Ip</surname> <given-names>JD</given-names></name><name><surname>Ng</surname> <given-names>AC-K</given-names></name><name><surname>Poon</surname> <given-names>RW-S</given-names></name><name><surname>Luo</surname> <given-names>C-T</given-names></name><name><surname>Cheng</surname> <given-names>VC-C</given-names></name><name><surname>Chan</surname> <given-names>JF-W</given-names></name><name><surname>Hung</surname> <given-names>IF-N</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Yuen</surname> <given-names>K-Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study</article-title><source>The Lancet Infectious Diseases</source><volume>20</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30196-1</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kampen</surname> <given-names>JJA</given-names></name><name><surname>van de Vijver</surname> <given-names>DAMC</given-names></name><name><surname>Fraaij</surname> <given-names>PLA</given-names></name><name><surname>Haagmans</surname> <given-names>BL</given-names></name><name><surname>Lamers</surname> <given-names>MM</given-names></name><name><surname>Okba</surname> <given-names>N</given-names></name><name><surname>van den Akker</surname> <given-names>JPC</given-names></name><name><surname>Endeman</surname> <given-names>H</given-names></name><name><surname>Gommers</surname> <given-names>D</given-names></name><name><surname>Cornelissen</surname> <given-names>JJ</given-names></name><name><surname>Hoek</surname> <given-names>RAS</given-names></name><name><surname>van der Eerden</surname> <given-names>MM</given-names></name><name><surname>Hesselink</surname> <given-names>DA</given-names></name><name><surname>Metselaar</surname> <given-names>HJ</given-names></name><name><surname>Verbon</surname> <given-names>A</given-names></name><name><surname>de Steenwinkel</surname> <given-names>JEM</given-names></name><name><surname>Aron</surname> <given-names>GI</given-names></name><name><surname>van Gorp</surname> <given-names>ECM</given-names></name><name><surname>van Boheemen</surname> <given-names>S</given-names></name><name><surname>Voermans</surname> <given-names>JC</given-names></name><name><surname>Boucher</surname> <given-names>CAB</given-names></name><name><surname>Molenkamp</surname> <given-names>R</given-names></name><name><surname>Koopmans</surname> <given-names>MPG</given-names></name><name><surname>Geurtsvankessel</surname> <given-names>C</given-names></name><name><surname>van der Eijk</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>267</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20568-4</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetter</surname> <given-names>P</given-names></name><name><surname>Eberhardt</surname> <given-names>CS</given-names></name><name><surname>Meyer</surname> <given-names>B</given-names></name><name><surname>Martinez Murillo</surname> <given-names>PA</given-names></name><name><surname>Torriani</surname> <given-names>G</given-names></name><name><surname>Pigny</surname> <given-names>F</given-names></name><name><surname>Lemeille</surname> <given-names>S</given-names></name><name><surname>Cordey</surname> <given-names>S</given-names></name><name><surname>Laubscher</surname> <given-names>F</given-names></name><name><surname>Vu</surname> <given-names>DL</given-names></name><name><surname>Calame</surname> <given-names>A</given-names></name><name><surname>Schibler</surname> <given-names>M</given-names></name><name><surname>Jacquerioz</surname> <given-names>F</given-names></name><name><surname>Blanchard-Rohner</surname> <given-names>G</given-names></name><name><surname>Siegrist</surname> <given-names>CA</given-names></name><name><surname>Kaiser</surname> <given-names>L</given-names></name><name><surname>Didierlaurent</surname> <given-names>AM</given-names></name><name><surname>Eckerle</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series</article-title><source>mSphere</source><volume>5</volume><elocation-id>e00827-20</elocation-id><pub-id pub-id-type="doi">10.1128/mSphere.00827-20</pub-id><pub-id pub-id-type="pmid">33177214</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Tong</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range</article-title><source>BMC Medical Research Methodology</source><volume>14</volume><elocation-id>135</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2288-14-135</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnke</surname> <given-names>P</given-names></name><name><surname>Warning</surname> <given-names>L</given-names></name><name><surname>Podbielski</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Some Are More Equal - A Comparative Study on Swab Uptake and Release of Bacterial Suspensions</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e102215</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0102215</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Nukuzuma</surname> <given-names>S</given-names></name><name><surname>Ito</surname> <given-names>M</given-names></name><name><surname>Ihara</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Viral load and rapid diagnostic test in patients with pandemic H1N1 2009</article-title><source>Pediatrics International</source><volume>53</volume><fpage>1097</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.1111/j.1442-200X.2011.03489.x</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>WE</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Chiew</surname> <given-names>CJ</given-names></name><name><surname>Yong</surname> <given-names>SE</given-names></name><name><surname>Toh</surname> <given-names>MP</given-names></name><name><surname>Lee</surname> <given-names>VJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Presymptomatic Transmission of SARS-CoV-2 â€” Singapore, January 23â€“March 16, 2020</article-title><source>MMWR. Morbidity and Mortality Weekly Report</source><volume>69</volume><fpage>411</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6914e1</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Enhanced spread of expiratory droplets by turbulence in a cough jet</article-title><source>Building and Environment</source><volume>93</volume><fpage>86</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.buildenv.2015.06.018</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wölfel</surname> <given-names>R</given-names></name><name><surname>Corman</surname> <given-names>VM</given-names></name><name><surname>Guggemos</surname> <given-names>W</given-names></name><name><surname>Seilmaier</surname> <given-names>M</given-names></name><name><surname>Zange</surname> <given-names>S</given-names></name><name><surname>Müller</surname> <given-names>MA</given-names></name><name><surname>Niemeyer</surname> <given-names>D</given-names></name><name><surname>Jones</surname> <given-names>TC</given-names></name><name><surname>Vollmar</surname> <given-names>P</given-names></name><name><surname>Rothe</surname> <given-names>C</given-names></name><name><surname>Hoelscher</surname> <given-names>M</given-names></name><name><surname>Bleicker</surname> <given-names>T</given-names></name><name><surname>Brünink</surname> <given-names>S</given-names></name><name><surname>Schneider</surname> <given-names>J</given-names></name><name><surname>Ehmann</surname> <given-names>R</given-names></name><name><surname>Zwirglmaier</surname> <given-names>K</given-names></name><name><surname>Drosten</surname> <given-names>C</given-names></name><name><surname>Wendtner</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Virological assessment of hospitalized patients with COVID-2019</article-title><source>Nature</source><volume>581</volume><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2196-x</pub-id><pub-id pub-id-type="pmid">32235945</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>U-I</given-names></name><name><surname>Wang</surname> <given-names>J-T</given-names></name><name><surname>Chen</surname> <given-names>Y-C</given-names></name><name><surname>Chang</surname> <given-names>S-C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Severity of pandemic H1N1 2009 influenza virus infection may not be directly correlated with initial viral load in upper respiratory tract</article-title><source>Influenza and Other Respiratory Viruses</source><volume>6</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1111/j.1750-2659.2011.00300.x</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyllie</surname> <given-names>AL</given-names></name><name><surname>Fournier</surname> <given-names>J</given-names></name><name><surname>Casanovas-Massana</surname> <given-names>A</given-names></name><name><surname>Campbell</surname> <given-names>M</given-names></name><name><surname>Tokuyama</surname> <given-names>M</given-names></name><name><surname>Vijayakumar</surname> <given-names>P</given-names></name><name><surname>Warren</surname> <given-names>JL</given-names></name><name><surname>Geng</surname> <given-names>B</given-names></name><name><surname>Muenker</surname> <given-names>MC</given-names></name><name><surname>Moore</surname> <given-names>AJ</given-names></name><name><surname>Vogels</surname> <given-names>CBF</given-names></name><name><surname>Petrone</surname> <given-names>ME</given-names></name><name><surname>Ott</surname> <given-names>IM</given-names></name><name><surname>Lu</surname> <given-names>P</given-names></name><name><surname>Venkataraman</surname> <given-names>A</given-names></name><name><surname>Lu-Culligan</surname> <given-names>A</given-names></name><name><surname>Klein</surname> <given-names>J</given-names></name><name><surname>Earnest</surname> <given-names>R</given-names></name><name><surname>Simonov</surname> <given-names>M</given-names></name><name><surname>Datta</surname> <given-names>R</given-names></name><name><surname>Handoko</surname> <given-names>R</given-names></name><name><surname>Naushad</surname> <given-names>N</given-names></name><name><surname>Sewanan</surname> <given-names>LR</given-names></name><name><surname>Valdez</surname> <given-names>J</given-names></name><name><surname>White</surname> <given-names>EB</given-names></name><name><surname>Lapidus</surname> <given-names>S</given-names></name><name><surname>Kalinich</surname> <given-names>CC</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Kim</surname> <given-names>DJ</given-names></name><name><surname>Kudo</surname> <given-names>E</given-names></name><name><surname>Linehan</surname> <given-names>M</given-names></name><name><surname>Mao</surname> <given-names>T</given-names></name><name><surname>Moriyama</surname> <given-names>M</given-names></name><name><surname>Oh</surname> <given-names>JE</given-names></name><name><surname>Park</surname> <given-names>A</given-names></name><name><surname>Silva</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>E</given-names></name><name><surname>Takahashi</surname> <given-names>T</given-names></name><name><surname>Taura</surname> <given-names>M</given-names></name><name><surname>Weizman</surname> <given-names>O-E</given-names></name><name><surname>Wong</surname> <given-names>P</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Bermejo</surname> <given-names>S</given-names></name><name><surname>Odio</surname> <given-names>CD</given-names></name><name><surname>Omer</surname> <given-names>SB</given-names></name><name><surname>Dela Cruz</surname> <given-names>CS</given-names></name><name><surname>Farhadian</surname> <given-names>S</given-names></name><name><surname>Martinello</surname> <given-names>RA</given-names></name><name><surname>Iwasaki</surname> <given-names>A</given-names></name><name><surname>Grubaugh</surname> <given-names>ND</given-names></name><name><surname>Ko</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2</article-title><source>New England Journal of Medicine</source><volume>383</volume><fpage>1283</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2016359</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Zhu</surname> <given-names>B</given-names></name><name><surname>Liang</surname> <given-names>H</given-names></name><name><surname>Fang</surname> <given-names>C</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>D</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Xia</surname> <given-names>H</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Gong</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding</article-title><source>Nature Medicine</source><volume>26</volume><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0817-4</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>J</given-names></name><name><surname>Grantham</surname> <given-names>M</given-names></name><name><surname>Pantelic</surname> <given-names>J</given-names></name><name><surname>Bueno de Mesquita</surname> <given-names>PJ</given-names></name><name><surname>Albert</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Ehrman</surname> <given-names>S</given-names></name><name><surname>Milton</surname> <given-names>DK</given-names></name><name><surname>Consortium</surname> <given-names>E</given-names></name><collab>EMIT Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community</article-title><source>PNAS</source><volume>115</volume><fpage>1081</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1073/pnas.1716561115</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J-R</given-names></name><name><surname>Lo</surname> <given-names>J</given-names></name><name><surname>Ho</surname> <given-names>Y-L</given-names></name><name><surname>Wu</surname> <given-names>H-S</given-names></name><name><surname>Liu</surname> <given-names>M-T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pandemic H1N1 and seasonal H3N2 influenza infection in the human population show different distributions of viral loads, which substantially affect the performance of rapid influenza tests</article-title><source>Virus Research</source><volume>155</volume><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2010.09.015</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonker</surname> <given-names>LM</given-names></name><name><surname>Neilan</surname> <given-names>AM</given-names></name><name><surname>Bartsch</surname> <given-names>Y</given-names></name><name><surname>Patel</surname> <given-names>AB</given-names></name><name><surname>Regan</surname> <given-names>J</given-names></name><name><surname>Arya</surname> <given-names>P</given-names></name><name><surname>Gootkind</surname> <given-names>E</given-names></name><name><surname>Park</surname> <given-names>G</given-names></name><name><surname>Hardcastle</surname> <given-names>M</given-names></name><name><surname>St. John</surname> <given-names>A</given-names></name><name><surname>Appleman</surname> <given-names>L</given-names></name><name><surname>Chiu</surname> <given-names>ML</given-names></name><name><surname>Fialkowski</surname> <given-names>A</given-names></name><name><surname>De la Flor</surname> <given-names>D</given-names></name><name><surname>Lima</surname> <given-names>R</given-names></name><name><surname>Bordt</surname> <given-names>EA</given-names></name><name><surname>Yockey</surname> <given-names>LJ</given-names></name><name><surname>D'Avino</surname> <given-names>P</given-names></name><name><surname>Fischinger</surname> <given-names>S</given-names></name><name><surname>Shui</surname> <given-names>JE</given-names></name><name><surname>Lerou</surname> <given-names>PH</given-names></name><name><surname>Bonventre</surname> <given-names>JV</given-names></name><name><surname>Yu</surname> <given-names>XG</given-names></name><name><surname>Ryan</surname> <given-names>ET</given-names></name><name><surname>Bassett</surname> <given-names>IV</given-names></name><name><surname>Irimia</surname> <given-names>D</given-names></name><name><surname>Edlow</surname> <given-names>AG</given-names></name><name><surname>Alter</surname> <given-names>G</given-names></name><name><surname>Li</surname> <given-names>JZ</given-names></name><name><surname>Fasano</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses</article-title><source>The Journal of Pediatrics</source><volume>227</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2020.08.037</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>ITS</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wong</surname> <given-names>TW</given-names></name><name><surname>Tam</surname> <given-names>W</given-names></name><name><surname>Chan</surname> <given-names>AT</given-names></name><name><surname>Lee</surname> <given-names>JHW</given-names></name><name><surname>Leung</surname> <given-names>DYC</given-names></name><name><surname>Ho</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus</article-title><source>New England Journal of Medicine</source><volume>350</volume><fpage>1731</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa032867</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>N</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Meng</surname> <given-names>F</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Mao</surname> <given-names>P</given-names></name><name><surname>Chuai</surname> <given-names>X</given-names></name><name><surname>Bi</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients</article-title><source>Science China Life Sciences</source><volume>20</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1007/s11427-020-1783-9</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Evaluating Transmission Heterogeneity and Super-Spreading Event of COVID-19 in a Metropolis of China</article-title><source>International Journal of Environmental Research and Public Health</source><volume>17</volume><elocation-id>3705</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph17103705</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>S</given-names></name><name><surname>Fan</surname> <given-names>J</given-names></name><name><surname>Yu</surname> <given-names>F</given-names></name><name><surname>Feng</surname> <given-names>B</given-names></name><name><surname>Lou</surname> <given-names>B</given-names></name><name><surname>Zou</surname> <given-names>Q</given-names></name><name><surname>Xie</surname> <given-names>G</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Gong</surname> <given-names>R</given-names></name><name><surname>Ma</surname> <given-names>Z</given-names></name><name><surname>Lu</surname> <given-names>S</given-names></name><name><surname>Xiao</surname> <given-names>Y</given-names></name><name><surname>Gu</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Yao</surname> <given-names>H</given-names></name><name><surname>Xu</surname> <given-names>K</given-names></name><name><surname>Lu</surname> <given-names>X</given-names></name><name><surname>Wei</surname> <given-names>G</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Fang</surname> <given-names>Q</given-names></name><name><surname>Cai</surname> <given-names>H</given-names></name><name><surname>Qiu</surname> <given-names>Y</given-names></name><name><surname>Sheng</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Liang</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang Province, China, January-March 2020: retrospective cohort study</article-title><source>BMJ</source><volume>369</volume><elocation-id>m1443</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.m1443</pub-id><pub-id pub-id-type="pmid">32317267</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>L</given-names></name><name><surname>Ruan</surname> <given-names>F</given-names></name><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Liang</surname> <given-names>L</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Hong</surname> <given-names>Z</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Kang</surname> <given-names>M</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Xia</surname> <given-names>J</given-names></name><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Song</surname> <given-names>T</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Yen</surname> <given-names>H-L</given-names></name><name><surname>Peiris</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients</article-title><source>New England Journal of Medicine</source><volume>382</volume><fpage>1177</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2001737</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Characteristics of contributing studies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Study*</th><th>Country</th><th>No. of cases included (no. of specimens)</th><th>No. of pediatric cases (no. of specimens)</th><th>No. of asymptomatic cases (no. of specimens)</th><th>Disease caused by virus (WHO case definition)</th><th>Treatments given (type)†</th><th>Individual data extracted (diluent volume reported)<sup>‡</sup></th><th>Adjusted viral load<sup>§</sup> (type of specimen)</th><th>Weight, % (meta-analysis category)<sup>||</sup></th><th>Weight, % (meta-regression)</th><th>Risk of bias<sup>¶</sup></th></tr></thead><tbody><tr><td valign="top"><xref ref-type="bibr" rid="bib2">Argyropoulos et al., 2020</xref></td><td valign="top">USA</td><td valign="top">205 (205)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">No (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.80 (V), 5.09 (A), 3.98 (S/Ps)</td><td valign="top">2.13</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib6">Baggio et al., 2020</xref></td><td valign="top">Switzerland</td><td valign="top">405 (405)</td><td valign="top">58 (58)</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.84 (V), 5.14 (A), 13.9 (P), 3.88 (S/Ps)</td><td valign="top">4.20</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib28">Fajnzylber et al., 2020</xref></td><td valign="top">USA</td><td valign="top">- (31)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (remdesivir)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS, OPS) <break/>No (Spu)</td><td valign="top">3.45 (V), 4.62 (A), 3.76 (S/Ps)</td><td valign="top">0.32</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td valign="top">South Korea</td><td valign="top">2 (8)</td><td valign="top">1 (6)</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">2.53 (V), 4.06 (S/Ps)</td><td valign="top">0.08</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td valign="top">South Korea</td><td valign="top">12 (27)</td><td valign="top">12 (27)</td><td valign="top">3 (7)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.43 (V), 17.5 (P), 4.10 (S/Ps), 14.3 (As)</td><td valign="top">0.28</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td valign="top">China</td><td valign="top">41 (310)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (control group: lopinavir ritonavir, antimicrobial treatment for secondary bacterial infection as indicated clinically, hydrocortisone for those requiring oxygen support)</td><td valign="top">No (no)</td><td valign="top">Yes (NPS, OPS, POS)</td><td valign="top">3.81 (V), 5.10 (A), 3.81 (S/Ps)</td><td valign="top">3.22</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib41">Hurst et al., 2020</xref></td><td valign="top">USA</td><td valign="top">133 (133)</td><td valign="top">54 (54)</td><td valign="top">52 (52)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (remdesivir)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.77 (V), 15.3 (P), 3.88 (S/Ps), 21.6 (As)</td><td valign="top">1.38</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib46">Iwasaki et al., 2020</xref></td><td valign="top">Japan</td><td valign="top">5 (5)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">2.53 (V), 3.37 (A), 4.12 (S/Ps)</td><td valign="top">0.05</td><td valign="top">****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib51">Kawasuji et al., 2020</xref></td><td valign="top">Japan</td><td valign="top">16 (16)</td><td valign="top">-</td><td valign="top">-</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (antivirals, antibiotics – specifics not reported)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.15 (V)</td><td valign="top">0.18</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib53">L'Huillier et al., 2020</xref></td><td valign="top">Switzerland</td><td valign="top">23 (23)</td><td valign="top">23 (23)</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">2.91 (V), 14.7 (P), 3.73 (S/Ps)</td><td valign="top">0.24</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib56">Lavezzo et al., 2020</xref></td><td valign="top">Italy</td><td valign="top">103 (110)</td><td valign="top">2 (3)</td><td valign="top">49 (49)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">3.77 (V), 5.03 (A), 11.57 (P), 3.57 (S/Ps), 21.8 (As)</td><td valign="top">1.14</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib62">Lennon et al., 2020</xref></td><td valign="top">USA</td><td valign="top">2200 (2,200)</td><td valign="top">18 (18)</td><td valign="top">2200 (2200<sup>#</sup>)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">No (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.88 (V), 5.20 (A), 24.0 (As)</td><td valign="top">22.84</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib75">Lucas et al., 2020</xref></td><td valign="top">USA</td><td valign="top">24 (33)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (tocilizumab for moderate and severe patients, glucocorticoid and vasopressor for severe patients)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.51 (V), 4.69 (A), 4.08 (S/Ps)</td><td valign="top">0.34</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib79">Mitjà et al., 2020</xref></td><td valign="top">Spain</td><td valign="top">148 (296)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">No (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.81 (V), 5.10 (A), 3.93 (S/Ps)</td><td valign="top">3.07</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib87">Pan et al., 2020</xref></td><td valign="top">China</td><td valign="top">75 (104)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (OPS) <break/>No (Spu)</td><td valign="top">3.45 (V), 2.50 (S/Ps)</td><td valign="top">1.24</td><td valign="top">****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib90">Peng et al., 2020</xref></td><td valign="top">China</td><td valign="top">6 (6)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (arbidol, lopinavir, ritonavir, interferon alfa-2b inhalation)</td><td valign="top">Yes (no)</td><td valign="top">Yes (OPS)</td><td valign="top">3.03 (V), 4.05 (A), 4.02 (S/Ps)</td><td valign="top">0.06</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib91">Perera et al., 2020</xref></td><td valign="top">China</td><td valign="top">- (36)</td><td valign="top">0</td><td valign="top">-</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes lopinavir-ritonavir alone, combination lopinavir-ritonavir and ribavirin, ribavirin and β interferon, β interferon alone, combination ribavirin, β interferon, and tocilizumab, and corticosteroid</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPA, NPS, OPS, Spu)</td><td valign="top">3.23 (V), 4.32 (A)</td><td valign="top">0.39</td><td valign="top">****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib102">Shi et al., 2020</xref></td><td valign="top">China</td><td valign="top">103 (103)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">No (samples drawn before antivirals given)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">3.87 (V), 5.18 (A), 4.34 (S/Ps)</td><td valign="top">1.07</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib103">Shrestha et al., 2020</xref></td><td valign="top">USA</td><td valign="top">171 (171)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (indicated no hydroxychloroquine or other COVID-19-related treatments were used)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.79 (V), 5.07 (A), 3.86 (S/Ps)</td><td valign="top">1.78</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib110">To et al., 2020</xref></td><td valign="top">China</td><td valign="top">23 (51)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (yes)</td><td valign="top">Yes (ETA, POS)</td><td valign="top">3.37 (V), 4.51 (A), 3.25 (S/Ps)</td><td valign="top">0.53</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib111">van Kampen et al., 2021</xref></td><td valign="top">The Netherlands</td><td valign="top">- (154)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (lopinavir-ritonavir with or without ribavirin and/or interferon beta 1b)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS, Spu)</td><td valign="top">3.80 (V), 5.09 (A), 4.10 (S/Ps)</td><td valign="top">1.60</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib112">Vetter et al., 2020</xref></td><td valign="top">Switzerland</td><td valign="top">5 (63)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (paracetamol, alfuzosin, ibuprofen, enoxaparin, amoxicillin clarithromycin, piperacillin, tazobactam, lopinavir, ritonavir, folic acid)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">3.68 (V), 4.93 (A), 4.14 (S/Ps)</td><td valign="top">0.65</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref></td><td valign="top">Germany</td><td valign="top">9 (136)</td><td valign="top">0</td><td valign="top">1 (4)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS, OPS) <break/>No (Spu)</td><td valign="top">3.76 (V), 5.03 (A), 3.93 (S/Ps)</td><td valign="top">1.38</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib120">Wyllie et al., 2020</xref></td><td valign="top">USA</td><td valign="top">40 (42)</td><td valign="top">-</td><td valign="top">9 (9)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.55 (V), 4.75 (A), 4.00 (S/Ps), 18.3 (As)</td><td valign="top">0.44</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib121">Xu et al., 2020</xref></td><td valign="top">China</td><td valign="top">7 (14)</td><td valign="top">7 (14)</td><td valign="top">1 (1)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (α-interferon oral spray, azithromycin)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.40 (V). 17.3 (P), 4.1 (S/Ps)</td><td valign="top">0.15</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib124">Yonker et al., 2020</xref></td><td valign="top">USA</td><td valign="top">17 (17)</td><td valign="top">14 (14)</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">2.58 (V), 9.79 (P), 3.28 (S/Ps)</td><td valign="top">0.18</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib127">Zhang et al., 2020b</xref></td><td valign="top">China</td><td valign="top">9 (9)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">2.97 (V), 3.97 (A), 3.68 (S/Ps)</td><td valign="top">0.09</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib128">Zheng et al., 2020</xref></td><td valign="top">China</td><td valign="top">- (19)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">Yes (gamma globulin, glucocorticoids, antibiotics, antiviral combination of interferon α inhalation, lopinavir-ritonavir combination, arbidol, favipiravir, and darunavir-cobicistat)</td><td valign="top">Yes (no)</td><td valign="top">Yes (POS, Spu)</td><td valign="top">3.66 (V), 4.90 (A), 4.23 (S/Ps)</td><td valign="top">0.20</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib129">Zou et al., 2020</xref></td><td valign="top">China</td><td valign="top">14 (55)</td><td valign="top">0</td><td valign="top">1 (4)</td><td valign="top">COVID-19 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">3.64 (V), 4.87 (A), 3.65 (S/Ps)</td><td valign="top">0.57</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib11">Chen et al., 2006</xref></td><td valign="top">China</td><td valign="top">154 (154<sup>#</sup>)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">14.0 (V)</td><td valign="top">1.59</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib17">Chu et al., 2004</xref>**</td><td valign="top">China</td><td valign="top">11 (11)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">Yes (control group: ribavirin, hydrocortisone, methylprednisolone)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">8.6 (V)</td><td valign="top">0.11</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib18">Chu et al., 2005</xref></td><td valign="top">China</td><td valign="top">57 (57)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPA)</td><td valign="top">13.3 (V)</td><td valign="top">0.59</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib14">Cheng et al., 2004</xref></td><td valign="top">China</td><td valign="top">59 (59)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">Yes (amoxicillin-clavulanate, azithromycin, levofloxacin, ribavirin, hydrocortisone, prednisolone, methylprednisolone)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPA)</td><td valign="top">13.4 (V)</td><td valign="top">0.61</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib38">Hung et al., 2004</xref></td><td valign="top">China</td><td valign="top">60 (60)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">N/A</td><td valign="top">No (yes)</td><td valign="top">Yes (NPA)</td><td valign="top">13.5 (V)</td><td valign="top">0.62</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib89">Peiris et al., 2003</xref>**</td><td valign="top">China</td><td valign="top">14 (42)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">Yes (ribavirin, hydrocortisone, prednisolone, methylprednisolone)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPA)</td><td valign="top">13.4 (V)</td><td valign="top">0.44</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib93">Poon et al., 2003</xref></td><td valign="top">China</td><td valign="top">40 (40)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">N/A</td><td valign="top">No (yes)</td><td valign="top">Yes (NPA)</td><td valign="top">11.3 (V)</td><td valign="top">0.42</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib94">Poon et al., 2004</xref></td><td valign="top">China</td><td valign="top">- (43)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">SARS (confirmed)</td><td valign="top">N/A</td><td valign="top">No (yes)</td><td valign="top">Yes (NPA)</td><td valign="top">12.5 (V)</td><td valign="top">0.45</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib99">Rodrigues Guimarães Alves et al., 2020</xref></td><td valign="top">Brazil</td><td valign="top">86 (86)</td><td valign="top">-</td><td valign="top">15 (15)</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">No (yes)</td><td valign="top">Yes (NPA, NPS, OPS)</td><td valign="top">3.7 (V)</td><td valign="top">0.89</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib10">Chan et al., 2011</xref></td><td valign="top">China</td><td valign="top">58 (58)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir, zanamivir, peramivir)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPA, NPS, OPS)</td><td valign="top">3.7 (V)</td><td valign="top">0.60</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib15">Cheng et al., 2010</xref></td><td valign="top">China</td><td valign="top">60 (60)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA)</td><td valign="top">3.7 (V)</td><td valign="top">0.62</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib20">Cowling et al., 2010</xref></td><td valign="top">China</td><td valign="top">45 (54)</td><td valign="top">22 (31)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">3.7 (V)</td><td valign="top">0.56</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib24">Duchamp et al., 2010</xref></td><td valign="top">France</td><td valign="top">209 (209)</td><td valign="top">209 (209)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir, zanamivir)</td><td valign="top">No (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.8 (V)</td><td valign="top">2.17</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib26">Esposito et al., 2011</xref></td><td valign="top">Italy</td><td valign="top">74 (282)</td><td valign="top">74 (282)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.8 (V)</td><td valign="top">2.93</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib39">Hung et al., 2010</xref></td><td valign="top">China</td><td valign="top">87 (87)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPA, NPS)</td><td valign="top">3.8 (V)</td><td valign="top">0.90</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib43">Ip et al., 2016</xref></td><td valign="top">China</td><td valign="top">17 (20)</td><td valign="top">7 (-)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">N/A</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS, OPS)</td><td valign="top">3.6 (V)</td><td valign="top">0.21</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib45">Ito et al., 2012</xref></td><td valign="top">Japan</td><td valign="top">34 (34)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.7 (V)</td><td valign="top">0.35</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib52">Killingley et al., 2010</xref></td><td valign="top">United Kingdom</td><td valign="top">12 (21)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.5 (V)</td><td valign="top">0.22</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib55">Launes et al., 2012</xref></td><td valign="top">Spain</td><td valign="top">47 (47)</td><td valign="top">47 (47)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA)</td><td valign="top">3.7 (V)</td><td valign="top">0.49</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib59">Lee et al., 2011a</xref></td><td valign="top">China</td><td valign="top">48 (48)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA)</td><td valign="top">3.7 (V)</td><td valign="top">0.50</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib59">Lee et al., 2011a</xref></td><td valign="top">Singapore</td><td valign="top">578 (578)</td><td valign="top">231 (231)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.8 (V)</td><td valign="top">6.00</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib63">Li et al., 2010a</xref></td><td valign="top">China</td><td valign="top">581 (581)</td><td valign="top">522 (522)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">No (no)</td><td valign="top">Yes (OPS)</td><td valign="top">3.8 (V)</td><td valign="top">6.03</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib64">Li et al., 2010b</xref></td><td valign="top">China</td><td valign="top">27 (59)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (control group no treatment)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA, NPS, OPS)</td><td valign="top">3.7 (V)</td><td valign="top">0.61</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib71">Loeb et al., 2012</xref></td><td valign="top">Canada</td><td valign="top">97 (218)</td><td valign="top">-</td><td valign="top">- (17)</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No</td><td valign="top">No (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.8 (V)</td><td valign="top">2.26</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib72">Lu et al., 2012</xref></td><td valign="top">China</td><td valign="top">13 (25)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir, zanamivir)</td><td valign="top">Yes (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.5 (V)</td><td valign="top">0.26</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib78">Meschi et al., 2011</xref></td><td valign="top">Italy</td><td valign="top">533 (533)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (no)</td><td valign="top">Yes (NPS)</td><td valign="top">3.8 (V)</td><td valign="top">0.92</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib86">Ngaosuwankul et al., 2010</xref></td><td valign="top">China</td><td valign="top">12 (33)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (yes)</td><td valign="top">Yes (NPA, NPS, OPS)</td><td valign="top">3.6 (V)</td><td valign="top">0.34</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib96">Rath et al., 2012</xref></td><td valign="top">Germany</td><td valign="top">27 (41)</td><td valign="top">27 (41)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.7 (V)</td><td valign="top">0.43</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib104">Suess et al., 2010</xref></td><td valign="top">Germany</td><td valign="top">51 (129)</td><td valign="top">12 (-)</td><td valign="top">1 (1)</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA, NPS, OPS)</td><td valign="top">3.8 (V)</td><td valign="top">1.34</td><td valign="top">********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib107">Thai et al., 2014</xref></td><td valign="top">Vietnam</td><td valign="top">33 (123)</td><td valign="top">16 (-)</td><td valign="top">5 (28)</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">Yes (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.8 (V)</td><td valign="top">1.28</td><td valign="top">*********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib108">To et al., 2010a</xref></td><td valign="top">China</td><td valign="top">50 (50)</td><td valign="top">0</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir, zanamivir, inotropes)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA, NPS)</td><td valign="top">3.6 (V)</td><td valign="top">0.52</td><td valign="top">******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib109">To et al., 2010b</xref></td><td valign="top">China</td><td valign="top">22 (22)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (no)</td><td valign="top">Yes (NPA, NPS, OPS)</td><td valign="top">3.4 (V)</td><td valign="top">0.23</td><td valign="top">*****</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib115">Watanabe et al., 2011</xref></td><td valign="top">Japan</td><td valign="top">251 (251)</td><td valign="top">251 (251)</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">No (pretreatment samples)</td><td valign="top">No (yes)</td><td valign="top">Yes (NPA)</td><td valign="top">3.8 (V)</td><td valign="top">2.61</td><td valign="top">**********</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib119">Wu et al., 2012</xref></td><td valign="top">China</td><td valign="top">64 (89)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">Yes (oseltamivir)</td><td valign="top">No (yes)</td><td valign="top">Yes (NPS)</td><td valign="top">3.7 (V)</td><td valign="top">5.53</td><td valign="top">*******</td></tr><tr><td valign="top"><xref ref-type="bibr" rid="bib123">Yang et al., 2011</xref></td><td valign="top">China</td><td valign="top">251 (251)</td><td valign="top">-</td><td valign="top">0</td><td valign="top">A(H1N1)pdm09 (confirmed)</td><td valign="top">N/A</td><td valign="top">No (yes)</td><td valign="top">Yes (OPS)</td><td valign="top">3.8 (V)</td><td valign="top">6.57</td><td valign="top">*****</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>Data shown as ‘-' were not obtained from the paper or authors.</p><p><sup>†</sup>Responses of ‘N/A’ indicate that no details were reported on treatment for COVID-19 in the study.</p></fn><fn><p><sup>‡</sup>For studies reporting specimen measurements as individual sample data (either in numerical or graphical formats), the sample data was extracted for analysis.</p><p><sup>§</sup>Specimen measurements were converted to rVLs based on the dilution factor for specimens in transport media.</p></fn><fn><p><sup>||</sup>Abbreviations for random-effects meta-analyses: virus meta-analysis (V), adult subgroup (A), pediatric subgroup (P), symptomatic/presymptomatic subgroup (S/Ps) and asymptomatic subgroup (As).</p><p><sup>¶</sup>The hybrid JBI critical appraisal checklist was used, with more stars indicating lower risk of bias. Studies were considered to have low risk of bias if they met the majority of the items (≥6/10 items). Results from each study are shown in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>.</p></fn><fn><p><sup>#</sup>For these studies, 2147 (<xref ref-type="bibr" rid="bib62">Lennon et al., 2020</xref>) and 134 (<xref ref-type="bibr" rid="bib11">Chen et al., 2006</xref>) individual specimen measurements were obtained for the individual sample datasets.</p><p><sup>**</sup>For <xref ref-type="bibr" rid="bib17">Chu et al., 2004</xref>, only specimen measurements at 20 DFSO were collected as 5–15 DFSO were specimens reported in <xref ref-type="bibr" rid="bib89">Peiris et al., 2003</xref>.</p></fn><fn><p>NPS: nasopharyngeal swab; OPS, oropharyngeal swab; Spu: sputum; POS, posterior oropharyngeal saliva; NPA: nasopharyngeal aspirate; ETA: endotracheal aspirate; DFSO: days from symptom onset; rVL: respiratory viral load.</p></fn></table-wrap-foot></table-wrap><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Assessment of risk of bias based on the hybrid JBI critical appraisal checklist.</title></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th/><th colspan="10">Checklist items*</th></tr></thead><tbody><tr valign="top"><td><bold>Study</bold></td><td><bold>1</bold></td><td><bold>2</bold></td><td><bold>3</bold></td><td><bold>4</bold></td><td><bold>5</bold></td><td><bold>6</bold></td><td><bold>7</bold></td><td><bold>8</bold></td><td><bold>9</bold></td><td><bold>10</bold></td></tr><tr><td><xref ref-type="bibr" rid="bib2">Argyropoulos et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib6">Baggio et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib28">Fajnzylber et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib40">Hung et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib46">Iwasaki et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib51">Kawasuji et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib53">L'Huillier et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib56">Lavezzo et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib62">Lennon et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib75">Lucas et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib79">Mitjà et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib87">Pan et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib90">Peng et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib91">Perera et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib102">Shi et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib103">Shrestha et al., 2020</xref></td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib110">To et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib111">van Kampen et al., 2021</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib112">Vetter et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib118">Wölfel et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib120">Wyllie et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib121">Xu et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib124">Yonker et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib127">Zhang et al., 2020b</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib128">Zheng et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib129">Zou et al., 2020</xref></td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib11">Chen et al., 2006</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib17">Chu et al., 2004</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib18">Chu et al., 2005</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib14">Cheng et al., 2004</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib38">Hung et al., 2004</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib89">Peiris et al., 2003</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib93">Poon et al., 2003</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib94">Poon et al., 2004</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib99">Rodrigues Guimarães Alves et al., 2020</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib10">Chan et al., 2011</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib15">Cheng et al., 2010</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib20">Cowling et al., 2010</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib24">Duchamp et al., 2010</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td></tr><tr><td><xref ref-type="bibr" rid="bib26">Esposito et al., 2011</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib39">Hung et al., 2010</xref></td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib43">Ip et al., 2016</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib45">Ito et al., 2012</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib52">Killingley et al., 2010</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib55">Launes et al., 2012</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib59">Lee et al., 2011a</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib59">Lee et al., 2011a</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib63">Li et al., 2010a</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib64">Li et al., 2010b</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib71">Loeb et al., 2012</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib72">Lu et al., 2012</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib78">Meschi et al., 2011</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib86">Ngaosuwankul et al., 2010</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib96">Rath et al., 2012</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib104">Suess et al., 2010</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib107">Thai et al., 2014</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib108">To et al., 2010a</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib109">To et al., 2010b</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib115">Watanabe et al., 2011</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib119">Wu et al., 2012</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr><tr><td><xref ref-type="bibr" rid="bib123">Yang et al., 2011</xref></td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b4" valign="top">U</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b2" valign="top">Y</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b6" valign="top">N</td><td style="author-callout-style-b2" valign="top">Y</td></tr></tbody></table><table-wrap-foot><fn><p>*Descriptions of each item are included in the hybrid JBI critical appraisal checklist (Appendix). Y (green), U (yellow) and N (red) represent yes, unclear and no, respectively.</p></fn></table-wrap-foot></table-wrap></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65774.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>van der Meer</surname><given-names>Jos WM</given-names></name><role>Reviewing Editor</role><aff><institution>Radboud University Medical Centre</institution><country>Netherlands</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Vermeulen</surname><given-names>Lucie</given-names> </name><role>Reviewer</role><aff><institution/><country>Netherlands</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The authors performed a systematic literature review and meta-analysis to develop a dataset of respiratory viral loads (rVLs)for three viruses (SARS-CoV-2, SARS-CoV-1 and influenza A(H1N1)pdm09). Furthermore, the kinetics of viral shedding over time during a respiratory infection are studied, and a model is developed for infectiousness via shedding of viable virus in aerosols and droplets. The study appears robust and comprehensive, and the results are valuable and contribute to the scientific knowledge in this field.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Senior/Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: Lucie Vermeulen (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Summary:</p><p>This is a very interesting study on an important subject. It uses a combination of approaches (systematic review, meta-regression, mathematical modelling) to study the association between the variability of respiratory viral loads (rVL) and heterogeneity in transmission rates. The authors argue that variability of rVL is a main determinant of the high heterogeneity of transmission rates and translate the rVL distribution into transmission probabilities for different transmission modes (droplets, aerosols; breathing, speaking, singing). These conclusions are interesting and potentially relevant for public health. The combination of rVL data from &gt;60 studies represents an impressive amount of work which may also be useful for future research.</p><p>The paper does not stop at a descriptive summary of these data but uses several modelling approaches (meta-regression, &quot;translation&quot; into transmission probabilities, dynamical modelling) to interpret these data. The evidence provided by these analyses is more tentative than presented by the authors in this version of the manuscript.</p><p>Essential revisions:</p><p>1. The meta-regression is based on only three viral species and hence it is unclear how generalisable the observed association between rVL and transmission heterogeneity is. In the best case the data show that the three virus species exhibit significantly different rVL-variation, which coincides with their different k values at the epidemiological level. However, this latter association is essentially based on only three data points (i.e. the three viral species). The current meta-regression approach (applying a simple linear regression but essentially ignoring the fact that all studies stem from only three virus species; i.e., ignoring the hierarchical nature of the data) provides p values which strongly exaggerate the degree of evidence.</p><p>2. One major potential confounder is the very strong dependence of rVL on infection time. The authors consider this in the section &quot;SARS-CoV 2 kinetics during respiratory infection&quot; where they show also a substantial variation of rVL across different strata of days from symptom onset (DFSO). However, it is unclear to what extent this affects the previous analyses (e.g., the meta-regression models). More fundamentally, the cross-sectional nature of the rVL data leads almost by necessity to an overestimation of the variability in the transmission potential of infections and in a very strong dependency of the rVL variation on the distribution of sampling time. Even a stratification on DFSO can only partly address these problems, firstly because DFSO is in most cases associated with a substantial uncertainty which in the case of a highly dynamic infection will translate into an even larger variation of rVLs. Moreover, even if DFSO were an exact measure of infection time, different infections do not need to be synchronous (e.g. because of stochastic effects or variation of the processes corresponding to the model parameters across individuals) such that different individuals will have their peak rVL at different time points. Taken together this implies that a reliable measure of heterogeneity would require determining something like the area under the curve of rVL (which of course is very challenging).</p><p>3. This limitation also strongly affects the practical, public health relevance of the findings. For example, the authors state that &quot;Our analyses suggest that heterogeneity in rVL may be generally associated with over-dispersion for viral respiratory infections. In this case, rVL distribution can serve as an early correlate for transmission patterns, including super-spreading, during outbreaks of novel respiratory viruses, providing insight for disease control before large-scale epidemiological studies empirically characterise k &quot;. This potential application assumes that the timing of rVL measurements is known early in a pandemic and that it can be controlled for, which requires a detailed knowledge of the within patient dynamics of the virus. I would assume that achieving this knowledge would take at least as long as estimating k in epidemiological studies. Thus it may be more appropriate to think about the two approaches in characterising heterogeneity as complementary (in the context of epidemiological triangulation; i.e. both approaches having their weaknesses and biases but which can be overcome in a joint consideration; generally, I think that attempting to achieve such a triangulation is one of the main strengths of the present study, despite its limitations).</p><p>4. The variation of rVL might also be strongly driven by the sampling method/procedure (even the same method will give very different results across health-care workers), which implies the same problems as (2) – i.e. overestimation of rVL variability and potential confounding.</p><p>5. The authors note that &quot;Talking, singing and coughing expelled virions at greater proportions via droplets (80.6-86.0%) than aerosols (14.0-19.4%).&quot; It should be noted that although more virions are expelled via droplets than aerosols according to the findings of this study, exposure to droplets and aerosols is not equal and this could affect the probability of transmission via these routes. For example, if social distancing and masking is observed then it is possible that larger droplets are more easily captured by masks or fall on the ground quickly and do not reach a susceptible individual, while aerosols do. Furthermore, smaller droplets and aerosols can penetrate more deeply into the lungs. It is as of yet unclear whether this would influence the probability of becoming (more severely) infected. This may also differ per virus. A discussion on these issues is relevant.</p><p>6. The authors also note that their results &quot;support aerosol spread as a transmission mode for SARS-CoV-2, including for conditional superspreading by highly infectious cases. However, with short durations of stay in well-ventilated areas, the exposure risk for aerosols, including long-range and buoyant ones, remains correlated with proximity to infectious cases.&quot;</p><p>7. A methodological note on the modelling that may affect the results (but likely do not impact the conclusions strongly) is the following.</p><p>The authors take a value of 0.1% for the fraction of SARS-CoV-2 RNA copies that represents viable virus (parameter 𝛾). This value is quite uncertain. More literature (not yet peer-reviewed) exists on the fraction of SARS-CoV-2 RNA copies that is infectious virus, providing different values. Van Kampen et al. (2020) only found a cytopathic effect on Vero cells if the swab sample from patients contained more than 7 log<sub>10</sub> RNA copies/mL. Fears et al. (2020) find an average of 0.003 (range 0.0008 – 0.02) CCID50/RNA copy. However, Lednicky et al. (2020) sampled SARS-CoV-2-containing aerosols in a room with COVID-19 patients with air samplers using a water vapor condensation mechanism and as such collect virus particles without damaging them, and found an average of 0.6 CCID50/RNA copy, much higher. The model is likely sensitive to this parameter, and this could influence the result. These issues should be taken into account in the revision.</p><p>8. Another methodological point is that more datasets in literature are available on the emission rates and size distribution of particles during breathing, speaking, coughing etc., than are currently used to base the model on. Schijven et al. (2020) compared seven datasets and found that they sometimes differ quite strongly. For example, the median volume of aerosol particles produced for coughing differs over two orders of magnitude when comparing two data sets. It is unclear what this difference represents, it might have to do with the sampling method. Furthermore, observed size distributions also differ in literature, with peak particle emission rates at different sizes. The authors should be aware that the choice of particle emission data for their study can impact their results strongly, and including discussion on the choice of data set and the implications on the results is warranted.</p><p>9. Taking 0.5 for the evaporation diameter factor is probably too large. Liu et al. (2017) find a value around one third for respiratory droplets from coughing, and the recent study on the evaporation of saliva droplets and aerosols by Lieber et al. (2021) find a value of 0.2 (for a range of temperature of 20-29 degrees C, and range of relative humidity of 6 – 65%). This likely matters for the result, as the difference between 0.5 and 0.2 leads to a factor ~15 change in droplet volume.</p><p>10. The kinetic model assumes that viral replication is controlled by the reduction of target cells over the course of the infection, but it neglects the effect of the immune system. This seems a rather strong assumption. What is the evidence for this in the case of SARS-CoV2? Also, it would be good if the authors could comment on the identifiability of the model parameters- especially the high uncertainty of the half-life of SARS-CoV2 in the respiratory tract (2.62-66hours) suggests that this might be a problem.</p><p>Additional points:</p><p>11. Line 453-454: &quot;log 𝑘 = 𝑎(𝑆𝐷) + 𝑏, where 𝑎 is the slope for association and 𝑏 is the intercept&quot;. This appears to be a strange notation for this equation, isn't &quot;a*SD + b&quot; more logical?</p><p>12. Line 544-545: &quot;To estimate the average duration of shedding, we extrapolated the model to 0 log<sub>10</sub> copies/ml post-symptom onset.&quot; If the tail of the model is very long, it might take a very long time to reach 0 log<sub>10</sub>. Is this the case? And if yes, is perhaps a 95% decrease compared to the maximum a better measure for the duration of shedding?</p><p>13. Line 560: Is this unit correct? &quot;𝜌 is the material density of the respiratory particle (997 g/m3)&quot; Shouldn't this density be in kg/m3?</p><p>14. Line 563 – 571: The estimate for 𝛾 for SARS-CoV-2 could turn out to be higher, if Lednicky et al. (2020) are to be believed. In any case, this warrants some further discussion in the paper, as the results are probably quite sensitive to this parameter!</p><p>15. Line 609 – 610: &quot;𝜌 is the material density of the respiratory particle (taken to be 1 g/cm3 based on the composition of dehydrated respiratory particles)&quot;. What is the reference for this statement? Zhang et al. (2011) find densities between 1.25 and 1.62 g/mL (Table 2). It seems logical that the drying process increases the density somewhat as compared to the density of water, as for instance the heavier salts do not evaporate.</p><p>16. Figure 2: this figure is somewhat unclear, maybe I do not understand it correctly. Why does one study have multiple standard deviations? And as there are only three values of k, regression seems to be an odd choice. A comparison between different groups of k seems more appropriate?</p><p>References:</p><p>Fears AC, Klimstra WB, Duprex P, Hartman A, Weaver SC, Plante KS, et al. 2020. Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of sars-cov-2 in aerosol suspensions. medRxiv:2020.2004.2013.20063784.</p><p>Lednicky JA, Lauzardo M, Fan ZH, Jutla AS, Tilly TB, Gangwar M, et al. 2020. Viable sars-cov-2 in the air of a hospital room with covid-19 patients. medRxiv:2020.2008.2003.20167395.</p><p>Lieber, C., Melekidis, S., Koch, R., Bauer, H.-J., 2021. Insights into the evaporation characteristics of saliva droplets and aerosols: Levitation experiments and numerical modeling. Journal of Aerosol Science 154, 105760.</p><p>Liu, L., Wei, J., Li, Y., Ooi, A., 2017. Evaporation and dispersion of respiratory droplets from coughing. Indoor Air 27, 179-190.</p><p>Schijven, J.F., Vermeulen, L.C., Swart, A., Meijer, A., Duizer, E., de RodaHusman, A.M., 2020. Exposure assessment for airborne transmission of SARS-CoV-2 via breathing, speaking, coughing and sneezing. medRxiv, 2020.2007.2002.20144832.</p><p>van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. 2020. Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (covid-19): Duration and key determinants. medRxiv: 2020.2006.2008. 20125310.</p><p>Zhang, T., 2011. Study on Surface Tension and Evaporation Rate of Human Saliva, Saline, and Water Droplets. West Virginia University,</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65774.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. The meta-regression is based on only three viral species and hence it is unclear how generalisable the observed association between rVL and transmission heterogeneity is. In the best case the data show that the three virus species exhibit significantly different rVL-variation, which coincides with their different k values at the epidemiological level. However, this latter association is essentially based on only three data points (i.e. the three viral species). The current meta-regression approach (applying a simple linear regression but essentially ignoring the fact that all studies stem from only three virus species; i.e., ignoring the hierarchical nature of the data) provides p values which strongly exaggerate the degree of evidence.</p></disp-quote><p>We have revised the reporting of the described analysis to address the points raised by the reviewers. We have edited the meta-regression result to specifically mention it refers to analysis of these three viruses. In addition, rather than report the specific <italic>P</italic>-value from our meta-regression (which was orders of magnitude lower), we now report “<italic>P</italic> &lt; 0.001”, which is revised in Figure 2 as well as the text. The revised text says, “meta-regression (Figure 2) showed a strong, negative association between k and heterogeneity in rVL for these three viruses (meta-regression slope t-test: <italic>P</italic> &lt; 0.001, Pearson’s <italic>r</italic> = -0.73).” (page 6, line 123-125). These revisions have have softened the described degree of evidence and report the results of our meta-regression as specifically based on the three viruses (SARS-CoV-2, SARS-CoV-1 and A(H1N1)pdm09).</p><disp-quote content-type="editor-comment"><p>2. One major potential confounder is the very strong dependence of rVL on infection time. The authors consider this in the section &quot;SARS-CoV 2 kinetics during respiratory infection&quot; where they show also a substantial variation of rVL across different strata of days from symptom onset (DFSO). However, it is unclear to what extent this affects the previous analyses (e.g., the meta-regression models). More fundamentally, the cross-sectional nature of the rVL data leads almost by necessity to an overestimation of the variability in the transmission potential of infections and in a very strong dependency of the rVL variation on the distribution of sampling time. Even a stratification on DFSO can only partly address these problems, firstly because DFSO is in most cases associated with a substantial uncertainty which in the case of a highly dynamic infection will translate into an even larger variation of rVLs. Moreover, even if DFSO were an exact measure of infection time, different infections do not need to be synchronous (e.g. because of stochastic effects or variation of the processes corresponding to the model parameters across individuals) such that different individuals will have their peak rVL at different time points. Taken together this implies that a reliable measure of heterogeneity would require determining something like the area under the curve of rVL (which of course is very challenging).</p></disp-quote><p>Our systematic review and data collection were designed to specifically develop a dataset of rVLs from the estimated infectious periods for each virus. While, as noted by the reviewers, the cross-sectional nature of data, like virus quantitation, means that some DFSO may be more prevalent in the dataset in each study. However, when considered together, the studies identified by the systematic review tended to span the estimated infectious period for each of the three viruses. Since the meta-analyses (before the “SARS-CoV-2 kinetics during the respiratory infection” section) are conducted cumulatively on the identified studies, they “approximated the expected rVL when encountering a COVID-19, SARS or A(H1N1)pdm09 case during the infectious period” (page 7, line 138-139). For the meta-regression, each study is an estimate of the SD of the rVLs in their analyzed period. Like described above, the meta-regression should approximate the SD of the rVLs throughout the infectious period. As a limitation of the study, we note that there were fewer studies that had data from the presymptomatic period: “The systematic search found a limited number of studies reporting quantitative specimen measurements from the presymptomatic period, meaning these estimates may be sensitive to sampling bias.” (page 15, line 399-401).</p><p>As the reviewers mentioned, there is uncertainty in DFSO. For example, DFSO is often based on patient recall, which is uncertain. Even in the scenario that DFSO is certain, then cases can have different peak rVLs on different DFSO, as the reviewers also mentioned. To discuss this potential confounder in the former point, we have written, “Specimen measurements (based on instrumentation, calibration, procedures and reagents) are not standardized and, as DFSO is typically based on patient recall, there is also inherent uncertainty in these values. While the above procedures (including only quantitative measurements after extraction as an inclusion criterion, considering assay detection limits and correcting for specimen dilution) have considered many of these factors, non-standardization remains an inherent limitation in the variability of specimen measurements.” (page 23, line 588-593). For the latter point, if rVL peaks on different DFSO for different individuals, then this variability should influence, and be shown in, our aggregate analyses and estimates. Stratification for DFSO also considers this. For example, when encountering a case on 5 DFSO, we wish to know what the expected distribution of rVLs that the case may have. Our analyses consider the distribution of rVLs on that DFSO, and thus this approach assesses rVL variability on each DFSO across cases.</p><disp-quote content-type="editor-comment"><p>3. This limitation also strongly affects the practical, public health relevance of the findings. For example, the authors state that &quot;Our analyses suggest that heterogeneity in rVL may be generally associated with over-dispersion for viral respiratory infections. In this case, rVL distribution can serve as an early correlate for transmission patterns, including super-spreading, during outbreaks of novel respiratory viruses, providing insight for disease control before large-scale epidemiological studies empirically characterise k &quot;. This potential application assumes that the timing of rVL measurements is known early in a pandemic and that it can be controlled for, which requires a detailed knowledge of the within patient dynamics of the virus. I would assume that achieving this knowledge would take at least as long as estimating k in epidemiological studies. Thus it may be more appropriate to think about the two approaches in characterising heterogeneity as complementary (in the context of epidemiological triangulation; i.e. both approaches having their weaknesses and biases but which can be overcome in a joint consideration; generally, I think that attempting to achieve such a triangulation is one of the main strengths of the present study, despite its limitations).</p></disp-quote><p>We have revised our manuscript to discuss the updated view, for which we express appreciation to the reviewers. We no longer discuss rVL as being characterized before epidemiological studies empirically characterizing k, but now write: “In this case, rVL distribution can serve as an early correlate for transmission patterns, including superspreading, during outbreaks of novel respiratory viruses. When considered jointly with contact-tracing studies, this provides epidemiological triangulation on <italic>k</italic>: heterogeneity in rVL indirectly estimates <italic>k</italic> via an association, whereas contact tracing empirically characterizes transmission chains to estimate <italic>k</italic> but is limited by incomplete or incorrect recall of contact events by cases.” (page 14, line 361-366).</p><disp-quote content-type="editor-comment"><p>4. The variation of rVL might also be strongly driven by the sampling method/procedure (even the same method will give very different results across health-care workers), which implies the same problems as (2) – i.e. overestimation of rVL variability and potential confounding.</p></disp-quote><p>The inclusion and exclusion criteria used in our systematic review protocol means that we considered a specific set of respiratory specimens from which virus quantitation was performed in a similar manner. We also accounted for variation between studies and specimen types in their processing (e.g., volume of viral transport media used) in the estimation of rVLs. Further assessment of these potential risks of bias was included through the JBI critical appraisal checklist.</p><p>We agree with the reviewers that there is increased variation in rVLs based on sampling, which is an intrinsic measurement error associated with virus quantitation. We do note this limitation with “Specimen measurements (based on instrumentation, calibration, procedures and reagents) are not standardized and, as DFSO is typically based on patient recall, there is also inherent uncertainty in these values. While the above procedures (including only quantitative measurements after extraction as an inclusion criterion, considering assay detection limits and correcting for specimen dilution) have considered many of these factors, non-standardization remains an inherent limitation in the variability of specimen measurements” (page 23, line 588-593).</p><p>Each viral load for each virus was measured in a comparable manner. Thus, the intrinsic measurement error should be similar for each virus. In other words, each virus will have a similar increase in variability from measurement error. Thus, this error should not drive the observed differences in rVL heterogeneity, and the difference in heterogeneity in rVL between viruses should arise from the viruses. We have also revised the manuscript to describe this point, “While there is intrinsic measurement error in virus quantitation, based on the systematic review protocol and study design (as described above), this error should similarly increase heterogeneity in rVL for each virus, and the difference in heterogeneity in rVL between viruses should arise from the viruses.” (page 24, line 614-617).</p><disp-quote content-type="editor-comment"><p>5. The authors note that &quot;Talking, singing and coughing expelled virions at greater proportions via droplets (80.6-86.0%) than aerosols (14.0-19.4%).&quot; It should be noted that although more virions are expelled via droplets than aerosols according to the findings of this study, exposure to droplets and aerosols is not equal and this could affect the probability of transmission via these routes. For example, if social distancing and masking is observed then it is possible that larger droplets are more easily captured by masks or fall on the ground quickly and do not reach a susceptible individual, while aerosols do. Furthermore, smaller droplets and aerosols can penetrate more deeply into the lungs. It is as of yet unclear whether this would influence the probability of becoming (more severely) infected. This may also differ per virus. A discussion on these issues is relevant.</p><p>6. The authors also note that their results &quot;support aerosol spread as a transmission mode for SARS-CoV-2, including for conditional superspreading by highly infectious cases. However, with short durations of stay in well-ventilated areas, the exposure risk for aerosols, including long-range and buoyant ones, remains correlated with proximity to infectious cases.&quot;</p></disp-quote><p>As these two comments are related, we address them together. Based on the revised evaporation diameter factor from Reviewer Comment 9, our model now estimates that “Talking, singing and coughing expelled virions at comparable proportions via droplets (55.6-59.4%) and aerosols (40.6-44.4%)” (page 11, line 276-278).</p><p>The discussion mentioned by the reviewers, however, remains relevant. We have provided a more nuanced revision on abating droplet and aerosol transmission, as exposure to both droplets and aerosols is correlated with proximity. We have revised the manuscript based on reviewer comments 5 and 6, with this nuanced perspective in mind, and it now reads: “While talking, singing and coughing, our models indicate that SARS-CoV-2 is carried by droplets (55.6-59.4% of shed virions), short-range aerosols (30.1-34.9%), long-range aerosols (7.7-8.3%) and buoyant aerosols (0.01-6.5%). Transmission, however, requires exposure. For direct transmission, droplets tend to be sprayed ballistically onto susceptible tissue, whereas aerosols can be inhaled, may penetrate more deeply into the lungs and more easily facilitate superspreading events. However, with short durations of stay in well-ventilated areas, the exposure risk for both droplets and aerosols remains correlated with proximity to infectious cases (Liu, Li, et al., 2017; Prather et al., 2020). Strategies to abate infection should limit crowd numbers and duration of stay while reinforcing distancing, low-voice amplitudes and widespread mask usage; well-ventilated settings can be recognized as lower-risk venues.” (page 16-17, line 430-453).</p><disp-quote content-type="editor-comment"><p>7. A methodological note on the modelling that may affect the results (but likely do not impact the conclusions strongly) is the following.</p><p>The authors take a value of 0.1% for the fraction of SARS-CoV-2 RNA copies that represents viable virus (parameter γ). This value is quite uncertain. More literature (not yet peer-reviewed) exists on the fraction of SARS-CoV-2 RNA copies that is infectious virus, providing different values. Van Kampen et al. (2020) only found a cytopathic effect on Vero cells if the swab sample from patients contained more than 7 log<sub>10</sub> RNA copies/mL. Fears et al. (2020) find an average of 0.003 (range 0.0008 – 0.02) CCID50/RNA copy. However, Lednicky et al. (2020) sampled SARS-CoV-2-containing aerosols in a room with COVID-19 patients with air samplers using a water vapor condensation mechanism and as such collect virus particles without damaging them, and found an average of 0.6 CCID50/RNA copy, much higher. The model is likely sensitive to this parameter, and this could influence the result. These issues should be taken into account in the revision.</p></disp-quote><p>A 𝛾 of 0.1% is “equivalent to one viable copy in 3 log<sub>10</sub> copies/ml for rVL or, after dilution in transport media, roughly one in 4 log<sub>10</sub> copies/ml for specimen concentration” (page 29, line 724-725). For both influenza A and SARS-CoV-2, culture-positive virus has been found in the respiratory specimens considered in our study down to 4 log<sub>10</sub> copies/ml, “including from pediatric (L'Huillier et al., 2020) and asymptomatic (Arons et al., 2020) [COVID-19] cases” (page 29, line 729-730). Thus, we took 𝛾 to be “0.1% as a population-level estimate” (page 29, line 722) in our model. As the reviewer mentioned, despite the discussion above, there is still uncertainty in the estimate of 𝛾. We have revised the limitations section in our manuscript to convey this, which is quoted in the response to the next reviewer comment (#8), as we combined it with the added discussion from those reviewer comments.</p><p>As research on this topic develops and methodological advances continue to improve the characterization of 𝛾, we hope that the models introduced in our study can be used as an initial basis towards even more accurate estimations of the rate, and extent, to which respiratory activities shed infectious virus via droplets and aerosols.</p><disp-quote content-type="editor-comment"><p>8. Another methodological point is that more datasets in literature are available on the emission rates and size distribution of particles during breathing, speaking, coughing etc., than are currently used to base the model on. Schijven et al. (2020) compared seven datasets and found that they sometimes differ quite strongly. For example, the median volume of aerosol particles produced for coughing differs over two orders of magnitude when comparing two data sets. It is unclear what this difference represents, it might have to do with the sampling method. Furthermore, observed size distributions also differ in literature, with peak particle emission rates at different sizes. The authors should be aware that the choice of particle emission data for their study can impact their results strongly, and including discussion on the choice of data set and the implications on the results is warranted.</p></disp-quote><p>We have added discussion on this topic and in its implications (please note that we combined this with added discussion from the above reviewer comment, #7): “Furthermore, this study considered population-level estimates of the infectious periods, viability proportions and profiles for respiratory particles, which omit individual or environmental variation. […] Cumulatively, these sources of variation may influence the shedding model estimates, further increasing heterogeneity in individual infectiousness.” (page 16, line 417-429).</p><disp-quote content-type="editor-comment"><p>9. Taking 0.5 for the evaporation diameter factor is probably too large. Liu et al. (2017) find a value around one third for respiratory droplets from coughing, and the recent study on the evaporation of saliva droplets and aerosols by Lieber et al. (2021) find a value of 0.2 (for a range of temperature of 20-29 degrees C, and range of relative humidity of 6 – 65%). This likely matters for the result, as the difference between 0.5 and 0.2 leads to a factor ~15 change in droplet volume.</p></disp-quote><p>We have adjusted the evaporation diameter factor to “0.3”, as an approximation between the factors of 0.5 (Johnson et al., 2011), 0.32 (Liu et al., 2017) and 0.2 (Lieber et al., 2017), as described in the Methods: “In our models, we took the diameter of dehydrated respiratory particles to be 0.3 times the initial size when atomized in the respiratory tract (Johnson et al., 2011; Lieber, Melekidis, Koch, and Bauer, 2021; Liu, Wei, Li, and Ooi, 2017).” (page 31, line 767-769).</p><p>This revision led to updates in Figure 5, Figure 5—Figure supplement 1 and Figure 5—Figure supplement 2, as well as in the reporting of the model results based on particle size (see edits throughout page 10, line 207-216).</p><disp-quote content-type="editor-comment"><p>10. The kinetic model assumes that viral replication is controlled by the reduction of target cells over the course of the infection, but it neglects the effect of the immune system. This seems a rather strong assumption. What is the evidence for this in the case of SARS-CoV2? Also, it would be good if the authors could comment on the identifiability of the model parameters- especially the high uncertainty of the half-life of SARS-CoV2 in the respiratory tract (2.62-66hours) suggests that this might be a problem.</p></disp-quote><p>Our kinetic model (Equations. 4-6, page 26, line 671-673) is dynamical and involves one independent variable (DFSO represented by <italic>t</italic>); one explicit dependent variable (rVL represented by <italic>V</italic>); two implicit dependent variables (the number of uninfected target cells represented by <italic>T</italic>, and the number of productively infected cells represented by <italic>I</italic>); and four fitted parameters: <italic>β</italic> (infection rate constant)<italic>, p</italic> (cellular shedding rate of virus), <italic>c</italic> (clearance rate of virus) and <italic>δ</italic> (clearance rate of infected epithelial cells).</p><p>Thus, this model does account for the effect of the immune system. It accounts for viral RNA clearance by any mechanism (via <italic>c</italic>) or infected cells cleared by any mechanism (via <italic>δ</italic>), including by the immune system for both, as described by the system of equations (Equations 4-6, page 26, line 671-673).</p><p>We have revised the manuscript on SARS-CoV-2 half-life, as the reviewers mentioned, it is a confusing term when described in the body. Virus half-life in the respiratory tract was calculated by <inline-formula><mml:math id="inf52"><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>/</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mi>/</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> (page 27, line 678). As the fitted estimate of <italic>c</italic> was 3.30 (0.25-6.34) days<sup>-1</sup>, the lower range of the 95% CI is below 1. The half-life equation uses <italic>c</italic> in the denominator, meaning <italic>t<sub>1/2</sub></italic> is particularly sensitive to values of <italic>c</italic> below 1. To reduce confusion over this, we have reported the half-life in days, as it is <italic>c</italic>’s original unit: “the half-life of SARS-CoV-2 RNA before clearance from the respiratory tract was 0.21 (0.11-2.75) days” (page 8, line 177-178) and both <italic>c</italic> and <italic>t<sub>1/2</sub></italic> are included in Figure 4—Figure Supplement 4. We have included discussion on this: “The estimated half-life of SARS-CoV-2 RNA has a skewed 95% CI (Figure 4—Figure Supplement 4). As <inline-formula><mml:math id="inf53"><mml:mi>c</mml:mi></mml:math></inline-formula> is in the denominator of the equation for half-life (<inline-formula><mml:math id="inf54"><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>/</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mrow><mml:mn>2</mml:mn><mml:mi>/</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula>), <inline-formula><mml:math id="inf55"><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>/</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> is sensitive to <italic>c</italic> below one, which is the case for its lower 95% CI (Figure 4—Figure Supplement 4) and the source of the skew.” (page 28, line 697-700).</p><disp-quote content-type="editor-comment"><p>Additional points:</p><p>11. Line 453-454: &quot;log k = a(SD) + b, where a is the slope for association and b is the intercept&quot;. This appears to be a strange notation for this equation, isn't &quot;a*SD + b&quot; more logical?</p></disp-quote><p>This equation has been modified to &quot;a*SD + b&quot; (page 23, line 596).</p><disp-quote content-type="editor-comment"><p>12. Line 544-545: &quot;To estimate the average duration of shedding, we extrapolated the model to 0 log<sub>10</sub> copies/ml post-symptom onset.&quot; If the tail of the model is very long, it might take a very long time to reach 0 log<sub>10</sub>. Is this the case? And if yes, is perhaps a 95% decrease compared to the maximum a better measure for the duration of shedding?</p></disp-quote><p>The tail of the model was nearly linear (Figure 4D) and should not have an extended tail for this extrapolation.</p><disp-quote content-type="editor-comment"><p>13. Line 560: Is this unit correct? &quot;ρ is the material density of the respiratory particle (997 g/m3)&quot; Shouldn't this density be in kg/m3?</p></disp-quote><p>We appreciate the reviewers for spotting this typo. The material density has been corrected to 997 kg/m<sup>3</sup> (page 29, line 719).</p><disp-quote content-type="editor-comment"><p>14. Line 563 – 571: The estimate for γ for SARS-CoV-2 could turn out to be higher, if Lednicky et al. (2020) are to be believed. In any case, this warrants some further discussion in the paper, as the results are probably quite sensitive to this parameter!</p></disp-quote><p>We have addressed this in our response to reviewer comment 7, as both questions focus on the estimate for 𝛾. Please refer to that response.</p><disp-quote content-type="editor-comment"><p>15. Line 609 – 610: &quot;𝜌 is the material density of the respiratory particle (taken to be 1 g/cm3 based on the composition of dehydrated respiratory particles)&quot;. What is the reference for this statement? Zhang et al. (2011) find densities between 1.25 and 1.62 g/mL (Table 2). It seems logical that the drying process increases the density somewhat as compared to the density of water, as for instance the heavier salts do not evaporate.</p></disp-quote><p>The respiratory particles are atomized from the extracellular fluid in the respiratory tract, we considered the particles to be hydrated during atomization. The model approximated particle material density based on the density of water while hydrated.</p><disp-quote content-type="editor-comment"><p>16. Figure 2: this figure is somewhat unclear, maybe I do not understand it correctly. Why does one study have multiple standard deviations? And as there are only three values of k, regression seems to be an odd choice. A comparison between different groups of k seems more appropriate?</p></disp-quote><p>Each dot in this figure represents a separate study. We took the value of <italic>k</italic> for each virus based on our pooled estimates of <italic>k</italic> from the literature. Then, we used the SD in each study as an estimate of the heterogeneity in rVL for the respective virus in estimated infectious period. Thus, we performed a meta-regression based on the SD from each study identified in our systematic review (Figure 2—Figure supplement 1) or on the SD from each study that was assessed as having low risk of bias (Figure 2).</p></body></sub-article></article>